var data={"specialtyName":"Authors and Editors in Oncology","contributorTypes":[{"name":"Editors-in-Chief","contributors":[{"name":"George P Canellos, MD","credentials":["Editor-in-Chief — Oncology\n","Section Editor — Miscellaneous Tumors\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Lowell Schnipper, MD","credentials":["Editor-in-Chief — Oncology\n","Theodore W and Evelyn G Berenson Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Eviti [Quality/value of care (N/A)]."}]},{"name":"Deputy Editors","contributors":[{"name":"Michael E Ross, MD","credentials":["Senior Deputy Editor — UpToDate\n","Deputy Editor — Oncology"],"disclosure":""},{"name":"Diane MF Savarese, MD","credentials":["Senior Deputy Editor — UpToDate\n","Deputy Editor — Oncology and Palliative Care\n","Clinical Instructor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Sadhna R Vora, MD","credentials":["Deputy Editor — Oncology\n","Instructor in Medicine\n","Harvard Medical School"],"disclosure":""}]},{"name":"Section Editors","contributors":[{"name":"David M Aboulafia, MD","credentials":["Section Editor — AIDS-Related Malignancies\n","Section Head\n","Division of Hematology and Oncology\n","Virginia Mason Medical Center\n","Clinical Professor"],"disclosure":""},{"name":"Michael B Atkins, MD","credentials":["Section Editor — Malignant Melanoma and Other Cutaneous Neoplasms; Cancer of the Kidney\n","Deputy Director\n","Georgetown Lombardi Comprehensive Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: BMS [Melanoma and RCC (Nivolumab and ipilimumab)]; Roche [Melanoma (Vemurafenib and cobimetinib); RCC (Atezolizumab and bevacizumab)]; Novartis [Melanoma (Dabrafenib and trametinib); RCC (Pazopanib and everolimus)]. Consultant/Advisory Boards: BMS; Merck; Novartis; Pfizer; Roche; Exelixis; Eisai [Melanoma; RCC; immunotherapy (Everoliumus, pazopanib; dabrafenib/trametinib; axitinib, sunitinib, avelumab; vemurafenib/cobimetinib, atezolizumab; ipilimumab/nivolumab; pembrolizumab, interferon; cabozantinib; lenvatinib)]."},{"name":"David M Brizel, MD","credentials":["Section Editor — Radiation Therapy\n","Leonard R Prosnitz Professor of Radiation Oncology\n","Professor of Otolaryngology Head & Neck Surgery\n","Duke University Cancer Institute"],"disclosure":""},{"name":"Bruce E Brockstein, MD","credentials":["Section Editor — Cancer of the Head and Neck\n","Clinical Professor of Medicine\n","University of Chicago Pritzker School of Medicine"],"disclosure":"Consultant/Advisory Boards: Astra Zeneca [Immunotherapy - head and neck and melanoma (Durvalumab, tremelimumab)]; Bristol Meyers [Melanoma, head and neck cancer (Ipilimumab, nivolumab)]; Novartis [GIST, sarcoma, melanoma (Imatinib, Dabrafenib, trametinib)]."},{"name":"Harold Burstein, MD, PhD","credentials":["Section Editor — Breast Cancer\n","Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"George P Canellos, MD","credentials":["Editor-in-Chief — Oncology\n","Section Editor — Miscellaneous Tumors\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Thomas F DeLaney, MD","credentials":["Section Editor — Bone and Soft Tissue Tumors\n","Professor of Radiation Oncology\n","Harvard Medical School"],"disclosure":""},{"name":"Don S Dizon, MD, FACP","credentials":["Section Editor – Gynecologic Oncology\n","Head of Women's Cancers, Lifespan Cancer Institute\n","Director of Medical Oncology, Rhode Island Hospital\n","Associate Professor of Medicine, Warren Alpert Medical School of Brown University"],"disclosure":"Consultant/Advisory Boards: Pfizer; Fuji Pharmaceuticals [Chemotherapy (Biosimilars)]."},{"name":"Reed E Drews, MD","credentials":["Section Editor — Complications of Cancer\n","Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Patricia A Ganz, MD","credentials":["Section Editor — Cancer Survivorship\n","Professor\n","UCLA Schools of Medicine and Public Health\n","Jonsson Comprehensive Cancer Center"],"disclosure":""},{"name":"Barbara Goff, MD","credentials":["Section Editor — Gynecologic Oncology\n","Department Chair, Gynecologic Oncology\n","Surgeon-in-Chief\n","University of Washington Medical Center"],"disclosure":"Employment (Spouse): Lilly [General oncology (Gemcitabine, pemetrexed)] - No relevant conflict on topics."},{"name":"Richard M Goldberg, MD","credentials":["Section Editor — Gastrointestinal Cancer\n","Director of the West Virginia University Cancer Institute and the Mary Babb Randolph Cancer Center\n","Professor of Medicine \n","Laurence S. & Jean J. DeLynn Chair of Oncology"],"disclosure":"Grant/Research/Clinical Trial Support: Merck [Colon cancer (Pembrolizumab)]. Consultant/Advisory Boards: EMD Serono [Drug development (Multiple experimental agents)]; Taiho [Drug development (TAS 102)]; Merck [GI cancers (Pembrolizumab)]; Merck Serano [GI cancers (Multiple experimental agents)]."},{"name":"Daniel F Hayes, MD","credentials":["Section Editor — Breast Cancer\n","Professor of Medicine\n","University of Michigan School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Janssen R&D, LLC [Breast cancer (Abiraterone)]; Menarini Silicon Biosystems, LLC [Breast cancer (CellSearch)]; Puma Biotechnology [Breast cancer (Neratinib)]; Pfizer [Breast cancer (Palbociclib)]; AstraZeneca [Breast cancer (Circulating tumor cells)]; Eli Lilly and Company [Breast cancer]. Speaker's Bureau: Lilly Oncology (Breast cancer). Patent Holder: Immunicon Corporation [Inventor (05725638.0-1223-US2005008602)]; University of Michigan [Inventor (US 8,790,878 B2)]; University of Michigan [Inventor (US 8,951,484 B2)]. Equity Ownership/Stock Options: Oncimmune LLC [Stock]; Inbiomotion [Stock]. Other Financial Interest: Menarini Silicon Biosystems [Breast cancer (CellSearch)]; University of Michigan [Inventor (US 8,790,878 B2)]."},{"name":"Paul J Hesketh, MD","credentials":["Section Editor — Supportive Care\n","Chair, Lahey Health Cancer Institute\n","Director, Thoracic Oncology, Lahey Hospital and Medical Center\n","Professor of Medicine, Tufts University School of Medicine"],"disclosure":""},{"name":"James R Jett, MD","credentials":["Section Editor — Lung Cancer\n","Professor of Medicine Emeritus\n","National Jewish Health"],"disclosure":"Employment: Oncimmune [Biomarkers for early cancer detection (Early CDT-Lung blood test)]. Equity Ownership/Stock Options: Oncimmune [Biomarkers for early cancer detection (Early CDT-Lung blood test)]."},{"name":"Philip W Kantoff, MD","credentials":["Section Editor — Testicular Cancer\n","Chairman of Medicine\n","Memorial Sloan Kettering Cancer Center"],"disclosure":""},{"name":"W Robert Lee, MD, MS, MEd","credentials":["Section Editor — Prostate Cancer\n","Professor of Radiation Oncology\n","Duke University Medical Center"],"disclosure":""},{"name":"Seth P Lerner, MD","credentials":["Section Editor — Bladder Cancer\n","Beth and Dave Swalm Chair in Urologic Oncology\n","Professor of Urology\n","Baylor College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Endo; FKD; Viventia [Bladder cancer (Valrubicin, Ad/IFN, Viccinium)]. Consultant/Advisory Boards: Biocancell; UroGen; Vaxxion; Incyte; Nucleix [Bladder cancer (BC-819, Mitogel, Vesigel)]."},{"name":"Rogerio C Lilenbaum, MD, FACP","credentials":["Section Editor — Lung Cancer\n","Yale Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Celgene [Non-small cell lung cancer (Nab-paclitaxel)]. Consultant/Advisory Boards: Genentech [Lung cancer (Bevacizumab/erlotinib)]; Boehringer Ingelheim [Non-small cell lung cancer (Afatinib)]; Celgene [Non-small cell lung cancer (Nab-paclitaxel)]; AstraZeneca [Non-small cell lung cancer (Osimertinib)]."},{"name":"Robert Maki, MD, PhD","credentials":["Section Editor — Bone and Soft Tissue Tumors\n","Professor of Medicine \n","Monter Cancer Center\n","Hofstra-Northwell School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Bayer [Medical oncology (Regorafenib)]; Gem Pharmaceuticals [Medical oncology (GPX-150)]; Immune Design [Medical oncology (LV305+G305)]; Janssen/Pharma Mar [Medical oncology (Trabectedin)]; Karyopharm [Medical oncology (Selinexor)]; Sarcoma Alliance for Research through Collaboration (SARC) [Medical oncology (Regorafenib, pembrolizumab)], Tracon (TRC105). Speaker’s Bureau:  ABIM [Medical oncology]; Sarcoma Alliance for Research through Collaboration (SARC) [Medical oncology (Regorafenib, pembrolizumab)].  Consultant/Advisory Boards: ABIM [Medical oncology]; AADi [Medical oncology (Nab-rapamycin)]; Arcus (medical oncology); Bayer [Medical oncology (Regorafenib); Gem Pharmaceuticals [Medical oncology (GPX-150)]; Immune Design [Medical oncology (LV305+G305)]; Janssen/Pharma Mar [Medical oncology (Trabectedin)]; Karyopharm [Medical oncology (Selinexor)]; Lilly/Imclone [Medical oncology (Olaratumab)]; Sarcoma Alliance for Research through Collaboration (SARC) [Medical oncology (Regorafenib, pembrolizumab)]."},{"name":"David E Midthun, MD","credentials":["Section Editor — Lung Cancer\n","Professor of Medicine, Mayo Clinic College of Medicine"],"disclosure":""},{"name":"John W Mucenski, PharmD","credentials":["Section Editor — Chemotherapy Regimens\n","Director\n","Pharmacy Operations\n","UPMC Cancer Centers"],"disclosure":""},{"name":"Arno J Mundt, MD","credentials":["Section Editor — Radiation Therapy\n","Chairman of Radiation Oncology\n","University of California, San Diego"],"disclosure":""},{"name":"Larissa Nekhlyudov, MD, MPH","credentials":["Section Editor — Cancer Survivorship\n","Associate Professor\n","Department of Medicine\n","Brigham & Women’s Hospital\n","Harvard Medical School"],"disclosure":""},{"name":"William K Oh, MD","credentials":["Section Editor — Testicular Cancer\n","Professor of Medicine\n","Mount Sinai School of Medicine\n","Chief, Division of Hematology Oncology\n","Tisch Cancer Institute"],"disclosure":""},{"name":"Alberto S Pappo, MD","credentials":["Section Editor — Pediatric Oncology\n","Head of Solid Malignancies Program\n","St. Jude Children's Research Hospital"],"disclosure":""},{"name":"Lori J Pierce, MD","credentials":["Section Editor — Radiation Therapy\n","Professor of Radiation Oncology\n","University of Michigan School of Medicine"],"disclosure":""},{"name":"Jerome B Posner, MD","credentials":["Editor-in-Chief — Neurology\n","Section Editor — Neurooncology\n","Evelyn Frew American Cancer Society Clinical Research Professor\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":""},{"name":"Marshall R Posner, MD","credentials":["Section Editor — Cancer of the Head and Neck\n","Professor of Gene and Cell Medicine\n","The Tisch Cancer Institute\n","Icahn School of Medicine at Mount Sinai"],"disclosure":"Consultant/Advisory Boards: Merck [DMC (Pembro)]; Cel Sci [DMC (IL-2 injections)]."},{"name":"Derek Raghavan, MD, PhD, FACP, FASCO","credentials":["Section Editor — Bladder Cancer\n","President, Levine Cancer Institute\n","Carolinas HealthCare System\n","Charlotte, NC"],"disclosure":"Other Financial Interest: Caris Life Sciences [Molecular prognostication (Panomic sequencing - unpaid)]."},{"name":"Jerome P Richie, MD, FACS","credentials":["Section Editor — Cancer of the Urethra, Penis, and Ureter; Urologic Surgery; Prostate Cancer\n","Elliott Carr Cutler Professor of Surgery\n","Harvard Medical School"],"disclosure":""},{"name":"Steven E Schild, MD","credentials":["Section Editor — Radiation Therapy\n","Professor of Radiation Oncology\n","Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Kenneth K Tanabe, MD","credentials":["Section Editor — Gastrointestinal Malignancies\n","Professor of Surgery\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Nimbus Therapeutics [Hepatocellular carcinoma (ND654, Acetyl Co-A Carboxylase allosteric inhibitor)]. Consultant/Advisory Boards: Best Doctors [GI cancers; melanoma (Medical care)]; CRICO [Medical malpractice (Case review)]. Patent Holder: EGF SNP to determine risk for HCC [Cirrhosis, hepatocellular carcinoma]; Use of EGFR inhibitors to prevent HCC [Cirrhosis, hepatocellular carcinoma]. Equity Ownership/Stock Options: Helix12 [Breast cancer (Company owns IP on selective estrogen receptor modulators for breast cancer)]."},{"name":"Eric Vallières, MD, FRCSC","credentials":["Section Editor — Lung Cancer\n","Surgical Director of the Lung Cancer Program\n","Swedish Cancer Institute"],"disclosure":""},{"name":"Nicholas Vogelzang, MD","credentials":["Section Editor — Prostate Cancer\n","Professor of Medicine\n","University of Nevada School of Medicine\n","US Oncology Research"],"disclosure":"Speaker's Bureau: Pfizer [Kidney cancer (Sunitinib, axitinib)]; Bayer [Prostate cancer (Radium 223)]; Novartis [Kidney cancer, PNET (Pazopanib, everolimus); Sanofi [Prostate cancer (Cabazitaxel)], BMS [Kidney cancer (BMS-nivolumab)]; Genentech/Roche [Bladder cancer (Atezolizumab); Astra Zeneca {Bladder cancer (durvalumab)]. Consultant/Advisory Boards: Amgen [Prostate cancer (Denosumab)]; Bayer [Prostate cancer (Radium 223)]; Pfizer [Kidney cancer (Sunitinib, axitinib)]; Novartis [Kidney cancer, PNET (Pazopanib, everolimus)]; Sanofi [Prostate cancer (cabazitaxel)]; BMS [Kidney cancer (BMS-nivolumab)]; Genentech/Roche (Bladder cancer (Atezolizumab)]; Astra Zeneca {Bladder cancer (durvalumab)]   Exelexis [Kidney cancer (Cabozantinib)];  Clinical Care Options, Cerulean [Kidney cancer (Liposomal irinotecan)]; Dava Oncology/PER; Dendreon; Medivation/Astellas [Prostate (Enzalutamide)], Janssen [Prostate cancer (Abiraterone,apalutamide)]; Heron [Nausea control (Liposomal granisetron)]; Eisai [Kidney cancer (Levantinib)]; Agensys [Kidney cancer (New targeted agent)]; Boehringer Ingelheim [Mesothelioma (Nerantinib)]. Employment: US Oncology [GU research (none)].  Equity Ownership/Stock Options: Caris [Genetic testing for cancer (none)]."},{"name":"David E Wazer, MD","credentials":["Section Editor — Radiation Therapy\n","Professor of Radiation Oncology\n","Tufts University School of Medicine\n","Brown University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Advanced Radiation Therapy, LLC [Breast cancer treatment (Brachytherapy device)]."},{"name":"Howard J West, MD","credentials":["Section Editor — Lung Cancer\n","Medical Director\n","Thoracic Oncology Program\n","Swedish Cancer Institute (Seattle)"],"disclosure":"Speaker’s Bureau: BristolMyersSquibb [Non-small cell lung cancer (Nivolumab)]; Genentech/Roche [Non-small cell lung cancer (Atezolizumab)]. Consultant/Advisory Boards: AstraZeneca [Non-small cell lung cancer (Gefitinib)]; Boehringer-Ingelheim [Non-small cell lung cancer (Afatinib)]; BristolMyersSquibb [Non-small cell lung cancer (Nivolumab)]; Celgene [Non-small cell lung cancer (nab-paclitaxel)]; Genentech/Roche [Non-small cell lung cancer (Alectinib, Atezolizumab, Erlotinib)]; Merck [Non-small cell lung cancer (Pembrolizumab)]; Novartis [Non-small cell lung cancer (Ceritinib)]; Pfizer [Non-small cell lung cancer (Crizotinib)]; Takeda [Non-small cell lung cancer (nab-Paclitaxel, dabrafenib, trametinib, durvlumab)]."},{"name":"Christopher G Willett, MD","credentials":["Section Editor — Radiation Therapy\n","Professor\n","Duke University Medical School"],"disclosure":"Consultant/Advisory Boards: Entrinsic Health [Esophageal, stomach,  pancreatic, and colorectal cancer and GIST (Amino acid medical foods, a liquid solution that may improve mucosal reactions to chemotherapy and radiation therapy)]."}]},{"name":"Editorial Assistants","contributors":[{"name":"Laura Blockhus, BA","credentials":["Editorial Assistant — UpToDate"],"disclosure":""},{"name":"Cara Rapoport, BA","credentials":["Senior Editorial Assistant — UpToDate"],"disclosure":""}]},{"name":"Authors","contributors":[{"name":"Sumaira Z Aasi, MD","credentials":["Professor\n","Department of Dermatology\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Eddie K Abdalla, MD","credentials":["Professor of Surgery\n","The Lebanese American University"],"disclosure":""},{"name":"Ghassan K Abou-Alfa, MD","credentials":["Associate Attending\n","Memorial Sloan Kettering Cancer Center\n","Associate Professor\n","Weill Cornell Medi"],"disclosure":"Grant/Research/Clinical Trial Support: CASI Pharmaceuticals [Fibrolamellar cancer (ENMD-2076)]. Consultant/Advisory Boards: CASI Pharmaceuticals [Fibrolamellar cancer (ENMD-2076)]; Blueprint [Fibrolamellar cancer]; Aslan [Fibrolamellar cancer]; Puma Biotechnbology [Fibrolamellar cancer (Neratinib)]."},{"name":"David H Abramson, MD, FACS","credentials":["Professor of Ophthalmology\n","Weill-Cornell Medical School\n","Chief\n","Ophthalmic Oncology Service\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":""},{"name":"Nadeem R Abu-Rustum, MD","credentials":["Professor of Obstetrics & Gynecology\n","Weill Cornell Medical College\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":""},{"name":"M Jacob Adams, MD, MPH","credentials":["Associate Professor (retired)\n","University of Rochester School of Medicine and Dentistry"],"disclosure":""},{"name":"Tomer Adar, MD","credentials":["Research Fellow, Gastroenterology Division\n","Massachusetts General Hospital\n","Senior Gastroenterologist, Digestive Diseases Institute \n","Senior Physician in Internal Medicine, Shaare-Zedek Medical Center\n","Hebrew University, Jerusalem, Israel"],"disclosure":"Research Support: Synageva [Hepatic steatosis (Sebelipase alfa)]. Consultant/Article Writing: Janssen Pharmaceuticals [IBD (Infliximab)]. Web Editor: United European Gastroenterology [Gastroenterology and Hepatology]. Lectures: Shire International [Gaucher disease (Velaglucerase alfa)]."},{"name":"Anjali S Advani, MD","credentials":["Director, Inpatient Leukemia Unit\n","Associate Professor, Cleveland Clinic Lerner College of Medicine\n","Staff, Department of Hematology/Oncology\n","Taussig Cancer Institute, The Cleveland Clinic"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen (ALL [blinotumomab]); Pfizer (ALL [inotuzumab]). Consultant/Advisory Boards: Pfizer (ALL [inotuzumab])."},{"name":"Maryam Rafael Aghalar, DO","credentials":["Attending Physician\n","Nassau University Medical Center"],"disclosure":""},{"name":"Ebtesam Ahmed, PharmD, MS","credentials":["Clinical Professor,\n","St. John's University College of Pharmacy\n","Clinical Pharmacy Specialist Innovative Institute for Palliative Care"],"disclosure":""},{"name":"Dennis J Ahnen, MD","credentials":["Director, Genetics Clinic\n","Gastroenterology of the Rockies"],"disclosure":"Speaker's Bureau: Ambry Genetics [Genetic testing (Genetic testing laboratory)]. Consultant/Advisory Boards: Cancer Prevention Pharmaceuticals [Chemoprevention (DFMO for chemoprevention)]."},{"name":"Vivek N Ahya, MD","credentials":["Assistant Professor of Medicine\n","University of Pennsylvania School of Medicine"],"disclosure":""},{"name":"Wei Ai, MD, PhD","credentials":["Clinical Associate Professor of Medicine\n","University of California, San Francisco"],"disclosure":""},{"name":"H Richard Alexander, Jr, MD","credentials":["Chief Surgical Officer,\n","Rutgers Cancer Institute of New Jersey\n","Professor, Department of Surgery,\n","Rutgers Robert Wood Johnson Medical School"],"disclosure":""},{"name":"Tarek Alhamad, MD, MS, FACP, FASN","credentials":["Assistant Professor of Medicine\n","Washington University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Mallinckrodt [Nephrotic syndrome (ACTH gel)]; Angion [BB3 analogue]. Speaker's Bureau: Veloxis [Immunosuppression medications (Tacrolimus XR)]. Consultant/Advisory Board: Veloxis [Immunosuppression medications (Tacrolimus XR)]."},{"name":"Larry Allen, MD, MHS","credentials":["Associate Professor of Medicine\n","Medical Director, Advanced Heart Failure and Transplantation\n","University of Colorado School of Medicine"],"disclosure":"Grant/Research Support: PCORI [Patient decision aid for LVAD]; NIH [Post-hospitalization transitions]; AHA [Patient engagement too for medication use]. Consultant/Advisory Boards: ACI [Clinical events adjudication committee (BNP assay)]; Boston Scientific [Steering committee MANAGE-HF]; Duke Clinical Research Institute [Steering committee CONNECT-HF]; Cytokinetics [Publication committee]; Jannsen [Steering committee ORBIT registry (Rivaroxiban)]; Novartis [Clinical events adjudication committee (Serelaxin)]."},{"name":"John Allendorf, MD, FACS","credentials":["Associate Professor of Surgery\n","SUNY Stony Brook\n","Vice Chairman of Surgery\n","Winthrop University Hospital"],"disclosure":""},{"name":"Maha Ali Al-Mohaya, BDS, MS, DMSc, ABOM","credentials":["Diplomate of American Board of Oral Medicine\n","Head of Oral Medicine\n","Department of Dentistry\n","Riyadh Military Hospital\n","Riyadh College of Dentistry and Pharmacy\n","Saudi Arabia"],"disclosure":""},{"name":"Richard F Ambinder, MD, PhD","credentials":["James B Murphy Professor of Oncology\n","Johns Hopkins School of Medicine"],"disclosure":"Consultant/Advisory Boards: Bristol-Myers Squibb [Cancer drugs (Checkpoint inhibitors)]; Viracta [Cancer drugs (Therapeutic trial for unlicensed drug)]; Cellgenesis [Cancer drugs (Imides, proteasome inhibitors)]; National Comprehensive Cancer Network [Hodgkin lymphoma, HIV malignancy)]."},{"name":"Robert J Amdur, MD","credentials":["Professor\n","Department of Radiation Oncology\n","University of Florida College of Medicine"],"disclosure":""},{"name":"Carey K Anders, MD","credentials":["Assistant Professor \n","University of North Carolina - Chapel Hill\n","Lineberger Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [Breast cancer (Everolimus)]; Sanofi [Breast cancer (Iniparib)]; to-BBB [Breast cancer (Iniparib, 2B3101)]; GERON [Breast cancer (GRN1005)]; Angiochem [Breast cancer (ANG1005)]; Merrimack Pharmaceuticals [Breast cancer (MM398, MM302)]; PUMA [Breast cancer (Neratinib)]; Lilly [Breast cancer (Abemacilib)]; Merck [Breast cancer (Pembrolizumab)]; Oncothyreon [Breast cancer (ONT380)]; TESARO [Breast cancer (Preclinical, Niraparib/Pembro)]; Cascadian Therapeutics; Nektar Therapeutics [Breast cancer]. Consultant/Advisory Boards: Novartis [Breast cancer and/or brain metastases (Everolimus)]; Sanofi [Breast cancer and/or brain metastases (Iniparib)]; to-BBB [Breast cancer and/or brain metastases (2B3101)]; GERON [Breast cancer and/or brain metastases (GRN1005)]; Angiochem [Breast cancer and/or brain metastases (ANG1005)]; Merrimack Pharmaceuticals [Breast cancer and/or brain metastases (MM398, MM302)]; Lilly [Breast cancer and/or brain metastases (Abemacilib)]; Genentech [Breast cancer and/or brain metastases (Etirinotecan pegol)]; Nektar Therapeutics [Breast cancer and/or brain metastases (KD019)]; Kadmon Corporation, LLC [Breast cancer and/or brain metastases (KD019)]."},{"name":"Christopher D Anderson, MD, FACS","credentials":["James D. Hardy Professor and Chair, Department of Surgery\n","Chief, Transplant and Hepatobiliary Surgery\n","University of Mississippi Medical Center"],"disclosure":""},{"name":"Stephan Anderson, MD","credentials":["Professor of Radiology\n","Boston University School of Medicine"],"disclosure":""},{"name":"Stephen M Ansell, MD, PhD","credentials":["Professor of Medicine, Division of Hematology\n","Mayo Clinic"],"disclosure":"Grant/Research/Clinical Trial Support: Bristol Myers Squibb, Merck [immune checkpoint inhibitors (nivolumab, pembrolizumab)]."},{"name":"Emmanuel S Antonarakis, MD","credentials":["Associate Professor of Oncology and Urology\n","Sidney Kimmel Comphrehensive Oncology Center\n","Johns Hopkins University"],"disclosure":""},{"name":"Gerald B Appel, MD","credentials":["Section Editor — Glomerular Diseases\n","Professor of Medicine\n","Columbia University College of Physicians and Surgeons"],"disclosure":"Grant/Research/Clinical Trial Support: Regulus Therapeutics [Alport syndrome (RG-012, for injection)]; Bristol-Myers Squibb [Focal Segmental Glomerulosclerosis (Abatacept)]; Achillion [C3 Glomerulopathies (ACH-0144471, tablets)]; EMD Serono [Immunoglobulin A nephropathy (Atacicept)]; Reatta [Alport syndrome (Bardoxolone)]; Mallinkrodt [Focal Segmental Glomerulosclerosis (Corticotropin)]; Chemocentryx [C3 Glomerulopathies (Avacopan)]; Chemocentryx [Anti-Neutrophil Cytoplasmic Antibody Vasculitis (Avacopan)]. Speaker's Bureau: Genentech [Vasculitis (Rituximab)]; Sanofi [Side effects (Alemtuzumab)]. Consultant/Advisory Boards: Genentech; Takeda Pharmaceuticals; Bristol-Myers Squibb; Mallinckrodt Pharmaceuticals; EMD Serono; Merck; Pfizer; Genzyme-Sanofi; Omeros; Achillion Pharmaceuticals; Ionis; Reatta; Chemocentryx [Immunosuppressives (Drugs under development for immunosuppression)]."},{"name":"Selim M Arcasoy, MD","credentials":["Associate Professor of Clinical Medicine\n","Columbia University School of Medicine\n","Medical Director, Lung Transplantation Program"],"disclosure":"Grant/Research/Clinical Trial Support: CMS Pharma Co., Ltd, Therakos, Inc. [Bronchiolitis obliterans syndrome (Extracorporeal photopheresis)]."},{"name":"Charlotte Ariyan, MD, PhD","credentials":["Associate Attending\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":""},{"name":"April W Armstrong, MD, MPH","credentials":["Associate Dean for Clinical Research\n","Department of Dermatology\n","University of Southern California"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen; AbbVie; Janssen; Eli Lilly and Company [Psoriasis (Etanercept, adalimumab, ustekinumab, ixekizumab)]. Speaker's Bureau: AbbVie; Eli Lilly and Company; Janssen [Psoriasis (Adalimumab, ixekizumab, guselkumab)]. Consultant/Advisory Boards: AbbVie; Janssen; Pfizer; Celgene; Novartis; Eli Lilly and Company; Sanofi; Regeneron [Psoriasis (Adalimumab, ustekinumab, tofacitinib, apremilast, tildrakizumab, ixekizumab, dupilumab)]."},{"name":"Deborah K Armstrong, MD","credentials":["Professor of Oncology\n","Professor of Gynecology & Obstetrics\n","Johns Hopkins Kimmel Cancer Center"],"disclosure":"Research Support: Genentech [endometrial carcinoma]; Medimmune [advanced solid tumors]; Clovis [ovarian cancer]; AstraZeneca [ovarian cancer]; Tesaro [endometrial cancer]; Syndax [ovarian cancer]; Pfizer [ovarian cancer]. Consultant/Advisory Boards: Cue Biopharma [cervical cancer]."},{"name":"Andrew Arnold, MD","credentials":["Murray-Heilig Professor of Molecular Medicine\n","University of Connecticut"],"disclosure":""},{"name":"Monish Aron, MD, MCh, FRCS","credentials":["Professor of Clinical Urology\n","Co-Director, Robotic Surgery & Advanced Laparoscopy\n","USC Institute of Urology, Keck School of Medicine\n","University of Southern California"],"disclosure":"Consultant/Advisory Boards: Baxter [Hemostasis (drug not relevant)]; Boston Scientific [AUS, IPP after RRP (drug not relevant)]."},{"name":"Maryam Asgari, MD, MPH","credentials":["Associate Professor\n","Massachusetts General Hospital at Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Psoriasis (Anti-tumor necrosis factor-alpha inhibitor, immunosuppressants)]; Valeant [Atopic dermatitis (Pimecrolimus, topical corticosteroid, topical calcineurin inhibitor)]."},{"name":"Stanley W Ashley, MD","credentials":["Section Editor — Pancreatic and Hepatobiliary Surgery\n","Chief Medical Officer and Senior Vice President for Clinical Affairs\n","Brigham and Women’s Hospital\n","Frank Sawyer Professor of Surgery\n","Harvard Medical School"],"disclosure":""},{"name":"Jon C Aster, MD","credentials":["Professor of Pathology\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Regeneron [Hematologic malignancies (Notch inhibitors)]; Lilly [Hematologic malignancies (Notch inhibitors)]; Cellestia [Hematologic malignancies (Notch inhibitors)]; Anastasis [Hematologic malignancies (Notch inhibitors)]. Equity Ownership/Stock Options: Cellestia; Anastasis."},{"name":"Ajlan Atasoy, MD","credentials":["Assistant Professor\n","GI Oncology\n","Department of Medicine\n","Roswell Park Cancer Institute"],"disclosure":"Consultant/Advisory Boards: Boston Biomedical [Oncology (Napabucasin)]."},{"name":"Michael B Atkins, MD","credentials":["Section Editor — Malignant Melanoma and Other Cutaneous Neoplasms; Cancer of the Kidney\n","Deputy Director\n","Georgetown Lombardi Comprehensive Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: BMS [Melanoma and RCC (Nivolumab and ipilimumab)]; Roche [Melanoma (Vemurafenib and cobimetinib); RCC (Atezolizumab and bevacizumab)]; Novartis [Melanoma (Dabrafenib and trametinib); RCC (Pazopanib and everolimus)]. Consultant/Advisory Boards: BMS; Merck; Novartis; Pfizer; Roche; Exelixis; Eisai [Melanoma; RCC; immunotherapy (Everoliumus, pazopanib; dabrafenib/trametinib; axitinib, sunitinib, avelumab; vemurafenib/cobimetinib, atezolizumab; ipilimumab/nivolumab; pembrolizumab, interferon; cabozantinib; lenvatinib)]."},{"name":"Edward K Avila, DO","credentials":["Associate Clinical Member, Department of Neurology\n","Memorial Sloan Kettering Cancer Center"],"disclosure":""},{"name":"Lisen Axell, MS, CGC","credentials":["Genetic Counselor\n","University of Colorado Comprehensive Cancer Center"],"disclosure":""},{"name":"Floor J Backes, MD","credentials":["Assistant Professor\n","Division of Gynecologic Oncology \n","Department of Obstetrics and Gynecology \n","The Ohio State University College of Medicine"],"disclosure":""},{"name":"Rebecca N Baergen, MD","credentials":["Professor of Clinical Pathology and Laboratory Medicine\n","Weill Medical College of Cornell University"],"disclosure":""},{"name":"Armita Bahrami, MD","credentials":["St. Jude Children’s Research Hospital\n","University of Tennessee Health Science Center"],"disclosure":""},{"name":"F Amos Bailey, MD","credentials":["Professor of Medicine \n","University of Colorado at Denver"],"disclosure":""},{"name":"Elizabeth H Baldini, MD, MPH","credentials":["Associate Professor of Radiation Oncology\n","Harvard Medical School"],"disclosure":""},{"name":"Robert A Balk, MD","credentials":["Professor of Medicine\n","Rush-University Medical Center"],"disclosure":""},{"name":"Douglas W Ball, MD","credentials":["Associate Professor of Medicine and Oncology\n","Johns Hopkins University School of Medicine"],"disclosure":""},{"name":"Jose Banchs, MD, FACC, FASE","credentials":["Director of Echocardiography\n","Associate Professor of Medicine\n","Cardiology Department\n","University of Texas \n","MD Anderson Cancer Center"],"disclosure":""},{"name":"Anindo K Banerjee, PhD, FRCP","credentials":["Consultant Respiratory Physician\n","Southampton General Hospital, Southampton, UK"],"disclosure":""},{"name":"Victoria Banuchi, MD, MPH","credentials":["Assistant Professor of Otolaryngology\n","Weill Cornell Medical College"],"disclosure":""},{"name":"Benjamin Barankin, MD, FRCPC","credentials":["Dermatologist, Medical Director \n","Toronto Dermatology Centre, Toronto, Canada"],"disclosure":""},{"name":"Aditya Bardia, MD, MPH","credentials":["Attending Physician\n","Massachusetts General Hospital Cancer Center\n","Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Novartis [Breast cancer (Letrozole)]; Pfizer [Breast cancer (Exemestane)]."},{"name":"Carlton C Barnett, Jr, MD","credentials":["Professor of Surgery\n","University of Colorado at Denver"],"disclosure":""},{"name":"Tracy Batchelor, MD, MPH","credentials":["Giovanni Armenise Professor of Neurology\n","Harvard Medical School"],"disclosure":"Grant/Research Support: Pfizer [Glioblastoma]. Consultant/Advisory Boards: Merck [Glioblastoma (temozolomide)]; Proximagen/Upsher [Glioblastoma]; Roche [Glioblastoma (rituximab)]; Oxigene [Glioblastoma]; Cavion [Glioblastoma]; Accerta [Lymphoma]; Amgen [Glioblastoma]; Genomicare [Brain tumors (diagnostic testing)]. Other Financial Interest: Oakstone Publishing; Champions Biotechnology; Imedex [Neuro-Oncology CME/Education (Educational Material)]."},{"name":"Clair J Beard, MD","credentials":["Associate Professor of Radiation Oncology\n","Harvard Medical School"],"disclosure":""},{"name":"Tanios Bekaii-Saab, MD","credentials":["Program Co-Director, GI Cancers, Mayo Clinic Cancer Center\n","Senior Associate Consultant , Mayo Clinic, Phoenix AZ\n","Professor, Mayo College of Medicine and Science"],"disclosure":""},{"name":"Joaquim Bellmunt, MD, PhD","credentials":["Associate Professor of Medicine, Harvard Medical School\n","GU Oncology Research Coordinator PSMAR\n","Director, IMIM-Hospital del Mar Medical Research Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech; Merck; Sanofi [Urothelial cancer (Pembrolizumab)]; Novartis, Sanofi [Research support (Urothelial cancer); Merck, Genentech, Bioclin [Clinical trial support (Urothelial cancer). Consultant/Advisory Boards: Genentech, Merck, Pfizer, Sanofi, Astra-Zeneca, Bioclin (Urothelial cancer)."},{"name":"Jennifer R Bellon, MD","credentials":["Associate Professor of Radiation Oncology\n","Harvard Medical School"],"disclosure":""},{"name":"Johanna Bendell, MD","credentials":["Director\n","GI Oncology Research\n","Sarah Cannon Research Institute"],"disclosure":""},{"name":"Jonathan S Berek, MD, MMS","credentials":["Laurie Kraus Lacob Professor\n","Stanford University School of Medicine\n","Fellow, Stanford Distinguished Careers Institute\n","Director, Stanford Women's Cancer Center\n","Senior Scientific Advisor, Stanford Cancer Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Tesaro, Inc. [Gynecologic cancers (Niraparib)]."},{"name":"James R Berenson, MD","credentials":["Medical and Scientific Director\n","Institute for Myeloma and Bone Cancer Research"],"disclosure":""},{"name":"Jonas Bergh, MD, PhD, FRCP (London UK)","credentials":["Professor of Oncology (Mimi Althainz´donation)\n","Karolinska Institutet and University Hospital\n","Cancer Center Karolinska\n","Stockholm, Sweden"],"disclosure":"Grant/Research/Clinical Trial Support: Karolinska Institutet/Karolinska University Hospital; Amgen; AstraZeneca; Bayer; Merck; Pfizer; Roche; Sanofi-Aventis [Breast cancer (Molecular markers)]."},{"name":"Amanda Bergner, MS, CGC","credentials":["Associate Professor of Genetics and Development\n","Columbia University"],"disclosure":""},{"name":"Emily Bergsland, MD","credentials":["Professor of Medicine \n","University of California San Francisco"],"disclosure":"Grant/Research/Clinical Trial Support: Lexicon [Carcinoid (telotristat)]; Merck [Carcinoid/panNET (Pembrolizumab)]; Novartis [Carcinoid/pNET]. Consultant/Advisory Board: Lexicon [Carcinoid (telotristat)]; Ipsen [ Neuroendocrine tumors (lanreotide)]; Exelixis [Carcinoid/panNET (cabozantinib)]."},{"name":"Ross S Berkowitz, MD","credentials":["William H. Baker Professor of Gynecology\n","Harvard Medical School\n","Director of Gynecologic Oncology and Gynecology     \n","Brigham and Women's Hospital and Dana Farber Cancer Institute\n","Co-Director\n","New England Trophoblastic Disease Center"],"disclosure":""},{"name":"Mark F Berry, MD","credentials":["Associate Professor\n","Department of Cardiothoracic Surgery\n","Stanford University"],"disclosure":"Consultant/Advisory Boards: Verb Surgical [surgical robot]."},{"name":"Simon Best, MD","credentials":["Assistant Professor \n","Johns Hopkins Department of Otolaryngology – Head and Neck Surgery"],"disclosure":""},{"name":"Mihir K Bhayani, MD, FACS","credentials":["Clinical Assistant Professor\n","Department of Surgery, University of Chicago Pritzker School of Medicine\n","Division of Otolaryngology, NorthShore University HealthSystem"],"disclosure":""},{"name":"Jonathan Bijron, MD","credentials":["University Medical Center Utrecht, The Netherlands"],"disclosure":""},{"name":"Mark Bilsky, MD","credentials":["Attending Neurologic Surgeon\n","Memorial Sloan-Kettering Cancer Center\n","Professor Neurologic Surgery\n","Weill Medical College of Cornell University"],"disclosure":""},{"name":"Kenneth F Binmoeller, MD, FASGE, FACG","credentials":["Director, Interventional Endoscopy\n","California Pacific Medical Center, San Francisco"],"disclosure":""},{"name":"Marc Birkhahn, MD","credentials":["Urologie am Ring\n","Cologne"],"disclosure":""},{"name":"Michael J Birrer, MD, PhD","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Roche Pharmaceuticals [Ovarian cancer]."},{"name":"Peter Black, MD, FACS, FRCSC","credentials":["Khosrowshahi Chair in Bladder Cancer Research\n","Professor\n","Department of Urologic Sciences\n","University of British Columbia\n","Vancouver Prostate Centre"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech; NewB; Innovation; iProgen [Bladder cancer (Atezolizumab, investigational agents)]. Consultant/Advisory Boards: AbbVie [Prostate cancer (Leuprolide)]; Astellas [Prostate/bladder cancer (Enzalutamide)]; Bayer [Prostate cancer (Alpharadin)]; Biocancell [Bladder cancer (BC819)]; Ferring [Nocturia (DDAVP)]; Janssen [Prostate cancer (Abiraterone)]; Lilly [Bladder cancer (Drug pipeline)]; Merck [Post-op ileus (Alvimopan)]; Sanofi [Prostate cancer (Leuprolide)]; Sitka [Bladder cancer (STK-01)]; Spectrum [Bladder cancer (Apaziquone)]; Allergan [Prostate cancer (Triptorelin pamoate)]; Biosyent [Bladder cancer (Hexaminolevulinate hydrochloride)]. Patent Holder: GenomeDx [Bladder cancer (Gene signature biomarker)]."},{"name":"Ronald Bleday, MD","credentials":["Associate Professor of Surgery\n","Harvard Medical School"],"disclosure":""},{"name":"Ira J Bleiweiss, MD","credentials":["Professor of Pathology\n","Perelman School of Medicine\n","University of Pennsylvania\n","Subspecialty Director, Breast Pathology\n","Section of Surgical Pathology\n","Hospital of the University of Pennsylvania Founders 6"],"disclosure":""},{"name":"Sharon L Bober, PhD","credentials":["Assistant Professor of Psychiatry\n","Harvard Medical School"],"disclosure":""},{"name":"Bernard H Bochner, MD","credentials":["Attending Surgeon , Urology Service\n","Vice Chairman, Department of Surgery\n","Memorial Sloan-Kettering Cancer Center\n","Professor of Urology\n","Weill Medical College of Cornell University"],"disclosure":""},{"name":"Almut Böer-Auer, MD","credentials":["Director of Academics, Dermatologikum Hamburg\n","Lecturer, Westfälischen Wilhelms-Universität Münster"],"disclosure":""},{"name":"Jeffrey A Bogart, MD","credentials":["Professor & Chair\n","Department of Radiation Oncology\n","Upstate Medical University"],"disclosure":""},{"name":"Peter A L Bonis, MD","credentials":["Chief Medical Officer of Clinical Effectiveness (UpToDate, Clinical Drug Information, and Emmi Solutions)\n","Deputy Editor — Gastroenterology/Hepatology\n","Adjunct Professor of Medicine\n","Tufts University School of Medicine"],"disclosure":""},{"name":"Barry A Borlaug, MD","credentials":["Section Editor — Heart Failure\n","Professor of Medicine\n","Mayo Clinic College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: AstraZeneca; Corvia; MAST Therapeutics; Medtronic; Mesoblast; GlaxoSmithKline; Novartis [Heart failure]. Consultant/Advisory Boards: Actelion; Amgen; Merck; AstraZeneca; MyoKardia [Heart failure]."},{"name":"Judith VMG Bovée, MD, PhD","credentials":["Pathologist\n","Professor of Pathology\n","Leiden University Medical Center"],"disclosure":""},{"name":"Carol R Bradford, MD, FACS","credentials":["Professor and Chair\n","Department of Otolaryngology-Head and Neck Surgery\n","University of Michigan"],"disclosure":""},{"name":"Kristin A Bradley, MD","credentials":["Associate Professor\n","University of Wisconsin School of Medicine and Public Health"],"disclosure":""},{"name":"Carlos E Bravo Iniguez, MD","credentials":["Fellow, Center for Surgery and Public Health\n","Brigham and Women's Hospital"],"disclosure":""},{"name":"Miriam Bredella, MD","credentials":["Associate Professor of Radiology\n","Harvard Medical School\n","Massachusetts General Hospital"],"disclosure":""},{"name":"William Breitbart, MD","credentials":["Professor of Clinical Psychiatry\n","Weill Medical College of Cornell University\n","Chairman\n","Department of Psychiatry and Behavioral Sciences\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":""},{"name":"Daniel C Brennan, MD, FACP","credentials":["Editor-in-Chief — Nephrology\n","Section Editor — Renal Transplantation\n","Professor of Medicine\n","Medical Director and Co-Director of the Comprehensive Transplant Center, Department of Internal Medicine, Division of Nephrology\n","Johns Hopkins Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Alexion; CareDx; Oxford Immunotech; Veloxis [Atypical hemolytic uremic syndrome, antibody mediated rejection, delayed graft function, immunosuppression, induction (Eculizumab, tacrolimus, belatacept, rituximab, mycophenolate, antithymocyte globulin)]. Speaker's Bureau: Alexion; Sanofi; Novartis; Veloxis [Atypical hemolytic uremic syndrome, antibody mediated rejection, long-term outcomes, immunosuppression, induction (Eculizumab, tacrolimus, belatacept, rituximab, mycophenolate, valganciclovir, antithymocyte globulin)]. Consultant/Advisory Boards: Alexion; Sanofi; Veloxis [Atypical hemolytic uremic syndrome, antibody mediated rejection, long-term outcomes, immunosuppression, induction (Eculizumab, tacrolimus, antithymocyte globulin)]."},{"name":"Tim Brenner, PharmD, BCOP","credentials":["Clinical Pharmacy Specialist\n","UPMC Cancer Centers"],"disclosure":""},{"name":"Molly Brewer, DVM, MD, MS","credentials":["Professor\n","Chief\n","Division of Gynecologic Oncology\n","Department of Obstetrics and Gynecology\n","Carole and Ray Neag Comprehensive Cancer Center\n","University of Connecticut Health Center"],"disclosure":""},{"name":"James D Brierley, MB, BS, FRCP, FRCR, FRCPC","credentials":["Professor\n","Department of Radiation Oncology\n","University of Toronto, Canada"],"disclosure":""},{"name":"Robert E Bristow, MD, MBA","credentials":["University of California, Irvine - Medical Center"],"disclosure":""},{"name":"Bruce E Brockstein, MD","credentials":["Section Editor — Cancer of the Head and Neck\n","Clinical Professor of Medicine\n","University of Chicago Pritzker School of Medicine"],"disclosure":"Consultant/Advisory Boards: Astra Zeneca [Immunotherapy - head and neck and melanoma (Durvalumab, tremelimumab)]; Bristol Meyers [Melanoma, head and neck cancer (Ipilimumab, nivolumab)]; Novartis [GIST, sarcoma, melanoma (Imatinib, Dabrafenib, trametinib)]."},{"name":"Kathleen Broglio, DNP, ANP-BC, ACHPN, CPE, FPCN","credentials":["Nurse Practitioner - Palliative Care\n","Dartmouth Hitchcock Medical Center"],"disclosure":""},{"name":"Jennifer R Brown, MD, PhD","credentials":["Associate Professor\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead; Verastem [CLL]. Consultant/Advisory Boards: Pharmacyclics; Infinity; Janssen; Celgene; Roche/Genentech; Gilead [CLL (Ibrutinib, IPI-145, lenalidomide, obinutuzumab, idelalisib)]; AbbVie [CLL (Venetoclax)]; Astra-Zeneca [CLL (Acalabrutinib)]."},{"name":"Paul Brown, MD","credentials":["Professor Radiation Oncology\n","Mayo Clinic, Rochester, MN"],"disclosure":"Other Financial Interest: Novella [DMC Member (None)]."},{"name":"Eduardo Bruera, MD","credentials":["Section Editor — Non Pain Symptoms: Assessment and Management\n","Professor of Oncology\n","University of Texas, MD Anderson Cancer Center at Houston"],"disclosure":"Grant/Research/Clinical Trial Support: Helsinn [Nausea, cachexia (Netupitant, Anamorelin)]."},{"name":"Glenn J Bubley, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Daniel Buchbinder, DMD, MD","credentials":["Professor and Chief Maxillofacial Surgery, Dept. of Otolaryngology Head and Neck Surgery\n","Icahn School of Medicine at Mount Sinai, New York, NY"],"disclosure":""},{"name":"Harold Burstein, MD, PhD","credentials":["Section Editor — Breast Cancer\n","Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Bryan M Burt, MD","credentials":["Assistant Professor of Surgery\n","Baylor College of Medicine"],"disclosure":""},{"name":"Jan Buter, MD, PhD","credentials":["department Medical Oncology, \n","VU University Medical Center,  \n","Amsterdam, The Netherlands"],"disclosure":""},{"name":"Antonio C Buzaid, MD","credentials":["General Medical Director, \n","Centro Oncologico Antonio Ermirio de Moraes, \n","BP de Sao Paulo, Brazil\n","Steering Committee Member,\n","Centro Oncológico do Hospital Israelita Albert Einstein, \n","Sao Paulo, Brazil"],"disclosure":""},{"name":"Lauren A Byers, MD","credentials":["Assistant Professor\n","University of Texas MD Anderson Cancer Center"],"disclosure":""},{"name":"Matthew R Callstrom, MD, PhD","credentials":["Professor of Radiology\n","Mayo Clinic"],"disclosure":"Grant/Research Support: Galil Medical (lung ablation trial [Cryoablation system]); EDDA Technology, Inc. [image registration system]. Consultant/Advisory Boards: Covidien; Medtronic [RF ablation (RF ablation)]; Johnson and Johnson [MW ablation (MW ablation)] Thermedical [RF ablation (RF ablation)]."},{"name":"Michael Camilleri, MD","credentials":["Professor of Medicine, Pharmacology, and Physiology\n","Mayo Clinic College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Rhythm Pharmaceuticals [Gastroparesis (RM-131)]; Takeda [Gastroparesis (TAK954)]; Novartis [Bile acid diarrhea (LJN452)]; AstraZeneca [Naloxegol effects on GI transit in health]; NGM Biopharma [Functional constipation (NGM282)]; Allergan [Bile acid malabsorption (Eluxadoline)]; ELIRA [Gastric emptying (T6 dermatome device)]; Vibrant [Vibrating capsule and constipation]. Consultant/Advisory Boards: Ironwood [Gastroparesis (Advisory Board on treatment and management approaches)]; Allergan [Diabetic gastroparesis]; AstraZeneca [Naloxegol and OIC]; ElobixAB [Bile acid inhibitor for constipation]; Shire [Prucalopride for constipation]; Takeda [Clinical trials]; Theravance [50-HT4 receptor agonists and PAMORA]; Bio-kier [Obesity, diabetes]; OUTPOST medicine [OP687 for IBS]. Equity Ownership/Stock Options: Dignify Therapeutics; Enterin."},{"name":"Steven C Campbell, MD, PhD","credentials":["Glickman Urological and Kidney Institute\n","Cleveland Clinic"],"disclosure":""},{"name":"Susana M Campos, MD","credentials":["Dana Farber Cancer Institute"],"disclosure":"Consultant/Advisory Boards: Genentech [Ovary (bevacizumab)]; AstraZeneca [Ovary]; Clovis [parp inhibitors]."},{"name":"George P Canellos, MD","credentials":["Editor-in-Chief — Oncology\n","Section Editor — Miscellaneous Tumors\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Marcia Irene Canto, MD, MHS","credentials":["Professor of Medicine and Oncology\n","Johns Hopkins University"],"disclosure":""},{"name":"Michael A Carducci, MD","credentials":["Aegon Professor of Prostate Cancer Research\n","Professor of Oncology and Urology\n","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead Sciences [Prostate cancer (GS5829)]; Pfizer [Renal cancer (avelumab)]; EMD Serrano [Solid tumors (metAP2 inhibitor)]. Consultant/Advisory Boards: Pfizer [Prostate cancer (AR antagonists)]; Astellas Pharma [Prostate cancer (AR antagonists)]; Merck [Prostate cancer (Immune checkpoint inhibitors)]; Roche Genentech [Prostate cancer (PI3K inhibitors)]; Churchill [Prostate cancer (Lyase inhibitors)]."},{"name":"Lisa A Carey, MD","credentials":["Professor of Medicine\n","University of North Carolina\n","Lineberger Comprehensive Cancer Center"],"disclosure":""},{"name":"Robert L Carithers, Jr, MD","credentials":["Professor of Medicine\n","University of Washington"],"disclosure":""},{"name":"Karen J Carlson, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Shamus Carr, MD, FACS","credentials":["Assistant Professor of Surgery\n","University of Maryland School of Medicine"],"disclosure":""},{"name":"Peter Carroll, MD, MPH","credentials":["Professor and Chair\n","Department of Urology\n","University of California, San Francisco"],"disclosure":"Grant/Research/Clinical Trial Support: Genomic Health [Prostate cancer (N/A)]"},{"name":"Bob S Carter, MD, PhD","credentials":["Professor of Neurosurgery\n","Harvard Medical School"],"disclosure":""},{"name":"Sally E Carty, MD, FACS","credentials":["Section Editor — Endocrine Surgery\n","Professor, Chief, Division of Endocrine Surgery\n","University of Pittsburgh School of Medicine"],"disclosure":"Other Financial Interest: Jaypee Brothers [Endocrine surgery (Textbook)]."},{"name":"Richard D Carvajal, MD","credentials":["Associate Professor of Medicine \n","Director, Experimental Therapeutics\n","Director, Melanoma Service\n","Columbia University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Castle Biosciences [Melanoma (DecisionDX)]; Iconic Therapeutics [Melanoma (ICON1)]; BMS [Melanoma (Ipilimumab, nivolumab)]; Novartis [Melanoma (Imatinib, nilotinib)]; AstraZeneca [Melanoma (Selumetinib)]; Immunocore [Melanoma (IMCgp100)]; Merck [Melanoma (Pembrolizumab)]; Aura Biosciences [Melanoma (AU-011)]."},{"name":"Mariana C Castells, MD, PhD","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Daniel Catovsky, MD, DSc (Med), FRCPath, FRCP, FMedSci","credentials":["Emeritus Professor of Haematology\n","Institute of Cancer Research, Sutton, Surrey, UK"],"disclosure":""},{"name":"Emi H Caywood, MD","credentials":["Director, Blood and Bone Marrow Transplant\n","Nemours/Alfred I duPont Hospital for Children"],"disclosure":""},{"name":"David Cella, PhD","credentials":["Professor\n","Feinberg School at Northwestern University"],"disclosure":""},{"name":"John Chabot, MD","credentials":["David V. Habif Professor of Surgery\n","Columbia University Medical Center"],"disclosure":""},{"name":"Jasmeet Chadha Singh, MD","credentials":["Attending Physician\n","Memorial Sloan Kettering Cancer Center\n","Commack, NY"],"disclosure":""},{"name":"A Bapsi Chakravarthy, MD, FASTRO","credentials":["Professor\n","Vanderbilt University"],"disclosure":""},{"name":"Annie On On Chan, MD","credentials":["Department of Medicine\n","University of Hong Kong"],"disclosure":""},{"name":"Anthony TC Chan, MD","credentials":["Professor of Clinical Oncology\n","Prince of Wales Hospital\n","The Chinese University of Hong Kong"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Nasopharyngeal carcinoma (Axitinib); Boehringer Ingelheim [Head and neck squamous cell carcinoma (Afatinib)]; Bristol-Myers Squibb [Head and neck squamous cell carcinoma (Nivolumab)]; MSD [Nasopharyngeal carcinoma]."},{"name":"Edward D Chan, MD","credentials":["Professor of Medicine\n","National Jewish Health"],"disclosure":""},{"name":"Jennifer Ang Chan, MD, MPH","credentials":["Dana-Farber Cancer Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Lilly [Neuroendocrine tumors (Ramucirumab)]; Sanofi [neuroendocrine tumors (aflibercept)]. Consultant/Advisory Boards: Novartis [Neuroendocrine tumors (Octreotide, everolimus)]; Ipsen [Neuroendocrine tumors (Lanreotide)]; Lexicon [Neuroendocrine tumors (Telotristat)]; Advanced Accelerator Applications [Neuroendocrine tumors (Lu-177 dotatate)]. Equity Ownership/Stock Options: Merck [Neuroendocrine tumors (Temozolomidede)]."},{"name":"Victor T Chang, MD","credentials":["Professor of Medicine,\n","Rutgers New Jersey Medical School,\n","VA New Jersey Health Care System"],"disclosure":""},{"name":"Paul H Chapman, MD","credentials":["Distinguished Nicholas T Professor of Neurosurgery\n","Harvard Medical School"],"disclosure":""},{"name":"Clark C Chen, MD, PhD","credentials":["Lyle A. French Chair of Neurosurgery\n","Professor and Department Head\n","University of Minnesota Neurosurgery"],"disclosure":"Grant/Research/Clinical Trial Support: Medtronic [Clinical applications of restriction spectrum imaging (None)]. Speaker's Bureau: Monteris [Laser thermal ablation (Edge)]; Varian [Radiosurgery (Edge)]. Consultant/Advisory Boards: Tocagen [Oncolytic virus (Clearpoint)]; MRI Intervention [MRI compatible stereotaxis (Clearpoint)]."},{"name":"Lee-may Chen, MD","credentials":["Professor of Obstetrics, Gynecology, & Reproductive Sciences\n","Division of Gynecologic Oncology\n","UCSF Helen Diller Family Comprehensive Cancer Center"],"disclosure":""},{"name":"Wendy Y Chen, MD, MPH","credentials":["Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Heather H Cheng, MD, PhD","credentials":["Assistant Professor, Division of Medical Oncology, University of Washington \n","Assistant Member, Division of Clinical Research, Fred Hutchinson Cancer Research Center"],"disclosure":""},{"name":"Athena M Cherry, PhD","credentials":["Professor of Pathology\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Winson Y Cheung, MD, MPH","credentials":["Associate Professor\n","British Columbia Cancer Agency\n","University of British Columbia\n","Division of Medical Oncology"],"disclosure":""},{"name":"Milan G Chheda, MD","credentials":["Assistant Professor\n","Washington University School of Medicine"],"disclosure":""},{"name":"Dennis S Chi, MD","credentials":["Memorial Sloan-Kettering Cancer Center"],"disclosure":"Consultant/Advisory Boards: Bovie Medical Corporation [Ovarian cancer (Surgical devices)]; Verthermia [Ovarian cancer (Heated chemotherapy device)]. Equity Ownership/Stock Options: Bovie Medical Corporation [Ovarian cancer (Surgical devices)]; Verthermia [Ovarian cancer (Heated chemotherapy device)]; CSurgeries [Ovarian cancer (Surgical devices)]."},{"name":"Stephen Chia, MD, FRCPC","credentials":["Associate Professor of Medicine\n","British Columbia Cancer Agency"],"disclosure":""},{"name":"Murali Chintagumpala, MD","credentials":["Professor of Pediatric Hematology and Oncology\n","Baylor College of Medicine"],"disclosure":""},{"name":"Steven J Chmura, MD, PhD","credentials":["Assistant Professor\n","University of Chicago"],"disclosure":""},{"name":"Noah C Choi, MD","credentials":["Professor of Radiation Oncology\n","Harvard Medical School\n","Distinguished Scholar of Thoracic Oncology\n","Massachusetts General Hospital"],"disclosure":""},{"name":"Toni K Choueiri, MD","credentials":["Director, The Lank Center for Genitourinary Oncology\n","Dana-Farber Cancer Institute and Brigham and Women's Hospital \n","Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: AstraZeneca; BMS; Exelixis; Genentech; GSK; Merck; Novartis; Peloton; Pfizer; Roche; Tracon; Eisai [Genitourinary oncology (Sunitinib, pazopanib, axitinib, temsirolimus, everolimus, nivolumab, bevacizumab, cabozantinib, TRC105, savolitinib, pembrolizumab, PT-2385)]. Consultant/Advisory Boards: AstraZeneca; Bayer; BMS; Cerulean; Eisai; Foundation Medicine Inc.; Exelixis; Genentech; Roche; GlaxoSmithKline; Merck; Novartis; Peloton; Pfizer; Prometheus Labs; Corvus [Genitourinary oncology (Sunitinib, pazopanib, axitinib, temsirolimus, everolimus, nivolumab, bevacizumab, levantinib, sorafenib, interleukin-2, pembrolizumab, cabozantinib, savolitinib; PT-2385)]."},{"name":"George P Chrousos, MD","credentials":["Professor and Chairman\n","First Department of Pediatrics\n","Director, Division of Endocrinology, Metabolism, and Diabetes\n","University of Athens Medical School, Greece"],"disclosure":""},{"name":"Rashmi Chugh, MD","credentials":["Associate Professor of Medical Oncology\n","University of Michigan Medical School"],"disclosure":""},{"name":"Daniel C Chung, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Jane E Churpek, MD","credentials":["Assistant Professor, Section of Hematology/Oncology\n","The University of Chicago"],"disclosure":""},{"name":"Jay P Ciezki, MD","credentials":["Staff Physician \n","Cleveland Clinic Department of Radiation Oncology"],"disclosure":""},{"name":"Paul M Cinciripini, PhD","credentials":["UT MD Anderson Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Cancer Prevention Research Institute in Texas (Varenicline, placebo)]."},{"name":"Thomas E Clancy, MD","credentials":["Assistant Professor of Surgery\n","Harvard Medical School"],"disclosure":""},{"name":"Jeffrey W Clark, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Mark W Clemens, MD, FACS","credentials":["Associate Professor, Plastic Surgery\n","MD Anderson Cancer Center, University of Texas"],"disclosure":""},{"name":"Mark Clemons, FRCP","credentials":["Professor, \n","Department of Medicine, University of Ottawa"],"disclosure":""},{"name":"Megan B Clowse, MD, MPH","credentials":["Assistant Professor of Medicine\n","Duke University Medical Center\n","Division of Rheumatology and Immunology"],"disclosure":""},{"name":"Harvey Jay Cohen, MD","credentials":["Director, Center for the Study of Aging\n","Walter Kempner Professor of Medicine\n","Chair Emeritus, Department of Medicine\n","Duke University"],"disclosure":""},{"name":"David E Cohn, MD","credentials":["Director, Division of Gynecologic Oncology \n","Professor of Obstetrics & Gynecology \n","Stuart M Sloan and Larry J Copeland Chair in Gynecologic Oncology\n","Ohio State University College of Medicine \n","James Cancer Hospital and Solove Research Institute"],"disclosure":"Consultant/Advisory Boards: Oncology Analytics [Medical Advisory Board]. Other Financial Interest: Gynecologic Oncology [journal Deputy Editor]."},{"name":"Robert L Coleman, MD","credentials":["Professor & Vice Chair\n","Clinical Research\n","Ann Rife Cox Chair in Gynecology\n","Department of Gynecologic Oncology\n","University of Texas MD Anderson Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Merck, Oncomed, Janssen, Clovis, Astrazeneca, Genentech/Roche, Abbvie [ovarian, uterine, cervix (pembrolizumab, demcizumab, trabectedin, rucaparib, olaparib, veliparib, bevacizumab, emactuzumab, durvalumab, tremelumumab, nivolumab, selumetinib, everolimus, ribociclib, AZD-1775)]. Consultant/Advisory Boards: Merck, Oncomed, Janssen, Clovis, Astrazeneca, Genentech/Roche, Abbvie, Bayer, immunogen [ovarian, uterine (pembrolizumab, demcizumab, trabectedin, rucaparib, olaparib, veliparib, bevacizumab, emactuzumab, AZD-1775, IMGN-853)]."},{"name":"Laura C Collins, MD","credentials":["Professor of Pathology\n","Harvard Medical School\n","Vice Chair of Anatomic Pathology\n","Beth Israel Deaconess Medical Center, Boston"],"disclosure":""},{"name":"Henri G Colt, MD","credentials":["Professor of Medicine\n","University of California Irvine"],"disclosure":""},{"name":"Steven E Come, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School\n","Director of Breast Medical Oncology Program\n","Beth Israel Deaconess Medical Center"],"disclosure":""},{"name":"Carolyn C Compton, MD, PhD","credentials":["Professor\n","Arizona State University"],"disclosure":""},{"name":"Heidi M Connolly, MD, FASE","credentials":["Section Editor — Congenital Heart Disease\n","Professor of Medicine\n","Mayo Medical School"],"disclosure":""},{"name":"Louis S Constine, MD","credentials":["Professor of Radiation Oncology and Pediatrics\n","Vice Chair\n","University of Rochester Medical Center"],"disclosure":""},{"name":"Suzanne D Conzen, MD","credentials":["Professor of Medicine\n","The University of Chicago"],"disclosure":""},{"name":"Timothy P Cooley, MD","credentials":["Associate Professor of Medicine\n","Boston University School of Medicine"],"disclosure":""},{"name":"Todd M Cooper, DO","credentials":["Associate Professor of Pediatrics \n","University of Washington\n","Director - Leukemia Program\n","Seattle Children's Cancer and Blood Disorders Center"],"disclosure":""},{"name":"David J Copenhaver, MD","credentials":["Director of Cancer Pain Management and Supportive Care, Anesthesiology and Pain Medicine Department \n","University of California at Davis"],"disclosure":""},{"name":"Pelayo Correa, MD","credentials":["Anne Potter Wilson Professor of Medicine\n","Division of Gastroenterology, Hepatology and Nutrition\n","Vanderbilt University Medical Center"],"disclosure":""},{"name":"Richard J Cote, MD, FRCPath","credentials":["Professor and Chair\n","Department of Pathology\n","University of Miami Miller School of Medicine"],"disclosure":""},{"name":"Scott J Cotler, MD","credentials":["Professor of Medicine\n","Director, Division of Hepatology\n","Loyola University Medical Center"],"disclosure":""},{"name":"Ross D Cranston, MD","credentials":["Visiting Professor\n","Fundació Lluita contra la Sida\n","Hospital Universitari Germans Trias i Pujol\n","Autonomous University of Barcelona\n","Barcelona, Spain"],"disclosure":"Grant/Research/Clinical Trial Support: ABIVAX [HIV small molecule therapeutics]. Consultant/Advisory Boards (Spouse): ABIVAX [HIV small molecule therapeutics]; Aelix Therapeutics [HIV therapeutic vaccine]; Novicol [topical HIV microbicide]."},{"name":"Sheila E Crowe, MD, FRCPC, FACP, FACG, AGAF","credentials":["Professor of Medicine\n","University of California, San Diego"],"disclosure":""},{"name":"Christopher P Crum, MD","credentials":["Department of Pathology\n","Brigham and Women's Hospital"],"disclosure":""},{"name":"Adam Cuker, MD, MS","credentials":["Assistant Professor of Medicine, Assistant Professor of Pathology & Laboratory Medicine\n","Perelman School of Medicine University of Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: Biogen-Idec, Spark Therapeutics, T2 Biosystems, Shire Pharmaceuticals. Consultant/Advisory Boards: Biogen-Idec, Diagnostica Stago."},{"name":"Clara Curiel-Lewandrowski, MD","credentials":["Associate Professor of Dermatology\n","Arizona Cancer Center, University of Arizona"],"disclosure":""},{"name":"Steven A Curley, MD, FACS","credentials":["Professor of Surgery\n","Baylor College of Medicine"],"disclosure":""},{"name":"James C Cusack, Jr, MD","credentials":["Associate Professor of Surgery\n","Harvard Medical School"],"disclosure":""},{"name":"Corey Cutler, MD, MPH, FRCP(C)","credentials":["Associate Professor of Medicine \n","Harvard Medical School\n","Medical Director \n","Bone Marrow Transplant Survivors Clinic\n","Division of Hematologic Malignancies\n","Dana-Farber Cancer Institute"],"disclosure":""},{"name":"Brian G Czito, MD","credentials":["Associate Professor\n","Duke University Medical Center"],"disclosure":"Speaker’s Bureau: Varian [GI malignancies (linear accelerators used for radiation)]."},{"name":"Roi Dagan, MD","credentials":["Assistant Professor, Radiation Oncology\n","University of Florida, College of Medicine"],"disclosure":""},{"name":"Nicholas Dainiak, MD, FACP","credentials":["Clinical Professor, Department of Therapeutic Radiology\n","Yale University School of Medicine\n","Medical and Technical Director\n","Radiation Emergency and Assistance Center (REAC/TS)"],"disclosure":""},{"name":"Josep Dalmau, MD, PhD","credentials":["ICREA Professor of Neurology\n","Hospital Clinic/IDIBAPS, University of Barcelona, Spain\n","Adjunct Professor of Neurology\n","University of Pennsylvania"],"disclosure":"Grant/Research Support (with spouse): Euroimmun Inc, [Identification of antibodies associated with disorders of the nervous system-paraneoplastic and non-paraneoplastic (diagnostic tests to measure these antibodies in serum and CSF)]. Patent Holder: Euroimmun, Inc, (I hold patents for the use of NMDAR, GABAA, GABAB, DPPX, IgLON5 as antibody tests that have been licensed to Euroimmun. and for which we receive royalties. My spouse holds a patent for the use of NMDAR as an antibody test that has been licensed to Euroimmun and for which she receives royalties); Athena Diagnostics (We hold a patent for the use of Ma2 as an antibody test that has been licensed to Athena and for which we receive royalties)."},{"name":"Anthony V D'Amico, MD, PhD","credentials":["Professor and Chief of Genitourinary Radiation Oncology\n","Brigham and Women's Hospital\n","Dana Farber Cancer Institute\n","Harvard Medical School"],"disclosure":""},{"name":"Timothy A Damron, MD","credentials":["Vice-Chair and David G. Murray Endowed Professor of Orthopedic Surgery\n","SUNY Upstate Medical University"],"disclosure":"Grant/Research/Clinical Trial Support: Stryker [Vitoss bone graft subsitute (Vitoss); Revision total joint clinical trial (Triathlon revision total knees)]; Wright Medical [Prodense bone graft substitute (Prodense)]."},{"name":"Siamak Daneshmand, MD","credentials":["Associate Professor of Urology\n","Director, Center for Urologic Oncology\n","University of Southern California"],"disclosure":""},{"name":"Marion Danis, MD","credentials":["Ethics Consultant"],"disclosure":""},{"name":"Matthew S Davids, MD, MMSc","credentials":["Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Brian Davis, MD, PhD","credentials":["Professor of Radiation Oncology\n","Mayo Clinic and Foundation"],"disclosure":"Speaker’s Bureau: Augmenix Inc. [Prostate cancer (Hydrogel spacer)]. Equity Ownership/Stock Options: Pfizer [Stock]. Equity Ownership/Stock Options (Spouse): Pfizer [Stock]."},{"name":"Nancy A Dawson, MD","credentials":["Professor of Medicine\n","Lombardi Comprehensive Cancer Center\n","Georgetown University"],"disclosure":"Grant/Research/Clinical Trial Support: Bayer [Prostate cancer (Radium-223)]; Genetech/Roche [Bladder cancer (Atezolizumab)]. Speaker’s Bureau: Bayer [Prostate cancer (Radium-223)]; Astellas [Prostate cancer (Enzalutamide)]; Janssen [Prostate cancer (Abirateorne)]; Sanofi [Prostate cancer (Cabazitaxel, deoetaxel)]; Amgen [Bone metastases (Denosumab)]; Pfizer [Kidney cancer (Sunitinib, axitinib, temsorilimus)]; Novartis [Kidney cancer (Pazopanib, everolimus)]; Genetech/Roche [Bladder cancer (Atezolizumab)]; Eisai [Kidney cancer (Lenvatanib)]; Exelexis [kidney cancer (Cabozantanib)]. Consultant/Advisory Boards: Janssen [Prostate cancer (Abiraterone)]; AstraZeneca [Bladder cancer (Durvalumab)]; Novartis [Kidney cancer (Pazopanib, everolimus)]; Abvie [Prostate cancer (Leuprolide acetate)]; Sanofi [Prosate cancer (Docetaxel, cabazitaxel)]."},{"name":"Marc E De Broe, MD, PhD","credentials":["Emeritus Professor of Medicine\n","University of Antwerp, Belgium"],"disclosure":""},{"name":"Jennifer F De Los Santos, MD","credentials":["Associate Professor\n","Department of Radiation Oncology\n","University of Alabama at Birmingham"],"disclosure":"Speaker's Bureau: Varian Medical Systems [Breast cancer (Course in breast cancer treatment)]."},{"name":"Claire Dearden, MD, BSc, FRCP, FRCPath","credentials":["Consultant Haematologist\n","The Royal Marsden Hospital and Institute of Cancer Research, London"],"disclosure":"Consultant/Advisory Boards: Roche [B-PLL (Rituximab)]; Gilead [B-PLL (Idelalisib)]; Janssen [B-PLL (Ibrutinib)]; Sanofi [T-PLL (Alemtuzumab)]."},{"name":"Malcolm M DeCamp, MD","credentials":["Fowler McCormick Professor of Surgery\n","Northwestern University Feinberg School of Medicine"],"disclosure":""},{"name":"John F Deeken, MD","credentials":["Associate Professor\n","Virginia Commonwealth University\n","Associate Director for Medical Oncology and Clinical Research\n","Inova Comprehensive Cancer and Research Institute"],"disclosure":""},{"name":"Mark E Deffebach, MD","credentials":["Associate Professor of Medicine\n","Oregon Health and Science University\n","Portland Veterans Affairs Medical Center"],"disclosure":""},{"name":"Marcela G del Carmen, MD","credentials":["Professor\n","Department of Obstetrics, Gynecology and Reproductive Biology\n","Harvard Medical School\n","Medical Director\n","Massachusetts General Physicians Organization"],"disclosure":""},{"name":"Giuseppe Del Priore, MD, MPH","credentials":["Professor\n","Morehouse School of Medicine"],"disclosure":""},{"name":"Thomas F DeLaney, MD","credentials":["Section Editor — Bone and Soft Tissue Tumors\n","Professor of Radiation Oncology\n","Harvard Medical School"],"disclosure":""},{"name":"George D Demetri, MD","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research Support: Bayer [GIST and soft tissue sarcoma therapy (Regorafenib)]; Novartis [GIST and soft tissue sarcoma therapy (Imatinib and pazopanib)]; Pfizer [GIST and soft tissue sarcoma therapy  (Sunitinib)]; Janssen/PharmaMar [Soft tissue sarcoma therapy (Trabectedin)]; Eisai [Soft tissue sarcoma therapy (Eribulin)]; Adaptimmune [Soft tissue sarcoma therapy (Engineered T cells)]. Consultant/Advisory Boards: Bayer [GIST and soft tissue sarcoma therapy (Regorafenib)]; Novartis [GIST and soft tissue sarcoma therapy (Imatinib and pazopanib)]; Pfizer [GIST and soft tissue sarcoma therapy (Sunitinib)]; Daiichi-Sankyo [GIST and soft tissue sarcoma therapy (Various new agents)]; Blueprint Medicines [GIST and soft tissue sarcoma therapy (BLU-285)]; Janssen/PharmaMar [GIST and soft tissue sarcoma therapy (Trabectedin)]; Eisai [GIST and soft tissue sarcoma therapy (Eribulin)]; EMD Serono [GIST and soft tissue sarcoma therapy (TH-302)]; Ariad [GIST and soft tissue sarcoma therapy (Ponatinib)]; Eli Lilly [GIST and soft tissue sarcoma therapy (Olaratumab)]; Caris Life Sciences [molecular diagnostics]. Patent Holder: Novartis [GIST (Use patent from Dana-Farber licensed to Novartis)]. Equity Ownership/Stock Options: Blueprint Medicines [GIST (BLU-285)]; Caris Life Sciences [molecular diagnostics]. Other Financial Interest: Blueprint Medicines [GIST (Independent member of board of directors; BLU-285)]."},{"name":"Elizabeth G Demicco, MD, PhD","credentials":["Associate Professor of Pathology\n","Mount Sinai Hospital\n","University of Toronto"],"disclosure":""},{"name":"Alexis Demopoulos, MD","credentials":["Assistant Professor, Department of Neurology\n","Hofstra North Shore - LIJ School of Medicine"],"disclosure":""},{"name":"Lynette Denny, MD, PhD","credentials":["Professor Obstetrics and Gynaecology\n","University of Cape Town\n","Groote Schuur Hospital and Institute of Infectious Diseases and Molecular Medicine"],"disclosure":""},{"name":"Jayesh Desai, MD, FRACP","credentials":["Medical Oncologist\n","Peter MacCallum Cancer Centre\n","Royal Melbourne Hospital\n","Senior Research Fellow\n","Walter and Eliza Hall Institute\n","Chair of Australasian Sarcoma Study Group"],"disclosure":""},{"name":"Daniel G Deschler, MD, FACS","credentials":["Section Editor — Otorhinolaryngology\n","Professor of Otology and Laryngology\n","Harvard Medical School"],"disclosure":""},{"name":"Rony Dev, DO","credentials":["Assistant Professor\n","University of Texas MD Anderson Cancer Center"],"disclosure":""},{"name":"Lara K Dhingra, PhD","credentials":["Assistant Professor of Neurology and Psychiatry and Behavioral Sciences\n","Albert Einstein College of Medicine"],"disclosure":""},{"name":"Steven J DiBiase, MD","credentials":["Professor of Radiation Oncology\n","Tulane University School of Medicine\n","Medical Director, Department of Radiation Oncology\n","Tulane Cancer Center"],"disclosure":"Speaker’s Bureau: Bayer Pharmaceuticals [Prostate cancer (Radium 223)]."},{"name":"Anna L Dickerman, MD","credentials":["Assistant Professor of Psychiatry\n","Weill Medical College of Cornell University"],"disclosure":""},{"name":"Maura Dickler, MD","credentials":["Interim Chief, Breast Medicine Service\n","Section Head, Endocrine Therapy Clinical Research Program"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis, Eli Lilly, Roche/Genentech [Breast cancer]. Consultant/Advisory Boards: Astra Zeneca [Breast cancer (Fulvestrant)]; Novartis [Breast cancer (Alpelisib, letrozole, ribociclib)]; Roche/Genentech [Breast cancer (Trastuzumab, pertuzumab, bevacizumab)]; Eli Lilly [Breast cancer (Abemaciclib)]; Pfizer [Breast cancer (Palbociclib)]; Syndax [Breast cancer (Etinostat)]; Puma Biotechnology [Breast cancer (Neratinib)]."},{"name":"Jorg Dietrich, MD, PhD","credentials":["Assistant Professor of Neurology\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Monteris Medical Corporation [Surgical laser device (Neuroblate)]."},{"name":"Paul A DiSilvestro, MD","credentials":["Professor\n","Program in Women's Oncology\n","Women and Infants Hospital\n","Alpert School of Medicine at Brown University"],"disclosure":""},{"name":"Angela Dispenzieri, MD","credentials":["Serene M. and Frances C. Durling Professor of Medicine and of Laboratory Medicine, and Pathology\n","Mayo Clinic"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer, Celgene, Takeda, Alnylam, Janssen, Prothena (tafamidis, lenalidomide, pomalidomide, ixazomib, bortezomib, NEOD001]."},{"name":"J Michael Dixon, MD","credentials":["Professor of Surgery and Consultant Surgeon\n","Edinburgh University"],"disclosure":""},{"name":"Don S Dizon, MD, FACP","credentials":["Section Editor – Gynecologic Oncology\n","Head of Women's Cancers, Lifespan Cancer Institute\n","Director of Medical Oncology, Rhode Island Hospital\n","Associate Professor of Medicine, Warren Alpert Medical School of Brown University"],"disclosure":"Consultant/Advisory Boards: Pfizer; Fuji Pharmaceuticals [Chemotherapy (Biosimilars)]."},{"name":"Donald C Doll, MD","credentials":["Professor Emeritus\n","Ellis Fischel Cancer Center\n","University of Missouri"],"disclosure":""},{"name":"John E Donahue, MD","credentials":["Associate Professor of Pathology and Laboratory Medicine and Neurology\n","Rhode Island Hospital, Warren Alpert Medical School of Brown University"],"disclosure":""},{"name":"Timothy F Donahue, MD","credentials":["Associate Attending Surgeon, Urology Service\n","Department of Surgery\n","Memorial Sloan-Kettering Cancer Center\n","Associate Professor of Urology\n","Weill Medical College of Cornell University"],"disclosure":""},{"name":"Kevin Donohoe, MD","credentials":["Assistant Professor of Radiology\n","Harvard Medical School"],"disclosure":""},{"name":"Tanya B Dorff, MD","credentials":["Associate Professor of Clinical Medicine\n","USC Keck School of Medicine\n","Norris Comprehensive Cancer Center"],"disclosure":""},{"name":"Chyke Doubeni, MD, FRCS, MPH","credentials":["Chair and Presidential Associate Professor,\n","Department of Family Medicine and Community Health\n","Perelman School of Medicine, University of Pennsylvania"],"disclosure":""},{"name":"Jan Drappatz, MD","credentials":["Associate Director\n","Adult Neuro-Oncology Program\n","Associate Professor\n","Departments of  Neurology and Medicine\n","University of Pittsburgh"],"disclosure":""},{"name":"Reed E Drews, MD","credentials":["Section Editor — Complications of Cancer\n","Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Marc K Drezner, MD","credentials":["Section Editor — Bone Disease\n","Professor of Medicine\n","University of Wisconsin Medical School"],"disclosure":""},{"name":"Marcia S Driscoll, MD, PharmD","credentials":["Clinical Associate Professor of Dermatology\n","University of Maryland School of Medicine"],"disclosure":""},{"name":"Steven G DuBois, MD, MS","credentials":["Member of Faculty\n","Department of Pediatrics\n","Harvard Medical School."],"disclosure":"Grant/Research/Clinical Trial Support: Loxo Oncology; Lilly; Merck; Novartis; Roche [Oncology (Multiple products)]. Consultant/Advisory Boards: Loxo Oncology [Oncology (Loxo-101)]."},{"name":"Deborah Dudgeon, MD, FRCPC","credentials":["W. Ford Connell Professor of Palliative Care Medicine\n","Director of Palliative Care Medicine, Queens University\n","Head, Palliative Medicine & Supportive Care Program, Kingston Regional Cancer Centre, Kingston, ON"],"disclosure":""},{"name":"Anette Duensing, MD","credentials":["Assistant Professor of Pathology\n","University of Pittsburgh School of Medicine"],"disclosure":""},{"name":"Shrina Duggal, PharmD, BCOP","credentials":["Clinical Pharmacy Specialist\n","UPMC Cancer Centers"],"disclosure":"Speaker’s Bureau: Incyte [Gastrointestinal cancer (Ruxolitinib)]; Boehringer Ingelheim [Gastrointestinal cancer (Afatinib)]; Pfizer/Astellas [Gastrointestinal cancer (Enzalutamide)]."},{"name":"Damian E Dupuy, MD","credentials":["Director of Tumor Ablation\n","Rhode Island Hospital\n","Professor of Diagnostic Imaging\n","Brown Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Medtronic [Oncology (Tumor ablation devices)]; Galil Medical [Oncology (Tumor ablation devices)]. Consultant/Advisory Boards: Perseon Medical [Oncology (Tumor ablation devices)]; Boston Scientific Corp [Tumor ablation (Medical consult)]. Equity Ownership/Stock Options: Perseon Corporation [Oncology (Tumor ablation devices)]. Other Financial Interest: Springer-Verlag [Interventional oncology (Textbook)]."},{"name":"Linda R Duska, MD","credentials":["Associate Professor\n","Fellowship Director\n","Gynecologic Oncology\n","University of Virginia"],"disclosure":""},{"name":"Raed A Dweik, MD, FACP, FCCP, FRCP(C), FCCM, FAHA","credentials":["Professor of Medicine\n","Cleveland Clinic Lerner College of Medicine"],"disclosure":""},{"name":"Peter T Dziegielewski, MD, FRCS(C)","credentials":["Assistant Professor\n","Chief of Head & Neck Surgical Oncology and Microvascular Reconstructive Surgery\n","University of Florida"],"disclosure":""},{"name":"Craig Earle, MD, MSc, FRCPC","credentials":["Director, Health Services Research Program\n","Cancer Care Center and the Ontario Institute for Cancer Research"],"disclosure":""},{"name":"Keith D Eaton, MD, PhD","credentials":["Associate Professor of Medicine\n","Division of Medical Oncology\n","University of Washington"],"disclosure":""},{"name":"Jason A Efstathiou, MD, DPhil","credentials":["Associate Professor of Radiation Oncology \n","Harvard Medical School\n","Associate Radiation Oncologist\n","Massachusetts General Hospital"],"disclosure":""},{"name":"Rachel A Egler, MD","credentials":["Assistant Professor of Pediatrics\n","Case Western Reserve University"],"disclosure":""},{"name":"April F Eichler, MD, MPH","credentials":["Senior Deputy Editor — UpToDate\n","Deputy Editor — Neurology and Sleep Medicine\n","Assistant Professor of Neurology\n","Harvard Medical School"],"disclosure":""},{"name":"Mark H Einstein, MD, MS, FACS, FACOG","credentials":["Professor and Chair\n","Department of Obstetrics, Gynecology, and Women’s Health\n","Assistant Dean\n","Clinical Research Unit Rutgers New Jersey Medical School"],"disclosure":""},{"name":"Avraham Eisbruch, MD","credentials":["Professor and Associate Chair for Clinical Research\n","Department of Radiation Oncology\n","University of Michigan"],"disclosure":""},{"name":"Aymen Elfiky, MD, MPH, MSc","credentials":["Dana-Farber Cancer Institute\n","Harvard Medical School"],"disclosure":""},{"name":"Moataz N El-Ghamry, MD","credentials":["Director of Brachytherapy Service\n","Department of Radiation Oncology\n","Baylor Scott & White Healthcare System"],"disclosure":""},{"name":"Ghada El-Hajj Fuleihan, MD, MPH","credentials":["Professor of Medicine\n","American University of Beirut Medical Center, Lebanon"],"disclosure":""},{"name":"Joann G Elmore, MD, MPH","credentials":["Editor-in-Chief — Primary Care (Adult)\n","Section Editor — General Medicine\n","Professor of Medicine, David Geffen School of Medicine at UCLA"],"disclosure":""},{"name":"Kevin Emerick, MD","credentials":["Assistant Professor in the Department of Otology and Laryngology\n","Harvard Medical School"],"disclosure":""},{"name":"Edzard Ernst, MD, PhD, FMEdSci, FSB, FRCP, FRCP (Edin.)","credentials":["Emeritus Professor of Complementary Medicine\n","Peninsula Medical School, University of Exeter"],"disclosure":""},{"name":"Carmen P Escalante, MD","credentials":["Professor\n","The University of Texas MD Anderson Cancer Center"],"disclosure":""},{"name":"Laura J Esserman, MD, MBA","credentials":["Professor of Surgery and Radiology\n","University of California, San Francisco\n","Director, UCSF Carol Franc Buck Breast Care Center"],"disclosure":""},{"name":"Elihu H Estey, MD","credentials":["Professor\n","University of Washington School of Medicine"],"disclosure":""},{"name":"Zeev Estrov, MD","credentials":["Professor of Medicine\n","University of Texas MD Anderson Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Incyte. Consultant/Advisory Boards: Incyte."},{"name":"D Gareth Evans, MD, FRCP","credentials":["Cancer Lead and Consultant in Clinical Genetics\n","Genetic Medicine\n","Manchester Academic Health Sciences Centre\n","Central Manchester University Hospitals NHS Foundation Trust"],"disclosure":""},{"name":"Sandy J Falk, MD, FACOG","credentials":["Director, Editorial Relations — UpToDate\n","Deputy Editor — Obstetrics, Gynecology and Women's Health \n","Instructor of Obstetrics, Gynecology and Reproductive Biology, Part-time\n","Harvard Medical School"],"disclosure":""},{"name":"Francis A Farraye, MD, MSc","credentials":["Professor of Medicine\n","Boston University School of Medicine"],"disclosure":""},{"name":"Alan Fein, MD","credentials":["Director, Center for Pulmonary and Critical Care Medicine\n","North Shore University Hospital"],"disclosure":""},{"name":"Steven H Feinsilver, MD","credentials":["Professor of Medicine\n","Hofstra Northwell School of Medicine"],"disclosure":""},{"name":"Darren Feldman, MD","credentials":["Assistant Attending Physician, \n","Department of Medicine, \n","Memorial Sloan Kettering Cancer Center\n","Assistant Professor in Medicine, \n","Weill Cornell Medical College"],"disclosure":""},{"name":"Sarah Feldman, MD, MPH","credentials":["Associate Professor\n","Harvard Medical School"],"disclosure":""},{"name":"Mary Feng, MD","credentials":["Associate Professor\n","University of California at San Francisco"],"disclosure":""},{"name":"Carlos Fernandez-del Castillo, MD","credentials":["Professor of Surgery\n","Harvard Medical School"],"disclosure":""},{"name":"Betty Ferrell, PhD, MA, FAAN, FPCN","credentials":["Director and Professor, Division of Nursing Research and Education\n","City of Hope Medical Center"],"disclosure":""},{"name":"Fernando C Fervenza, MD, PhD","credentials":["Section Editor — Glomerular Diseases \n","Professor of Medicine\n","Mayo Clinic College of Medicine"],"disclosure":"Grant/Research/Clinical Trial support: Genentech [Membranous nephropathy, Fibrillary GN (Rituximab)]; Mallinckrodt [IgA nephropathy] and FSGS(Corticotropin injection gel)]; Janssen Pharmaceutical [Monoclonal protein-mediated renal diseases (Daratumumab)]. Consultant/Advisory Boards: Alexion pharmaceutical [complement-mediated diseases]; Visterra pharmaceutical [complement-mediated diseases]. Employment: Mayo Clinic."},{"name":"Petra Feyer, MD","credentials":["Professor, \n","Head of Department, Radiation Oncology\n","Vivantes Clinics Berlin Neukoelln"],"disclosure":"Consultant/Advisory Boards: MSD/MERCK; Amgen; Riemser; TEVA [Aantiemetics (aprepitant, fosaprepitant)]; Mundipharma; TESARO [Complementary medicine (selen, mistletoe)]."},{"name":"David C Fisher, MD","credentials":["Assistant Professor of Medicine  \n","Harvard Medical School"],"disclosure":"Speaker's Bureau: Seattle Genetics [Hodgkin's disease (Brentuximab)]; Celgene [Cutaneous T-cell lymphoma (Romidepsin)]."},{"name":"David E Fisher, MD, PhD","credentials":["Chief, Department of Dermatology\n","Director, Melanoma Program, MGH Cancer Center\n","Director, Cutaneous Biology Research Center\n","Massachusetts General Hospital"],"disclosure":""},{"name":"Kevin R Flaherty, MD, MS","credentials":["Section Editor — Interstitial Lung Disease\n","Associate Professor of Medicine\n","University of Michigan Health System"],"disclosure":"Grant/Research/Clinical Trial Support: Boehringer Ingelheim [IPF (Nintedanib)]; Roche/Genentech [IPF (Pirfenidone)]. Consultant/Advisory Boards: Boehringer Ingelheim [IPF (Nintedanib)]; Genetech [IPF (Pirfenidone)]; Roche [IPF (Pirfenidone)]; Veracyte [IPF];  Fibrogen [IPF]; Celgene [ILD]; Sanofi-Genzyme [IPF]."},{"name":"Steven Flamm, MD","credentials":["Chief, Liver Transplantation Program\n","Professor of Medicine\n","Feinberg School of Medicine\n","Northwestern University"],"disclosure":"Grant/Research/Clinical Trial Support: Abbvie, Gilead (HCV). Speaker’s Bureau:\t Abbvie, Gilead, Merck (HCV). Consultant/Advisory Boards: Abbvie, Gilead, Merck (HCV)."},{"name":"Gini Fleming, MD","credentials":["Professor of Medicine\n","University of Chicago Medical Center"],"disclosure":""},{"name":"Charles W Flexner, MD","credentials":["Professor of Medicine, Pharmacology and Molecular Sciences, and International Health\n","Johns Hopkins University School of Medicine and Bloomberg School of Public Health"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead Sciences [HIV (tenofovir, elvitegravir, bictegravir, emtricitabine, cobicistat)]. Consultant/Advisory Boards: Merck [HIV (Efavirenz, indinavir, raltegravir)]; ViiV Healthcare [HIV (Abacavir, lamivudine, dolutegravir)]; Janssen [HIV (darunavir, rilpivirine, etravirine)]; Mylan [HIV (Generic antiretroviral drugs)]; Cipla LLC [HIV (Generic antiretroviral drugs)]."},{"name":"Franklin P Flowers, MD","credentials":["Professor Emeritus\n","Division of Dermatology and Cutaneous Surgery\n","University of Florida College of Medicine"],"disclosure":""},{"name":"Justin Floyd, DO","credentials":["Cancer Care Specialists of Illinois\n","Assistant Professor of Clinical Medicine\n","Washington University School of Medicine, St. Louis"],"disclosure":""},{"name":"Robert Foote, MD, FACR, FASTRO","credentials":["Professor and Chair, Department of Radiation Oncology\n","Mayo Clinic College of Medicine"],"disclosure":"Patent Holder: TruGuard/Bionix [Oral cavity and sinus cancer (Treatment device with RT)]. Other Financial Interest: Elsevier [Radiation oncology (Editor for Clinical Radiation Oncology journal)]."},{"name":"Theodoros Foukakis, MD, PhD","credentials":["Department of Oncology\n","Karolinska Institutet and University Hospital\n","Stockholm, Sweden"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Breast cancer (palbociclib)]."},{"name":"Jeffrey M Fowler, MD","credentials":["Vice Chairman and Professor\n","Department of Obstetrics and Gynecology\n","Division of Gynecologic Oncology\n","John G. Boutselis Chair in Gynecologic Oncology\n","The Ohio State University Medical Center"],"disclosure":""},{"name":"Jasmine H Francis, MD","credentials":["Attending\n","Ophthalmic Oncology Service\n","Memorial Sloan Kettering Cancer Center"],"disclosure":""},{"name":"Stephen Freedland, MD","credentials":["Editor-in-Chief, Prostate Cancer and Prostatic Diseases\n","Professor of Surgery (Urology)\n","Director, Center for Integrated Research on Cancer and Lifestyle (CIRCL)\n","Associate Director, Samuel Oschin Comprehensive Cancer Center\n","Cedars Sinai Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: GenomeDx [Molecular prognostic for prostate cancer (genetic test for prostate cancer)]; Myriad [Molecular prognostic for prostate cancer (genetic test for prostate cancer)]; MDxHealth [Molecular prognostic for prostate cancer (genetic test for prostate cancer)]. Consultant/Advisory Boards: Gave one talk for GenomeDx [Molecular prognostic for prostate cancer (genetic test for prostate cancer)]."},{"name":"Arnold S Freedman, MD","credentials":["Section Editor — Lymphoproliferative Disorders\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Kahr Therapeutics [SAB]. Other Financial Interest: Novartis [DMB (Ofatumumab)]; Bayer [DMB (Bayer 17833)]."},{"name":"Neil Freedman, MD","credentials":["Head, Division of Pulmonary, Critical Care, Allergy and Immunology\n","North Shore University Health System"],"disclosure":""},{"name":"Jonathan W Friedberg, MD","credentials":["Professor of Medicine\n","James P Wilmot Cancer Center, University of Rochester"],"disclosure":"Consultant/Advisory Boards: Bayer [DSMB for trials (Investigational agents)]; Astellas [DSMB for trials (Acalabrutinib)]."},{"name":"Lawrence S Friedman, MD","credentials":["Section Editor — General Gastroenterology\n","Professor of Medicine\n","Harvard Medical School\n","Tufts University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Consultant, FDA (Antimicrobial Drugs Advisory Committee); Trustee, Newton-Wellesley Hospital (through June 2017). Employment: Boston Health Care for the Homeless. Other Financial Interest: Elsevier [Gastroenterology (Royalties from textbooks)]; McGraw-Hill [Gastroenterology (Royalties from textbooks)]; Wiley [Gastroenterology (Royalties from textbooks)]; American Society for Gastrointestinal Endoscopy [Gastroenterology and hepatology (Honorarium as newsletter editor)]."},{"name":"Erik K Fromme, MD","credentials":["Member of the faculty of Harvard Medical School\n","Associate Physician at Brigham and Women's Hospital and Dana Farber Cancer Institute"],"disclosure":""},{"name":"Harold Frucht, MD","credentials":["Associate Professor of Clinical Medicine\n","College of Physicians and Surgeons, Columbia University"],"disclosure":""},{"name":"Michael Frumovitz, MD, MPH","credentials":["Professor of Gynecologic Oncology\n","MD Anderson Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Novadaq [Cervical cancer (Clinical trial support)]; Navidea [Cervical cancer (Clinical trial support)]. Consultant/Advisory Boards: Novadaq [Surgical imaging technology (PinPoint system for detection of sentinel nodes)]; Genentech [Bevacizumab (Educational content for business)]."},{"name":"Keiichi Fujiwara, MD, PhD","credentials":["Professor of Gynecologic Oncology\n","Saitama Medical University"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Ovarian cancer (Avelumab)]; AstraZeneca [Ovarian cancer (Olaparib)]; Esai [Ovarian cancer (Farletuzumab)]; Zeria Pharmaceutical [Ovarian cancer (Z-100)]; MSD Pharmaceuticals [Ovarian cancer (Penblorizumab)]; Ono Pharmaceutical [Ovarian cancer (Nivolumab)]; Taiho Pharmaceutical [Ovarian cancer (TAS-117)]; Clovis Oncology [Ovarian cancer (Rucaparib)]. Speaker's Bureau: Chugai Pharmaceutical [Ovarian cancer]; Nippon Kayaku [Ovarian cancer]; Yakult Pharmaceutical [Ovarian cancer]; Taiho Pharmaceutical [Ovarian cancer, Cervical Cancer]; Janssen [Ovarian Cancer]. Consultant/Advisory Boards: Pfizer [Ovarian cancer (Avelumab)]; AstraZeneca [Ovarian cancer (Olaparib)]; Esai [Ovarian cancer (Farletuzumab)]; Zeria Pharmaceutical [Ovarian cancer (Z-100)]; MSD Pharmaceuticals [Ovarian cancer (Penblorizumab)]; GlaxoSmithKline[Ovarian cancer (Pazopanib)]; Taiho Pharmaceutical [Ovarian cancer (TAS-117)]; Eisai Co., Ltd. [Endometrial cancer (Lenvatinib)]."},{"name":"Suzanne A.W. Fuqua, PhD","credentials":["Professor, Departments of Medicine and Molecular Cell Biology\n","Lester and Sue Smith Breast Center\n","Baylor College of Medicine"],"disclosure":""},{"name":"William H Gaasch, MD","credentials":["Section Editor — Valvular Disease\n","Professor of Medicine\n","University of Massachusetts Medical School\n","Tufts University School of Medicine\n","Senior Consultant in Cardiology\n","Lahey Clinic"],"disclosure":""},{"name":"Paul J Gaglio, MD","credentials":["Professor of Medicine (in Surgery)\n","Director: Hepatology Outreach\n","Columbia University College of Physicians and Surgeons Center for Liver Disease and Transplantation \n","\n","NY Presbyterian Hospital-Columbia University Medical Center\n","622 West 168th Street PH 14 Room 202 F\n","NY, NY 10032"],"disclosure":"Consultant/Advisory Boards: Abbvie, Gilead, Salix [Viral hepatitis (Sofosbuvir/Ledipasvir/ Velpatasvir/Voxilaprevir/Glecaprevir Pibrenastvix)]."},{"name":"Stéphanie Gaillard, MD, PhD","credentials":["Director, Gynecologic Cancer Trials\n","Assistant Professor, Oncology and Gynecology & Obstetrics\n","Johns Hopkins University School of Medicine"],"disclosure":""},{"name":"Thomas Galloway, MD","credentials":["Assistant Professor\n","Department of Radiation Oncology\n","Fox Chase Cancer Center"],"disclosure":"Consultant/Advisory Boards: Varian Medical Systems [Head and neck cancer (Training course)]."},{"name":"Moira Garraus, MD","credentials":["Paediatric Oncologist\n","Hospital San Joan de Deu"],"disclosure":""},{"name":"Mark C Gebhardt, MD","credentials":["Frederic W. and Jane M. Ilfeld Professor of Orthopedic Surgery\n","Harvard Medical School"],"disclosure":"Employment: Clinical Orthopedics and Related Research (journal) [Senior Associate Editor]."},{"name":"AJ Gelderblom, MD, PhD","credentials":["Medical Oncologist\n","Department of Clinical Oncology\n","Leiden University Medical Center"],"disclosure":""},{"name":"Alan C Geller, RN, MPH","credentials":["Senior Lecturer\n","Social and Behavioral Sciences\n","Harvard School of Public Health"],"disclosure":""},{"name":"Daniel George, MD","credentials":["Professor of Medicine and Surgery\n","Duke University Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Acerta [Urothelial CA (Acalabrutinib)]; Astellas/Medivation [Prostate CA (Enzalutamide)]; Astrazeneca (Bladder CA (Durvalumumab)]; Bayer [Prostate CA (Radium 223)]; BMS [Renal cell carcinoma (Nivolumab)]; Celldex [Bladder CA (Varlilumab)]; Exelixis [Prostate CA/Renal cell carcinoma (Cabozanitinib)]; Genentech [Renal cell carcinoma (Bevacizumab)]; GSK [Renal cell carcinoma (Pazopanib)]; Janssen [Prostate CA (Abiraterone)]; Millenium [Prostate CA (Orteronel)]; Novartis [Renal cell carcinoma (Everolimus)], Pfizer [Prostate CA (Sunitinib, Temsirolimus), RCC (Axitinib)]; Viamet/Innocrin [Prostate CA (Seviteronel)]. Speaker's Bureau: Bayer [Prostate Cancer (Radium 223)]; Dendreon [Renal cell carcinoma (Sipuleucel-T)]; Sanofi [Prostate CA (cabazitaxel)]. Consultant/Advisory Boards: Astellas/Medivation [Prostate CA (Enzalutamide)]; Bayer [Prostate CA (Radium-223)]; BMS [Renal cell carcinoma (Nivolumab, ipilimumab)]; Dendreon [Renal cell carcinoma (Sipuleucel-T)]; Exelixis [Prostate CA, renal cell carcinoma (Cabozanibinib)]; Merck [Renal cell cancer (Pembrolizumab)]; Pfizer [Prostate CA, renal cell carcinoma (Sunitinib, axitinib, temsirolimus)]; Innocrin [Prostate CA (Seviteronel)]; Acceleron Pharma [Renal cell carcinoma (Dalantercept)]; Clovis [Prostate (Rucaparib)]; Genentech [Bladder CA (Atezolizumab)]; Janssen [Prostate CA (Nirapanib)]; Novartis [Renal cell carcinoma (Everolimus)]; Sanofi [Prostate CA (Jevtana)]; Myovant Sciences, Inc [Prostate CA (Steering committee)]."},{"name":"James N George, MD","credentials":["Professor of Medicine\n","University of Oklahoma Health Sciences Center"],"disclosure":"Grant/Research/Clinical Trial Support: Ablynx [TTP (caplacizumab)]."},{"name":"Suzanne George, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Blueprint; Decipera; Pfizer; Bayer; Ariad; Novartis; [GIST (BLU285; DCC sunitinib; regorafenib; ponatinib; imatinib)]."},{"name":"David M Gershenson, MD","credentials":["J Taylor Wharton MD Distinguished Chair in Gynecologic Oncology\n","Professor of Gynecologic Oncology\n","The University of Texas MD Anderson Cancer Center"],"disclosure":""},{"name":"Jeffrey E Gershenwald, MD, FACS","credentials":["Professor of Surgery and Cancer Biology\n","The University of Texas MD Anderson Cancer Center"],"disclosure":"Consultant/Advisory Boards: Merck [Melanoma therapy (Pembrolizumab, interferonxx)]."},{"name":"Peter C Gerszten, MD, MPH, FACS","credentials":["Professor of Neurosurgery and Radiation Oncology\n","University of Pittsburgh Medical Center"],"disclosure":""},{"name":"Scott Gettinger, MD","credentials":["Associate Professor of Medicine\n","Yale University School of Medicine\n","Yale Cancer Center"],"disclosure":"Consultant/Advisory Boards: Bristol Meyers Squibb [Lung cancer (Nivolumab)]."},{"name":"Nicholas J Giacalone, MD","credentials":["Resident\n","Radiation Oncology Program\n","Harvard Medical School"],"disclosure":""},{"name":"Giuseppe Giaccone, MD, PhD","credentials":["Professor of Medical Oncology and Pharmacology\n","Lombardi Comprehensive Cancer Center, Georgetown University"],"disclosure":"Grant/Research Support: Eli-Lilly [oncology (CHK1 INHIBITOR)]. Consultant/Advisory Boards: Astra-Zeneca [IMMUNOONCOLOGY]; Syndax [HYPOTHEYLATING AGENTS]; G1 therapeutics [HDAC INHIBITORS]."},{"name":"Michael K Gibson, MD, PhD, FACP","credentials":["Associate Professor of Medicine\n","Research Director for Head and Neck Oncology\n","Vanderbilt University"],"disclosure":"Grant/Research/Clinical Trial Support: NCCN [Head and Neck Cancer (Afatinib)]; NCI [Head and Neck Cancer (cooperative group tirals)]. Consultant/Advisory Boards: Amgen [Gastric cancer (pembrolizumab)]."},{"name":"Jill Gilbert, MD","credentials":["Professor of Medicine\n","Vanderbilt University Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Astra Zeneca [head and neck cancer (durvalumab and tremilumimab)]; BMS [head and neck cancer (nivolumab)]; Pfizer [head and neck cancer (avelumab and cisplatin, pablociclib and cetuximab)]; Merck [head and neck cancer (pembrolizumab)]; Speake’s Bureau: EPIC /TRIM [HPV related head and neck cancer and metastatic thyroid cancer]; Consultant/Advisory Boards: IRX [head and neck cancer (DSMB for clinical trial of a vaccine, IRX-2)]; Genzyme [thyroid cancer (treatment paradigms, not drug specific)]"},{"name":"James M Gilchrist, MD","credentials":["Professor and Chair, Department of Neurology\n","Southern Illinois University School of Medicine"],"disclosure":""},{"name":"Inderbir S Gill, MD, MCh","credentials":["Chairman and Professor\n","Department of Urology\n","Executive Director of the USC Institute of Urology\n","Associate Dean (Clinical Innovation)\n","Keck School of Medicine\n","University of Southern California"],"disclosure":"Consultant/Advisory Boards: EDAP [HIFU]; Mimic Technologies [Simulation]."},{"name":"Timothy D Gilligan, MD","credentials":["Associate Professor of Medicine\n","Cleveland Clinic Lerner College of Medicine\n","Vice-Chair for Education\n","Cleveland Clinic Taussig Cancer Institute\n","Director of Coaching, Center for Excellence in Healthcare Communication\n","Cleveland Clinic"],"disclosure":""},{"name":"Bonnie S Glisson, MD, FACP","credentials":["Professor and Associate Chair \n","Department of Thoracic/Head and Neck Medical Oncology\n","University of Texas MD Anderson Cancer Center"],"disclosure":""},{"name":"Lucy A Godley, MD, PhD","credentials":["Professor of Medicine\n","The University of Chicago"],"disclosure":"Grant/Research/Clinical Trial Support: Onconova, Inc [epigenetic profiling of rigosertib response (rigosertib)]."},{"name":"Barbara Goff, MD","credentials":["Section Editor — Gynecologic Oncology\n","Department Chair, Gynecologic Oncology\n","Surgeon-in-Chief\n","University of Washington Medical Center"],"disclosure":"Employment (Spouse): Lilly [General oncology (Gemcitabine, pemetrexed)] - No relevant conflict on topics."},{"name":"S Nahum Goldberg, MD","credentials":["Director of Abdominal Intervention and Tumor Ablation\n","Minimally-Invasive Tumor Therapies Laboratory\n","Beth Israel Deaconess Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Angiodynamics [tumor ablation (tumor ablation devices)]. Consultant/Advisory Boards: Angiodynamics; Cosman Instruments [tumor ablation (tumor ablation devices)]."},{"name":"Gary Goldenberg, MD","credentials":["Assistant Professor of Dermatology and Pathology\n","Mount Sinai School of Medicine\n","Medical Director of the Dermatology Faculty Practice"],"disclosure":""},{"name":"Donald Peter Goldstein, MD","credentials":["Professor of Obstetrics, Gynecology, and Reproductive Biology\n","Harvard Medical School\n","Founder and Co-Director \n","New England Trophoblastic Disease Center"],"disclosure":""},{"name":"Vinai Gondi, MD","credentials":["Clinical Assistant Professor\n","University of Wisconsin School of Medicine and Public Health"],"disclosure":""},{"name":"Annekathryn Goodman, MD, MPH","credentials":["Professor\n","Obstetrics, Gynecology, Reproductive Biology\n","Harvard Medical School\n","Division of Gynecologic Oncology\n","Massachusetts General Hospital\n","MGH Global Disaster Response"],"disclosure":""},{"name":"Peter D Gorevic, MD","credentials":["Professor of Medicine, Rheumatology\n","Mount Sinai School of Medicine"],"disclosure":""},{"name":"Michael K Gould, MD, MS","credentials":["Senior Research Scientist \n","Director for Health Services Research\n","Department of Research and Evaluation\n","Kaiser Permanente Southern California"],"disclosure":"Grant/Research/Clinical Trial Support: Medial EarlySign [Lung cancer (Risk models)]."},{"name":"Mrinal M Gounder, MD","credentials":["Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College"],"disclosure":"Grant/Research/Clinical Trial Support: Bayer [Sarcoma (Sorafenib)]. Consultant/Advisory Boards: Epizyme; Karyopharm; Daiichi-Sankyo; Amgen [Sarcoma (None)]."},{"name":"William J Gradishar, MD","credentials":["Professor of Medicine\n","Feinberg School of Medicine\n","Northwestern University"],"disclosure":""},{"name":"William M Grady, MD","credentials":["Professor of Medicine\n","University of Washington and the Fred Hutchinson Cancer Research Center"],"disclosure":""},{"name":"David Graham, MD, FASCO","credentials":["Medical Director\n","Western Region, Levine Cancer Institute\n","Carolinas HealthCare System\n","Charlotte, NC"],"disclosure":"Consultant/Advisory Boards: Biopeps, Inc [Prostate]."},{"name":"David Y Graham, MD","credentials":["Professor of Medicine\n","Michael E. DeBakey VAMC and Baylor College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: RedHill Biopharma [H pylori]. Consultant/Advisory Boards: BioGaia; Takeda [H pylori]."},{"name":"Jane M Grant-Kels, MD","credentials":["Founding Chair, Emeritus, Department of Dermatology\n","Vice Chair, Department of Dermatology\n","Professor of Dermatology, Pathology, and Pediatrics\n","Founding Director, Cutaneous Oncology Center and Melanoma Program\n","University of Connecticut Health Center"],"disclosure":""},{"name":"Ana M Grau, MD, FACS","credentials":["Associate Professor\n","Vanderbilt University"],"disclosure":""},{"name":"Heidi J Gray, MD","credentials":["Associate Professor\n","Division of Gynecologic Oncology\n","Dept of OB/GYN\n","University of Washington"],"disclosure":""},{"name":"F Anthony Greco, MD","credentials":["Medical Director\n","Sarah Cannon Cancer Center"],"disclosure":"Speaker's Bureau: BioTheranostics [CUP (Molecular assay)]. Consultant/Advisory Boards: BioTheranostics [CUP (Molecular assay)]."},{"name":"Frank G Gress, MD","credentials":["Professor of Medicine \n","Columbia University College of Physicians and Surgeons"],"disclosure":""},{"name":"Jerome E Groopman, MD","credentials":["Dina and Raphael Recanati Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Neil D Gross, MD, FACS","credentials":["Professor\n","Head and Neck Surgery\n","MD Anderson Cancer Center"],"disclosure":"Consultant/Advisory Boards: PDS Biotechnology [Head and neck cancer (Investigation agents)]."},{"name":"Thomas G Gross, MD, PhD","credentials":["Deputy Director for Science\n","Center for Global Health, NCI, NIH, DHHS"],"disclosure":""},{"name":"Axel Grothey, MD","credentials":["Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Shilpa Grover, MD, MPH, AGAF","credentials":["Deputy Editor — Gastroenterology/Hepatology\n","Assistant Professor of Medicine, Part-time\n","Harvard Medical School"],"disclosure":"Other Financial Interest: Honorarium (travel)- Novartis ($3,000)"},{"name":"Sandeep Gurbuxani, MBBS, PhD","credentials":["Associate Professor, Section of Hematopathology, Department of Pathology\n","University of Chicago"],"disclosure":""},{"name":"Robert I Haddad, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: BMS; Merck; Astra Zeneca; Celgene [Head and neck cancer clinical trials support to institution (None)]. Consultant/Advisory Boards: BMS; Astra Zeneca; Merck; Pfizer; Eisai [Head and neck cancer clinical trials (None)]."},{"name":"Daniel E Haggstrom, MD","credentials":["Co-leader, Senior Oncology Program\n","Levine Cancer Institute\n","Charlotte, NC"],"disclosure":""},{"name":"David A Haggstrom, MD, MAS","credentials":["Investigator\n","VA HSR&D Center of Excellence on Implementing Evidence-Based Practice\n","Associate Professor\n","Indiana University School of Medicine\n","Division of General Internal Medicine & Geriatrics"],"disclosure":""},{"name":"John D Hainsworth, MD","credentials":["Chief Scientific Officer\n","Sarah Cannon Research Institute"],"disclosure":""},{"name":"Omid Hamid, MD","credentials":["Director, Melanoma Center\n","The Angeles Clinic and Research Institute"],"disclosure":"Grant/Research Support: Astra Zenica; BMS; Celldex; Genentech; Immunocore; Incyte; Novartis; Merck; Merck Serano; Medimmune; Pfizer; Rinat; Roche [Melanoma phase I (Avelumab, atezolizunab, pembrolizumab, novolomab, durvalumab, iprlimumab, talimogene laheperepoec)]. Speaker's Bureau: Genentech [Oncology (Trametanib)]; BMS [Melanoma (Dabrafenib)]; Novartis [Immuno (Remurafenib)]; Amgen [Solid tumors (Cobimetamib)]. Consultant/Advisory Boards: Amgen, Novartis, Roche, BMS, Merck [Mucosal melanoma]."},{"name":"Gary D Hammer, MD, PhD","credentials":["Millie Schembechler Professor of Adrenal Cancer\n","University of Michigan"],"disclosure":"Grant/Research/Clinical Trial Support: Eisai Co Ltd [Differentiated thyroid cancer (Lenvatinib E7080)]. Consultant/Advisory Boards: Embera NeuroTherapeutics [Adrenal cancer (Drug development)]; HRA Pharma [Adrenal cancer]; Ionis Pharmaceuticals; Millendo [Adrenal cancer (ATR-101)]; Orphagen Pharmaceuticals; [Adrenal cancer (Drug development)]. Equity Ownership/Stock Options: Embera NeuroTherapeutics; Millendo."},{"name":"M Elizabeth H Hammond, MD, FCAP","credentials":["Professor of Pathology\n","University of Utah School of Medicine"],"disclosure":""},{"name":"George Handzo, BCC, CSSBB","credentials":["Director of Health Services Research & Quality\n","HealthCare Chaplaincy, New York, NY"],"disclosure":""},{"name":"Nasser Hanna, MD","credentials":["Indiana University"],"disclosure":"Grant/Research/Clinical Trial Support: Merck; Bristol Myers Squibb [Lung cancer (Research grant)]."},{"name":"Wendy Hara, MD","credentials":["Clinical Associate Professor, Department of Radiation Oncology\n","Stanford University"],"disclosure":""},{"name":"Daniel J Haraf, MD","credentials":["Professor\n","University of Chicago"],"disclosure":""},{"name":"J William Harbour, MD","credentials":["Professor, Vice Chairman & Dr. Mark J. Daily Endowed Chair, \n","Bascom Palmer Eye Institute;\n","Associate Director for Basic Research,\n","Sylvester Comprehensive Cancer Center,\n","University of Miami Miller School of Medicine"],"disclosure":"Consultant/Advisory Boards: Castle Bioscience [Uveal melanoma (DecisionDx-UM)]; Aura Biosciences [Uveal melanoma (AU-011)]; Immunocore, Ltd [Uveal melanoma (IMCgp100)]. Other Financial Interest (royalties): Castle Biosciences [Uveal melanoma (DecisionDx-UM)]."},{"name":"Seth P Harlow, MD","credentials":["Associate Professor of Surgery\n","University of Vermont College of Medicine"],"disclosure":""},{"name":"Stephanie M Harman, MD","credentials":["Clinical Associate Professor\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Griffith R Harsh, IV, MD, MBA","credentials":["Professor and Vice Chairman\n","Department of Neurosurgery\n","Stanford Medical School"],"disclosure":""},{"name":"Ken D Hatch, MD","credentials":["Professor of Obstetrics & Gynecology\n","University of Arizona College of Medicine"],"disclosure":""},{"name":"Julie Hauer, MD","credentials":["Assistant Professor\n","Children's Hospital Boston"],"disclosure":""},{"name":"Daniel F Hayes, MD","credentials":["Section Editor — Breast Cancer\n","Professor of Medicine\n","University of Michigan School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Janssen R&D, LLC [Breast cancer (Abiraterone)]; Menarini Silicon Biosystems, LLC [Breast cancer (CellSearch)]; Puma Biotechnology [Breast cancer (Neratinib)]; Pfizer [Breast cancer (Palbociclib)]; AstraZeneca [Breast cancer (Circulating tumor cells)]; Eli Lilly and Company [Breast cancer]. Speaker's Bureau: Lilly Oncology (Breast cancer). Patent Holder: Immunicon Corporation [Inventor (05725638.0-1223-US2005008602)]; University of Michigan [Inventor (US 8,790,878 B2)]; University of Michigan [Inventor (US 8,951,484 B2)]. Equity Ownership/Stock Options: Oncimmune LLC [Stock]; Inbiomotion [Stock]. Other Financial Interest: Menarini Silicon Biosystems [Breast cancer (CellSearch)]; University of Michigan [Inventor (US 8,790,878 B2)]."},{"name":"Frances J Hayes, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Pamela Hebbard, MD, FRCS","credentials":["Assistant Professor of Surgery\n","University of Manitoba and CancerCare Manitoba"],"disclosure":""},{"name":"John E Heffner, MD","credentials":["Professor of Medicine\n","Oregon Health & Science University\n","Providence Portland Medical Center"],"disclosure":""},{"name":"Josh H Heinzerling, MD","credentials":["Radiation Oncologist\n","Southeast Radiation Oncology\n","Charlotte, North Carolina"],"disclosure":"Speaker's Bureau: Vision RT [Radiation therapy (Surface guided radiation therapy)]."},{"name":"Matthew Hellman, MD","credentials":["Assistant Attending, Memorial Sloan Kettering Cancer Center\n","Instructor, Weill Cornell Medical College"],"disclosure":"Grant/Research Support: BMS [Immunotherapy]. Consultant/Advisory Boards: BMS; Genentech; Merck; AstraZeneca; Janssen; Novartis [Immunotherapy]."},{"name":"C William Helm, MD","credentials":["Consultant Gynaecological Oncologist\n","Royal Cornwall Hospitals Trust\n","Truro, United Kingdom"],"disclosure":""},{"name":"Martee L Hensley, MD, MSc","credentials":["Attending Physician\n","Gynecologic Medical Oncology\n","Memorial Sloan-Kettering Cancer Center\n","Professor of Medicine\n","Weill Cornell Medical College"],"disclosure":"Grant/Research/Clinical Trial Support: Bristol-Myers Squibb [Uterine cancers (Nivolumab)]. Consultant/Advisory Boards: Janssen Pharmaceutica [Soft tissue sarcoma (Trabectedin)]; Lilly [Soft tissue sarcoma (Olaratumab)]; Tesaro [Ovarian cancer (Niraparib)]. Employment (spouse): Sanofi [Prostate cancer] - No relevant conflict on topic."},{"name":"Dwight E Heron, MD, MBA, FACRO, FACR","credentials":["Vice Chairman & Professor\n","University of Pittsburgh School of Medicine\n","Director of Radiation Services\n","University of Pittsburgh Cancer Institute"],"disclosure":""},{"name":"Felix JF Herth, MD, PhD","credentials":["Professor of Medicine\n","University of Heidelberg"],"disclosure":"Grant/Research/Clinical Trial Support: BTG; Boston Scientific; Olympus; Pulmonx [Uptake Interventional Pneumology]. Speaker's Bureau:  BTG; Boston Scientific; Olympus; Pulmonx [Uptake Interventional Pneumology]. Consultant/Advisory Boards: BTG; Boston Scientific; Olympus; Pulmonx [Uptake Interventional Pneumology]."},{"name":"Martin Hertl, MD","credentials":["Professor of Surgery\n","Rush University Medical Center"],"disclosure":""},{"name":"Thomas J Herzog, MD","credentials":["Deputy Director\n","University of Cincinnati Cancer Institute"],"disclosure":"Consultant/Advisory Boards: AstraZeneca; J & J; Roche; Clovis; Tesaro [Ovarian cancer (Olaparib, PLD, bevacizumab, rucaparib, niraparib)]; Genmab [Cervical cancer (Tisotumab)]."},{"name":"Paul J Hesketh, MD","credentials":["Section Editor — Supportive Care\n","Chair, Lahey Health Cancer Institute\n","Director, Thoracic Oncology, Lahey Hospital and Medical Center\n","Professor of Medicine, Tufts University School of Medicine"],"disclosure":""},{"name":"Patricia L Hibberd, MD, PhD","credentials":["Chair, Department of Global Health\n","Boston University School of Public Health"],"disclosure":""},{"name":"John Hicks, MD, DDS, PhD","credentials":["Professor\n","Department of Pathology\n","Baylor College of Medicine"],"disclosure":""},{"name":"Andrew Hines, MD","credentials":["Vascular and Interventional Specialists\n","Charlotte Radiology"],"disclosure":""},{"name":"Ariel Hirsch, MD","credentials":["Associate Professor of Radiation Oncology\n","Boston University Medical Center"],"disclosure":""},{"name":"Michelle S Hirsch, MD, PhD","credentials":["Associate Professor\n","Brigham and Women's Hospital\n","Harvard Medical School"],"disclosure":""},{"name":"Johann Hitzler, MD, FRCP(C), FAAP","credentials":["Professor, Department of Pediatrics\n","University of Toronto"],"disclosure":""},{"name":"Ephraim Hochberg, MD","credentials":["Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Fred H Hochberg, MD","credentials":["Professor, Department of Neurology\n","University of California at San Diego Moores Cancer Center"],"disclosure":""},{"name":"Lauri Hochberg, MD","credentials":["Assistant Professor of Obstetrics and Gynecology\n","Director of Imaged Based Gynecology Service\n","University of South Florida College of Medicine"],"disclosure":""},{"name":"Sarah E Hoffe, MD","credentials":["Associate Member\n","Moffitt Cancer Center\n","Department of Radiation Oncology\n","H. Lee Moffitt Cancer Center and Research Institute"],"disclosure":""},{"name":"Henry T Hoffman, MD, MS, FACS","credentials":["Professor of Otolaryngology  \n","University of Iowa"],"disclosure":"Consultant/Advisory Boards: Cook Medical (They purchased licensing rights to a patent I share with the U of Iowa Research foundation treating the larynx, also work with them on salivary disorders). Patent Holder:  COOK Medical (They purchased licensing rights to a patent I share with the U of Iowa Research foundation treating the larynx, also work with them on salivary disorders)."},{"name":"Mitchel S Hoffman, MD","credentials":["Professor\n","USF Morsani College of Medicine"],"disclosure":""},{"name":"Richard M Hoffman, MD, MPH","credentials":["Professor of Medicine\n","University of Iowa Carver College of Medicine"],"disclosure":""},{"name":"Christine H Holschneider, MD","credentials":["Professor of Obstetrics and Gynecology\n","David Geffen School of Medicine at UCLA"],"disclosure":""},{"name":"Angela M Hong, MBBS, MMed, PhD, FRANZCR","credentials":["Melanoma Institute Australia, \n","The University of Sydney"],"disclosure":""},{"name":"Richard T Hoppe, MD","credentials":["Professor of Radiation Oncology\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Francis J Hornicek, MD, PhD","credentials":["Associate Professor of Orthopaedic Surgery\n","Harvard Medical School"],"disclosure":""},{"name":"Neil S Horowitz, MD","credentials":["Assistant Professor of  Obstetrics, Gynecology, and Reproductive Biology\n","Harvard Medical School\n","Director of Clinical Research, Gynecologic Oncology\n","Brigham and Women’s Hospital"],"disclosure":"Grant/Research/Clinical Trial Support: TRACON Pharmaceuticals [Gestational trophoblastic neoplasia (TRC105)]."},{"name":"Terzah M Horton, MD, PhD","credentials":["Assistant Professor, Hematology/Oncology\n","Baylor College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Takeda Pharmaceuticals/Millennium [Proteasome inhibitors (Bortezomib); Seattle Genetics [Anti-CD30 antibodies (Brentuximab)]."},{"name":"Mara J Horwitz, MD","credentials":["Assistant Professor of Medicine\n","University of Pittsburgh"],"disclosure":""},{"name":"Steven Horwitz, MD","credentials":["Associate Attending\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Celgene Corporation [mycosis fungoides (romidepsin)]; Millennium Pharmaceuticals/Takeda [Hodgkin lymphoma (brentuximab vedotin)]; Kyowa-Hakka-Kirin [mycosis fungoides (mogamulizumab)]; Seattle Genetics [Hodgkin lymphoma (brentuximab vedotin)]; Spectrum Pharmaceuticals [mycosis fungoides (pralatrexate)]; Forty-Seven; Infinity/Verastem; ADCT Therapeutics; Aileron Therapeutics. Consultant/Advisory Boards: Celgene Corporation; Millennium Pharmaceuticals/Takeda; Kyowa-Hakka-Kirin; Seattle Genetics; Forty-Seven; Infinity/Verastem; HUYA; BMA; Mundipharma."},{"name":"Ralph H Hruban, MD","credentials":["Professor of Pathology and Oncology\n","The Sol Goldman Pancreatic Cancer Research Center\n","Johns Hopkins Medical Institutions"],"disclosure":""},{"name":"James Huang, MD","credentials":["Thoracic Service\n","Department of Surgery\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":""},{"name":"Warner K Huh, MD","credentials":["Margaret Cameron Spain Chair in Obstetrics/Gynecology\n","Professor, Division of Gynecologic Oncology\n","Senior Scientist, UAB Comprehensive Cancer Center"],"disclosure":"Consultant/Advisory Boards: Merck [Cervical cytology (HPV vaccines)]; Intuitive Surgical (Robotic Surgery); LICOR (fluorescence imaging); InCellDx (cervical cancer screening)."},{"name":"Edwin P Hui, MD","credentials":["Clinical Associate Professor (Honorary)\n","Department of Clinical Oncology\n","Prince of Wales Hospital\n","The Chinese University of Hong Kong"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Nasopharyngeal cancer (Axitinib)]. Speaker’s Bureau: Merck Sharp & Dohme [Head and neck cancer, nasopharyngeal cancer (Pembrolizumab)]; Merck Serono [Head and neck cancer, nasopharyngeal cancer (Cetuximab)]. Consultant/Advisory Boards: Bristol-Myers Squibb [Head and neck cancer, nasopharyngeal cancer (Nivolumab, ipilimumab)]; Merck Sharp & Dohme [Head and neck cancer, nasopharyngeal cancer (Pembrolizumab)]."},{"name":"Linda Humphrey, MD","credentials":["Professor of Medicine and Public Health and Preventive Medicine\n","Oregon Health and Science University\n","Portland Veterans Affairs Medical Center"],"disclosure":""},{"name":"Klaudia U Hunter, MD","credentials":["Lahey Clinic Department of Radiation Oncology"],"disclosure":""},{"name":"David Huntsman, MD, FRCPC, FCCMG","credentials":["Professor of Pathology and Laboratory Medicine\n"," University of British Columbia"],"disclosure":""},{"name":"Arti Hurria, MD","credentials":["Associate Professor of Medicine\n","Director of Cancer and Aging Research Program\n","Medical Oncology and Therapeutics Research\n","City of Hope"],"disclosure":"Grant/Research/Clinical Trial Support: GlaxoSmithKline, Novartis [Breast cancer (Lapatinib)]; Celgene [Breast cancer (Nab-paclitaxel)]. Consultant/Advisory Boards: Boehringer Ingelheim Parmaceuticals [Breast cancer (Afatinib)]; Carevive [Geriatric oncology (None)]; Sanofi [Breast cancer (Docetaxel)]; Pierian Biosciences [Geriatric oncology (None)]; MJH Healthcare Holdings, LLC [Breast cancer (Endopredict)]."},{"name":"Arif Hussain, MD","credentials":["Professor of Medicine, Pathology, and Biochemistry\n","University of Maryland School of Medicine"],"disclosure":""},{"name":"Michael Ieong, MD","credentials":["Assistant Professor of Medicine\n","Boston University School of Medicine"],"disclosure":""},{"name":"Raghava Induru, MD","credentials":["Co-leader, Senior Oncology Program\n","Levine Cancer Institute\n","Charlotte, NC"],"disclosure":""},{"name":"Shams I Iqbal, MD","credentials":["Assistant Professor of Radiology\n","Tufts University Medical School\n","Department of Radiology\n","Lahey Clinic"],"disclosure":""},{"name":"Richard S Irwin, MD","credentials":["Professor of Medicine\n","University of Massachusetts Medical School"],"disclosure":""},{"name":"Claudine Isaacs, MD","credentials":["Professor of Medicine and Oncology\n","Georgetown University Medical School\n","Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research"],"disclosure":"Grant/Research/Clinical Trial Support: Tesaro [Breast/ovarian cancer (Niriparib). Consultant/Advisory Boards: Medivation [Breast/ovarian cancer (Talazoparib)]; AstraZeneca [Breast/ovarian cancer (Olaparib)]."},{"name":"Leanne Jackson, MD","credentials":["Assistant Professor of Medicine\n","Michael E. DeBakey Veterans Affairs Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer, Inc [Breast cancer (Early intervention palliative care trial)]."},{"name":"Vicki Jackson, MD, MPH","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer, Inc [Breast cancer (Early intervention palliative care trial)]."},{"name":"Eric Jacobsen, MD","credentials":["Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Celgene [Histiocytoses (Lenalidomide)]. Consultant/Advisory Boards: Seattle Genetics [T cell lymphoma (Brentuximab)]; Spectrum [T cell lymphoma (Pralatrexate, romidepsin)]; Merck (Temsirolimus); Pharmacyclics (Ibrutinib)."},{"name":"Brian C Jacobson, MD, MPH","credentials":["Associate Professor of Medicine\n","Boston University School of Medicine"],"disclosure":"Consultant/Advisory Boards: MOTUS GI [Bowel cleaning for colonoscopy (Device under development to help with bowel cleaning during colonoscopy)]."},{"name":"Michael T Jaklitsch, MD","credentials":["Professor in Surgery\n","Harvard Medical School\n","Brigham and Women's Hospital"],"disclosure":""},{"name":"Maija Jakobsson, MD, PhD","credentials":["Helsinki University Hospital"],"disclosure":""},{"name":"Katherine A Janeway, MD","credentials":["Attending Physician of Pediatric Oncology\n","Dana Farber Cancer Institute\n","Assistant Professor of Pediatrics\n","Harvard Medical School"],"disclosure":""},{"name":"Aminah Jatoi, MD","credentials":["Professor of Oncology\n","Mayo Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Enterahealth [Nutrition support (Protein supplement)]."},{"name":"Milind Javle, MD","credentials":["Professor of Medicine\n","University of Texas MD Anderson Cancer Center\n","Department of GI Medical Oncology"],"disclosure":""},{"name":"James R Jett, MD","credentials":["Section Editor — Lung Cancer\n","Professor of Medicine Emeritus\n","National Jewish Health"],"disclosure":"Employment: Oncimmune [Biomarkers for early cancer detection (Early CDT-Lung blood test)]. Equity Ownership/Stock Options: Oncimmune [Biomarkers for early cancer detection (Early CDT-Lung blood test)]."},{"name":"Kenar D Jhaveri, MD","credentials":["Professor of Medicine\n","Associate Chief, Division of Kidney Diseases and Hypertension\n","Zucker School of Medicine at Hofstra/Northwell"],"disclosure":""},{"name":"Ramon E Jimenez, MD","credentials":["Associate Professor of Surgery\n","Florida International University\n","Herbert Wertheim College of Medicine"],"disclosure":""},{"name":"Bonnie N Joe, MD, PhD","credentials":["Professor of Radiology and Biomedical Imaging\n","Chief\n","UCSF Breast Imaging"],"disclosure":""},{"name":"Shruti Jolly, MD","credentials":["Assistant Professor\n","University of Michigan Health System"],"disclosure":"Grant/Research/Clinical Trial Support: NIH [lung cancer (adaptive radiation therapy)]. Consultant/Advisory Boards: Varian [gynecologic brachytherapy]."},{"name":"Eric Jonasch, MD","credentials":["Professor\n","The University of Texas MD Anderson Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Exelixis; Novartis; Pfizer [Kidney cancer (Pazopanib, cabozantinib, sunitinib)]. Consultant/Advisory Boards: BMS; Exelixis; Esai; Novartis; Pfizer [Kidney cancer (Nivolumab, everolimus, pazopanib, temsirolimus, cabozantinib, sunitinib, lenvatinib)]."},{"name":"Karin Jordan, MD","credentials":["Associate Professor\n","Universitätsklinikum Heidelberg"],"disclosure":"Consultant/Advisory Boards: MSD/Merck & Co [Antiemetics (Aprepitant)]; Helsinn [Antiemetics (NEPA)]; Tesaro, Inc [Antiemetics (Rolapitant)]."},{"name":"Jeffrey Joseph, MD, PhD","credentials":["Professor of Pathology\n","University of Calgary School of Medicine"],"disclosure":""},{"name":"Lisa A Kachnic, MD","credentials":["Chair and Professor\n","Department of Radiation Oncology\n","Vanderbilt University School of Medicine"],"disclosure":""},{"name":"Larry R Kaiser, MD","credentials":["President and CEO, Temple University Health System\n","Sr. Executive Vice President for Health Sciences, Temple University\n","Dean, Temple University School of Medicine"],"disclosure":""},{"name":"Virginia Kaklamani, MD, DSc","credentials":["Professor of Medicine\n","Leader, Breast Oncology Program\n","CTRC, University of Texas Health Science Center San Antonio"],"disclosure":""},{"name":"Gregory P Kalemkerian, MD","credentials":["Professor of Medicine\n","Co-Director, Thoracic Oncology\n","University of Michigan Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Takeda Pharmaceuticals [Lung cancer (pevonedistat)]; Novartis [Lung cancer (Dabrafenib/trametinib)]; Merck [Lung cancer (Pembrolizumab)]; OncoMed Pharmaceuticals [Lung cancer (OMP-59R5)]; Abbvie [Lung Cancer (SC002)]. Consultant/Advisory Boards (spouse): Takeda Pharmaceuticals, BioMed Valley Discoveries, Esperion [drug development and safety analysis]."},{"name":"Richard S Kalman, MD","credentials":["Division of Hepatology, \n","Assistant Professor of Medicine,  \n","Einstein Medical Center/Sidney Kimmel Medical College of Thomas Jefferson University"],"disclosure":""},{"name":"Kala Kamdar, MD, MS Epi","credentials":["Associate Professor, Department of Pediatrics, Section of Hematology/Oncology\n","Baylor College of Medicine"],"disclosure":""},{"name":"Stephen Kang, MD","credentials":["Head and Neck Oncology Fellow\n","The Ohio State University Wexner Medical Center"],"disclosure":""},{"name":"Philip W Kantoff, MD","credentials":["Section Editor — Testicular Cancer\n","Chairman of Medicine\n","Memorial Sloan Kettering Cancer Center"],"disclosure":""},{"name":"Andre A Kaplan, MD","credentials":["Professor of Medicine\n","University of Connecticut Health Center"],"disclosure":"Grant/Research/Clinical Trial Support: Nipro Corporation [Dialysis (Dialysis filters)]. Speaker's Bureau: Terumo [Plasmapheresis (Plasmapheresis machines)]. Consultant/Advisory Boards: Vital Therapeutics [Extracorporeal liver assist device (ELAD)]."},{"name":"Lawrence D Kaplan, MD","credentials":["Clinical Professor of Medicine\n","University of California, San Francisco"],"disclosure":""},{"name":"Amer Karam, MD","credentials":["Clinical Associate Professor\n","Associate Director and Director of Outreach\n","Division of Gynecologic Oncology\n","Department of Obstetrics and Gynecology\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Maher Karam-Hage, MD","credentials":["UT MD Anderson Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Smoking cessation (Varenicline)]."},{"name":"Wassim Kassouf, MD, CM, FRCS","credentials":["Professor of Surgery (Urology)\n","McGill University Health Center"],"disclosure":""},{"name":"Anne Katz, PhD, RN, FAAN","credentials":["CancerCare Manitoba\n","Winnipeg MB"],"disclosure":""},{"name":"Laurence Katznelson, MD","credentials":["Associate Dean of Graduate Medical Education\n","Professor of Neurosurgery and Medicine (Endocrinology and Metabolism)\n","Stanford School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [Acromegaly (Pasireotide)]; Chiasma [Acromegaly (Octreotide)]. Consultant/Advisory Board: Chiasma [Acromegaly (Octreotide)]."},{"name":"Steven M Kawut, MD","credentials":["Associate Professor of Medicine and Epidemiology, Director, Pulmonary Vascular Disease Program\n","Perelman School of Medicine, University of Pennsylvania"],"disclosure":""},{"name":"Electron Kebebew, MD, FACS","credentials":["Senior Investigator\n","Chief, Endocrine Oncology Branch\n","National Cancer Institute\n","Professor of Surgery\n","George Washington University School of Medicine & Health Sciences"],"disclosure":""},{"name":"Vicki L Keedy, MD, MSCI","credentials":["Assistant Professor of Medicine\n","Vanderbilt University Medical Center"],"disclosure":"Grant/Research Support: Plexxicon [PVNS (PLX3397)]; Bayer [sarcoma (regorafenib)]; Hoffman-Laroche [cancer (vemurafenib)]."},{"name":"Yair Y Keilson, MD","credentials":["Adjunct Clinical Assistant Professor of Medicine\n","Touro College of Osteopathic Medicine"],"disclosure":""},{"name":"Robert L Keith, MD","credentials":["Professor of Medicine and Cancer Biology\n","Associate Chief of Staff\n","Research, Division of Pulmonary Sciences and Critical Care Medicine\n","Denver Veterans Affairs Medical Center\n","University of Colorado Cancer Center\n","University of Colorado School of Medicine"],"disclosure":"Patent Holder: US Patent 8,623,917 (Chemoprevention [Prostacyclin, iloprost])."},{"name":"Karen Kelly, MD","credentials":["Professor of Medicine\n","University of California Davis Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: BMS [BMS Immunotherapy pipeline discussion]; AbbVie [Lung cancer]."},{"name":"Thomas Archibald Kerr, MD, PhD","credentials":["Assistant Professor of Internal Medicine\n","Division of Digestive and Liver Diseases\n","University of Texas Southwestern Medical Center at Dallas"],"disclosure":"Grant/Research/Clinical Trial Support: Conatus [Fatty liver]. Speaker's Bureau: AbbVie [HCV (Viekira Pak, Viekira XR)]; Gilead Sciences [HCV (Harvoni, Epclusa)]; Intercept [Primary Biliary Cholagitis (Ocaliva)]; Alexion [Fatty liver (Kanuma)]. Consultant/Advisory Boards: AbbVie [HCV (Viekira Pak, Viekira XR)]; Gilead Sciences [HCV (Harvoni, Epclusa)]; Intercept [Primary Billiary Cholangitis (Ocaliva)]; Alexion [Fatty Liver (Kanuma)]."},{"name":"Joshua P Kesterson, MD","credentials":["Chief, Division of Gynecologic Oncology\n","Associate professor\n","Penn State Hershey Medical Center\n","Hershey, Pennsylvania"],"disclosure":""},{"name":"Elizabeth A Kidd, MD","credentials":["Assistant Professor\n","Department of Radiation Oncology\n","Stanford University"],"disclosure":""},{"name":"Mark W Kieran, MD, PhD","credentials":["Boston Children's Hospital\n","Dana-Farber Cancer Institute"],"disclosure":"Grant/Research/Clinical Trial Support: GSK [BRAF V600E in pediatric low-grade gliomas (Dabrafenib)]; Novartis [Sonic hedgehog medulloblastoma (LDE225)]; Novartis [mTOR inhibition in pediatric low-grade gliomas (Everolimus)]; Boehringer [ErbB inhibition in brain tumors (Afatinib)]; Millenium/Takada [Low-grade gliomas (MLN2480)]; Bristol-Myers Squibb [pediatric brain tumors (Nivolumab/ipilumumab)]. Consultant/Advisory Boards: GSK [BRAF V600E in pediatric low-grade gliomas (Dabrafenib)]; Novartis [Sonic hedgehog medulloblastoma (LDE225)]; Boehringer [ErbB inhibition in brain tumors (Afatinib)]; Bayer [Phase 1 pediatric cancer]; Celgene [Phase I portfolio (Thalidomide, lenolidomide)]; Merck [Thrombocytopenia (Eltrombopag)]."},{"name":"Ellen J Kim, MD","credentials":["Associate Professor of Dermatology\n","Perelman School of Medicine at the University of Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: Kyowa Hakko Kirin [CTCL clinical trial investigator (anti-CCR4 [KW0761, mogamulizumab])]; Solgenix [CTCL clinical trial investigator (hypericin photodynamic topical agent)]; Actelion [CTCL clinical trial investigator (nitrogen mustard gel)]. Consultant/Advisory Boards: Actelion [CTCL (nitrogen mustard gel)]."},{"name":"Youn H Kim, MD","credentials":["Professor of Dermatology\n","Stanford University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Esai [CTCL (E7777/denileukin diftitox)], Kyowa Hakko Kirin [CTCL (mogamulizumab)], Merck [CTCL (Pembromulizumab)], Millennium/Takeda [CTCL (brentuximab vedotin)], Seattle Genetics [CTCL (brentuximab vedotin)], Soligenix [CTCL (TOPICAL SGX301)], Tetralogic [CTCL (SHAPE)], Neumedicine [CTCL (Interleukin-12)], Innate [CTCL (IPH4102)], Infinity Pharmaceuticals. Consultant/Advisory Boards: Actelion [CTCL], Celgene [CTCL (Romidepsin)], Eisai [CTCL (E7777/denileukin diftitox)], Galderma [CTCL], Kyowa Hakko Kirin [CTCL (Mogamulizumab)], Millennium/Takeda Pharma [CTCL (Brentuximab Vedotin)], Seattle Genetics [CTCL (Brentuximab Vedotin)], Forty Seven Inc [CTCL], Horizon Pharma [CTCL (Actimmune)], Portola Pharma [CTCL (Cerdulatinib)], miRagen [CTCL (AntimiR-155 MRG-106)], Medivir."},{"name":"Gretchen Kimmick, MD, MS","credentials":["Associate Professor in Medicine\n","Duke University Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: PUMA Biotech;  [breast cancer (neratinib)]; GlaxoSmithKline [breast cancer (lapatinib)]. Other Financial Interest: Genomic Health [breast cancer (OncotypeDX)]."},{"name":"Hedy Lee Kindler, MD","credentials":["Professor of Medicine\n","Director, Mesothelioma and Gastrointestinal Oncology Programs\n","University of Chicago Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Aduro [Mesothelioma (CRS-207)]; Bayer [Mesothelioma (Anetumab ravtanisine)]; GSK, Five Prime Therapeutics [Mesothelioma (GSK3052230)]; Merck [Mesothelioma (Pembrolizumab)]; Medimmune/AZ [Mesothelioma (Tremelimumab)]; Polaris [Mesothelioma (ADI-PEG 20)]; Bristol-Myers Squibb [Mesothelioma (Nivolumab, Ipilimumab)]. Consultant/Advisory Boards: Aduro [Mesothelioma (CRS-207)]; Bayer [Mesothelioma (Anetumab ravtanisine)]; Medimmune/AZ [Mesothelioma (Tremelimumab)]; Boehringer-Ingleheim [Mesothelioma (Nintedanib)]; Paredox [Mesothelioma]."},{"name":"Talmadge E King, Jr, MD","credentials":["Editor-in-Chief — Pulmonary and Critical Care Medicine\n","Section Editor — Interstitial Lung Disease\n","Dean, School of Medicine \n","Vice Chancellor, Medical Affairs\n","University of California San Francisco"],"disclosure":""},{"name":"David G Kirsch, MD, PhD","credentials":["Professor of Radiation Oncology\n","Duke University Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: XRad Therapeutics [Radiation sensitizers (Not applicable)]; Lumicell Inc. [Intraoperative imaging (Not applicable)]; Merck [Immunotherapy (Not applicable)]; Eli Lilly and Company [Radiation sensitizers (Not applicable)]. Consultant/Advisory Boards: Lumicell Inc. [Intraoperative imaging (Not applicable)]; Sarcoma Alliance for Research through Collaboration [Sarcoma (Not applicable)]. Patent Holder: Lumicell Inc. [Intraoperative imaging (Not applicable)]. Equity Ownership/Stock Options: Lumicell Inc. [Intraoperative imaging (Not applicable)]; XRad Therapeutics [Radiation Sensitizers (Not applicable)]."},{"name":"Tobias Klatte, MD","credentials":["UCLA David Geffen School of Medicine"],"disclosure":""},{"name":"Eric A Klein, MD","credentials":["Chairman, Glickman Urological and Kidney Institute\n","Professor of Surgery\n","Cleveland Clinic"],"disclosure":"Consultant/Advisory Boards: Cellanyx [Prostate cancer]."},{"name":"Heidi D Klepin, MD, MS","credentials":["Associate Professor of Internal Medicine, Hematology and Oncology\n","Comprehensive Cancer Center of Wake Forest University"],"disclosure":""},{"name":"David S Klimstra, MD","credentials":["Attending Pathologist and Chairman\n","Department of Pathology\n","James Ewing Alumni Chair in Pathology\n","Memorial Sloan Kettering Cancer Center\n","Professor of Pathology and Laboratory Medicine\n","Weill Medical College of Cornell University"],"disclosure":""},{"name":"Laurence Klotz, MD","credentials":["Professor of Surgery\n","University of Toronto\n","Chief\n","Sunnybrook Health Sciences Centre"],"disclosure":""},{"name":"Michael D Kluger, MD, MPH","credentials":["Assistant Professor of Surgery\n","College of Physicians and Surgeons\n","New York-Presbyterian Hospital/CUMC"],"disclosure":""},{"name":"Wayne M Koch, MD, FACS","credentials":["Professor of Otolaryngology\n","Director\n","Division of Head & Neck Surgery\n","The Johns Hopkins Outpatient Center"],"disclosure":""},{"name":"Claus-Henning Köhne, MD","credentials":["Department of Hematology and Oncology\n","Onkologie Klinikum Oldenburg"],"disclosure":""},{"name":"E Anders Kolb, MD","credentials":["Director, Nemours Center for Cancer and Blood Disorders\n","Nemours/Alfred I duPont Hospital for Children"],"disclosure":""},{"name":"Jonathan E Kolitz, MD","credentials":["Professor of Medicine\n","Hofstra Northwell School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Celator [AML (CPX-351)]; Boehringer-Ingelheim [AML (volasertib, BI836858)]; Millennium [AML, MDS (pevonedistat)]; Cantex [AML (CX-01)]; Erytech Pharma [ALL (ERYASP)]. Consultant/Advisory Boards: Pharmacyclics, Seattle Genetics, Novartis, Gilead."},{"name":"Lavanya Kondapalli, MD","credentials":["Assistant Professor of Medicine\n","University of Colorado"],"disclosure":""},{"name":"Panagiotis A Konstantinopoulos, MD, PhD","credentials":["Assistant Professor of Medicine\n","Harvard Medical School\n","Gynecologic Medical Oncology Program\n","Dana Farber Cancer Institute"],"disclosure":""},{"name":"Scott E Kopec, MD","credentials":["Assistant Professor of Medicine\n","University of Massachusetts Medical Center"],"disclosure":""},{"name":"Tamar Kotz, MS CCC-SLP","credentials":["Head and Neck Speech Pathologist\n","Otolaryngology-Head and Neck Surgery\n","Icahn School of Medicine at Mount Sinai"],"disclosure":""},{"name":"Kris V Kowdley, MD, FACP, FACG, FASGE, AGAF","credentials":["Director, Liver Care Network and Organ Care Research\n","Swedish Medical Center\n","Seattle, WA"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead [PSC (FXR agonist)]; Intercept [PSC (INT-747, OCA, FXR agonist)]; NGM Biopharma [PSC (NGM-282)]. Speaker’s Bureau: Gilead [PSC (FXR agonist)]; Intercept [PSC (INT-747, OCA, FXR agonist)]. Consultant/Advisory Boards: Gilead [PSC (FXR agonist)]; Intercept [PSC (INT-747, OCA, FXR agonist)]; NGM Biopharma [PSC (NGM-282)]."},{"name":"Shlomo A Koyfman, MD","credentials":["Assistant Professor of Medicine\n","Departments of Radiation Oncology and Bioethics\n","Cleveland Clinic"],"disclosure":""},{"name":"Dennis Kraus, MD","credentials":["Director, Center for Head and Neck Oncology\n","New York Head & Neck Institute\n","North Shore-LIJ Health System"],"disclosure":""},{"name":"Mary Lee Krinsky, DO","credentials":["Professor of Medicine\u2028\n","University of California, San Diego Healthcare System"],"disclosure":""},{"name":"Smitha S Krishnamurthi, MD","credentials":["Associate Professor,\n","Case Western Reserve University and University Hospitals Cleveland Medical Center;\n","Director,\n","Clinical Trials Office, Case Comprehensive Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Taiho [colorectal cancer (TAS-102)]; Regeneron [solid tumors (REGN2810)]; CytomX Therapeutics [solid tumors (CX-072)]."},{"name":"Susan E Krown, MD","credentials":["Member Emerita\n","Memorial Sloan-Kettering Cancer Center\n","Vice-Chair for International Activities \n","The AIDS Malignancy Consortium"],"disclosure":""},{"name":"Matthew Kulke, MD","credentials":["Chief, Hematology and Oncology, Boston Medical Center\n","Deputy Director, Cancer Center, Boston University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Lexicon [Neuroendocrine tumors (Telotristat)]; Novartis [Neuroendocrine tumors (Octreotide, everolimus)]; Ipsen [Neuroendocrine tumors (Lanreotide)]."},{"name":"Senthil Kumar, MS, FRCS (Ed), FRCS (Gen Surg)","credentials":["Additional Professor, Liver Transplantation and Hepatopancreaticobiliary Surgery\n","Institute of Liver and Biliary Sciences"],"disclosure":""},{"name":"Hiroko Kunitake, MD","credentials":["Assistant in Surgery, Massachusetts General Hospital\n","Assistant Professor of Surgery, Harvard Medical School"],"disclosure":""},{"name":"Calvin J Kuo, MD, PhD","credentials":["Professor of Medicine\n","Stanford University School of Medicine"],"disclosure":"Consultant/Advisory Boards: OncoMed [angiogenesis (anti-DLL4 antibody)]. Equity Ownership/Stock Options (Self and Spouse): OncoMed [angiogenesis inhibitors (anti-DLL4 antibody)]. Employment (Spouse): OncoMed [angiogenesis inhibitors (anti-DLL4 antibody)] - No relevant conflict on topic."},{"name":"Anil Nicholas Kurup, MD","credentials":["Associate Professor of Radiology\n","Mayo Clinic College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Galil Medical [ablation of skeletal metastases (multiple cryoablation systems)]"},{"name":"Bonnie Ky, MD, MSCE","credentials":["Assistant Professor of Medicine and Epidemiology\n","University of Pennsylvania School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Investigator initiated award]; Roche [Investigator initiated grant support (biomarkers)]; Singulex [Research support (biomarkers)]. Consultant/Advisory Boards: Bristol Myers Squibb [consultant]; Mateon Therapeutics [vascular disrupting agents (consultant)]; Roche [consultant (biomarkers)]."},{"name":"Robert A Kyle, MD","credentials":["Section Editor — Plasma Cell Disorders\n","Professor of Medicine\n","Mayo Medical School"],"disclosure":"Consultant/Advisory Boards: Celgene Disease Monitoring Committee [Dysproteinemias (lenalidomide, pomalidomide)]; Bristol-Myers Squibb Independent Monitoring Committee [Dysproteinemias (elotuzumab)]; Onyx Pharma (Amgen) Data Monitoring Committee [Dysproteinemias (carfilzomib)]; Pharmacyclics Data Safety Monitoring Board [Dysproteinemias (ibrutinib)]. Other Financial Interest: Pfizer [Lecture on therapy of multiple myeloma, made comments concerning a new Pfizer product and received an honorarium]."},{"name":"Ann S LaCasce, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Board: BMS (DMB); Seattle Genetics (education materials)."},{"name":"Mario E Lacouture, MD","credentials":["Associate Professor of Medicine \n","Cornell University\n","Member\n","Memorial Hospital\n","Memorial Sloan Kettering Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Berg [Rash (Calcitriol)]; Bristol-Myers Squibb [Rash (Cetuximab)]. Consultant/Advisory Boards: Quintiles [Rash (Anti-epidermal growth factor receptor monoclonal antibody mixture)]; Boehringer Ingelheim [Rash (Afatinib)]; AstraZeneca [Rash (Osimertinib)]; Foamix Pharmaceuticals [Rash (Doxycycline)]; Novartis [Rash (Alpelisib)]; Novocure [Rash (Device used to treat glioblastoma multiforme)]."},{"name":"André Lacroix, MD","credentials":["Section Editor — Adrenal Disease\n","Professor of Medicine\n","University of Montreal, Quebec, Canada"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [Pituitary tumors, Cushing's syndrome (Pasireotide, octreotide, osilodrostat)]; Cortendo [Cushing's syndrome (Levoketoconazole)]. Speaker's Bureau: Novartis [Cushing's syndrome (Pasireotide, octreotide, osilodrostat)]; EMD Serono [Cushing's syndrome (Lanreotide)]. Consultant/Advisory Boards: Novartis [Pituitary tumors, Cushing's syndrome (Pasireotide, octreotide, osilodrostat)]; EMD Serono [Pituitary tumors (Lanreotide)]."},{"name":"Ruth L Lagman, MD, MPH, FACP, FAAHPM","credentials":["The Harry R. Horvitz Center for Palliative Medicine and Supportive Oncology \n","Taussig Cancer Institute\n","Cleveland Clinic"],"disclosure":""},{"name":"Thierry Lamy, MD, PhD","credentials":["Professor in Hematology\n","University of Rennes, France"],"disclosure":""},{"name":"Paul H Lange, MD, FACS","credentials":["Professor \n","Department of Urology\n","School of Medicine\n","University of Washington"],"disclosure":""},{"name":"Christine Laronga, MD, FACS","credentials":["Professor\n","Moffitt Cancer Center, University of South Florida"],"disclosure":"Speaker’s Bureau: Genomic Health [Breast cancer genomic assays (Oncotype DCIS)]."},{"name":"Richard A Larson, MD","credentials":["Editor-in-Chief — Hematology\n","Section Editor — Leukemia\n","Professor of Medicine\n","University of Chicago Pritzker School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas [leukemia (gilteritinib)]; Erytech [leukemia (eryaspase)]; Novartis [leukemia (nilotinib, ascininib)]; Daiichi Sankyo [leukemia (quizartinib)]; Celgene [leukemia (enasidenib)]. Consultant/Advisory Boards: Novartis [leukemia (imatinib, nilotinib)]; Ariad Data Safety Monitoring Board [leukemia (ponatinib)]; CVS/Caremark [leukemia (drug prior authorization program)]; Celgene Data Safety Monitoring Board [leukemia (azacitidine, durvalumab)]; Amgen [leukemia (blinatumomab)]; Astellas [leukemia (gilteritinib)]; Jazz [leukemia (CPX-351)]."},{"name":"Ilya Laufer, MD","credentials":["Assistant Professor\n","Weill Medical College of Cornell University"],"disclosure":"Consultant/Advisory Boards: Globus; DePuy Synthes; Medtronic; Spine Wave; Brainlab [Spine surgery]."},{"name":"Shannon K Laughlin-Tommaso, MD","credentials":["Consultant and Assistant Professor, Division of Gynecology, Departments of Obstetrics & Gynecology and Surgery\n","Mayo Clinic and Mayo Medical School"],"disclosure":"Grant Support: InSightec, Inc [Fibroid (Focused ultrasound ablation device)]. Consultant/Advisory Boards: Halt Medical DSMB [Fibroids (Acessa)]; Allergan [Fibroids (Esmya)]."},{"name":"Scott A Laurie, MD, FRCPC","credentials":["The Ottawa Hospital Cancer Centre\n","University of Ottawa"],"disclosure":""},{"name":"Christine L Lay, MD, FRCPC","credentials":["Associate Professor\n","Women's College Hospital"],"disclosure":""},{"name":"Quynh-Thu Le, MD","credentials":["Professor and Chair\n","Stanford University"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen [Head and neck cancer (Palifermin)]; RedHill [Head and neck cancer (Yeliva)]. Consultant/Advisory Boards: Varian Medical Systems [Head and neck cancer (Proton therapy)]; BMS [Head and neck cancer (Galectin-1)]."},{"name":"Michelle M Le Beau, PhD","credentials":["Professor of Medicine\n","University of Chicago Pritzker School of Medicine"],"disclosure":""},{"name":"Michael S Leapman, MD","credentials":["Assistant Professor\n","Department of Urology\n","Yale University School of Medicine"],"disclosure":""},{"name":"Eudocia Quant Lee, MD, MPH","credentials":["Assistant Professor of Neurology\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Genentech/Roche [Radiographic response criteria for brain Metastases]; Lilly [Brain metastases]."},{"name":"James Lee, MD","credentials":["Edwin C. and Anne K. Weiskopf Associate Professor of Surgical Oncology (in Surgery and in the Herbert Irving Comprehensive Cancer Center)\n","Columbia University Medical Center"],"disclosure":""},{"name":"Nancy Y Lee, MD","credentials":["Attending Physician\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":""},{"name":"Richard J Lee, MD, PhD","credentials":["Assistant Professor of Medicine\n","Harvard Medical School\n","Massachusetts General Hospital"],"disclosure":""},{"name":"Sei Lee, MD","credentials":["Assistant Adjunct Professor\n","University of California, San Francisco"],"disclosure":""},{"name":"W Robert Lee, MD, MS, MEd","credentials":["Section Editor — Prostate Cancer\n","Professor of Radiation Oncology\n","Duke University Medical Center"],"disclosure":""},{"name":"Michael D Leise, MD","credentials":["Assistant Professor of Medicine\n","Mayo Clinic College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Merck [Hepatitis C (Grazoprevir, elbasvir)]; Abbvie [Hepatitis C (Glecaprevir/Pibrentasvir)]."},{"name":"Mario M Leitao, Jr, MD","credentials":["Assistant Member\n","Division of Gynecology \n","Department of Surgery\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":""},{"name":"Anthony J Lembo, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Salix (Rifaximin); Valaent (Rifaximin); Takeda (Lubiprostone); Ironwood (Linaclotide); Allergan (Linaclotide); Alkermes; Shire (Prucalopride)."},{"name":"Daniel J Lenihan, MD","credentials":["Professor of Medicine\n","Director, Cardio-Oncology Center of Excellence\n","Washington University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Takeda [Cardiotoxicity (Bortezomib)]. Consultant/Advisory Boards: Roche [DSMB (Trastuzumab)]; Bristol Myers Squibb [Cardiac safety (Dasatinib)]; Amgen [Cardiac safety [Carfilzomib]); Janssen [Cardiac safety (Rivaroxaban)]."},{"name":"Seth P Lerner, MD","credentials":["Section Editor — Bladder Cancer\n","Beth and Dave Swalm Chair in Urologic Oncology\n","Professor of Urology\n","Baylor College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Endo; FKD; Viventia [Bladder cancer (Valrubicin, Ad/IFN, Viccinium)]. Consultant/Advisory Boards: Biocancell; UroGen; Vaxxion; Incyte; Nucleix [Bladder cancer (BC-819, Mitogel, Vesigel)]."},{"name":"Nelson Leung, MD","credentials":["Professor of Medicine\n","Mayo Clinic College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Omeros Corporation [thrombotic microangiopathy]. Consultant/Advisory Boards: Prothena [amyloidosis]; Thrasos Therapeutics [myeloma kidney (cast nephropathy)]."},{"name":"Deborah Levine, MD","credentials":["Section Editor — Imaging\n","Professor of Radiology\n","Director of Ob/Gyn Ultrasound\n","Department of Radiology\n","Beth Israel Deaconess Medical Center"],"disclosure":""},{"name":"Jan S Lewin, PhD","credentials":["Professor, Department of Head and Neck Surgery\n","Section Chief, Speech Pathology and Audiology\n","The University of Texas MD Anderson Cancer Center"],"disclosure":""},{"name":"Andrew John Li, MD","credentials":["Co-Director, Women’s Reproductive Cancers Center of Excellence\n","Division of Gynecologic Oncology, Cedars-Sinai Medical Center\n","Health Sciences Associate Clinical Professor\n","Department of Obstetrics and Gynecology\n","David Geffen School of Medicine at UCLA"],"disclosure":""},{"name":"Stuart M Lichtman, MD","credentials":["Attending Physician\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":""},{"name":"Jennifer Ligibel, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Fitbit [Physical activity (Fitbit, Aria Scale)]."},{"name":"Rogerio C Lilenbaum, MD, FACP","credentials":["Section Editor — Lung Cancer\n","Yale Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Celgene [Non-small cell lung cancer (Nab-paclitaxel)]. Consultant/Advisory Boards: Genentech [Lung cancer (Bevacizumab/erlotinib)]; Boehringer Ingelheim [Non-small cell lung cancer (Afatinib)]; Celgene [Non-small cell lung cancer (Nab-paclitaxel)]; AstraZeneca [Non-small cell lung cancer (Osimertinib)]."},{"name":"Jean Lee Lim, MD","credentials":["Department of Dermatology\n","Kaiser Permanente Medical Group, Santa Rosa, CA"],"disclosure":""},{"name":"Sewanti Limaye, MD","credentials":["Consultant - Medical Oncology\n","Center for Cancer\n","Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute"],"disclosure":""},{"name":"Andrew H Limper, MD","credentials":["Professor of Pulmonary Medicine\n","Mayo Clinic College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead [Pulmonary fibrosis (Simtuzumab)]. Consultant/Advisory Boards: NSCI Group [Pulmonary fibrosis]."},{"name":"Nancy U Lin, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School\n","Dana Farber Cancer Institute\n","Adult Oncology"],"disclosure":"Grant/Research/Clinical Trial Support: Array BioPharma [Breast cancer (ONT-380)]; Cascadian [Breast cancer (ONT-380)]; Genentech [Breast cancer (Trastuzumab, pertuzumab)]."},{"name":"Noralane M Lindor, MD","credentials":["Professor of Medical Genetics\n","Mayo Clinic School of Medicine"],"disclosure":""},{"name":"Cornelis J Lips, MD, PhD","credentials":["Professor of Endocrinology and Metabolism\n","Department of Internal Medicine\n","University Medical Center Utrecht, The Netherlands"],"disclosure":""},{"name":"Jennifer K Litton, MD","credentials":["Assistant Professor of Medicine\n","The University of Texas MD Anderson Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer, Medivation, Novartis, Genentech, AstraZeneca, EMD-Serono, GSK [Breast cancer clinical trials]."},{"name":"Leslie A Litzky, MD","credentials":["Professor of Pathology and Laboratory Medicine\n","University of Pennsylvania Medical Center"],"disclosure":""},{"name":"Catherine Y Liu, MD, PhD","credentials":["The Gavin Herbert Eye Institute\n","University of California - Irvine"],"disclosure":""},{"name":"Vincent Liu, MD","credentials":["Clinical Professor\n","Departments of Dermatology and Pathology\n","University of Iowa Carver College of Medicine"],"disclosure":""},{"name":"Joseph LoCicero, III, MD, FCCP","credentials":["Professor of Surgery Emeritus\n","SUNY Downstate"],"disclosure":""},{"name":"Jay S Loeffler, MD","credentials":["Section Editor — Neurooncology\n","Professor of Radiation Oncology\n","Harvard Medical School"],"disclosure":""},{"name":"Daniel S Longnecker, MD","credentials":["Professor Emeritus\n","Dartmouth Medical School"],"disclosure":"Grant/Research Support: Shire [ADHD (Guanfacine)]. Consultant/Advisory Boards: AstraZeneca [Dyslipidemia (Rosuvastatin)]."},{"name":"George F Longstreth, MD","credentials":["Voluntary Clinical Professor of Medicine\n","University of California San Diego School of Medicine"],"disclosure":""},{"name":"Billy W Loo Jr., MD, PhD","credentials":["Associate Professor and Thoracic Radiation Oncology Program Leader\n","Stanford University"],"disclosure":"Grant/Research/Clinical Trial Support: Varian Medical Systems [Radiation therapy (Medical linear accelerators)]; RaySearch Laboratories [Radiation therapy (Radiation treatment planning systems)]. Equity Ownership/Stock Options: TibaRay [Radiation therapy (Developing future radiation therapy technology)]."},{"name":"Charles L Loprinzi, MD","credentials":["Regis Professor of Breast Cancer Research\n","Mayo Clinic College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Prevention and treatment of chemotherapy-induced peripheral neuropathy (pregabalin)]; Pfizer [Treating blood clots (Apixaban)]; Janssen [Preventing blood clots (Rivaroxaban)]. Consultant/Advisory Boards: Mitsubishi Tanabe Pharma [menopausal hot flashes]; PledPharma; Metys; Lpath; Mundipharma [Prevention and treatment of chemotherapy-induced peripheral neuropathy]."},{"name":"Yair Lotan, MD","credentials":["Professor\n","Department of Urology\n","UT Southwestern Medical Center at Dallas"],"disclosure":"Grant/Research/Clinical Trial Support: Abbott [bladder cancer (Urovysion FISH assay)]; MDxHealth [bladder cancer]; Cepheid; Pacific Edge Bladder cancer [bladder cancer (CxBladder)]; Photocure [cystoscopy (Hexvix)]; Genomedx [bladder cancer]. Consultant/Advisory Boards: Cepheid; Pacific Edge Bladder cancer [bladder cancer (CxBladder)]; Photocure [cystoscopy (Hexvix)]; MDxHealth [bladder cancer]."},{"name":"Thomas P Loughran, Jr, MD","credentials":["Director, University of Virginia Cancer Center\n","University of Virginia"],"disclosure":""},{"name":"David N Louis, MD","credentials":["Pathologist-in-Chief\n","Massachusetts General Hospital\n","Benjamin Castleman Professor of Pathology\n","Harvard Medical School"],"disclosure":""},{"name":"Robert C Lowe, MD","credentials":["Assistant Professor of Medicine\n","Boston University School of Medicine"],"disclosure":""},{"name":"Karen H Lu, MD","credentials":["Professor\n","Department of Gynecologic Oncology\n","MD Anderson Cancer Center"],"disclosure":""},{"name":"Aimee L Lucas, MD, MS","credentials":["Assistant Professor \n","Icahn School of Medicine at Mount Sinai"],"disclosure":""},{"name":"William M Lydiatt, MD","credentials":["Clinical Professor\n","United States Naval Hospital \n","Department of Otolaryngology \n","Portsmouth Virginia\n","Nebraska Methodist Hospital"],"disclosure":""},{"name":"Gary H Lyman, MD, MPH, FASCO, FACP, FRCP (Edin)","credentials":["Professor of Medicine, Public Health and Pharmacy\n","University of Washington\n","\n","Co-Director, Hutchinson Institute for Cancer Outcomes Research, Public Health Sciences and Clinical Research Divisions\n","Fred Hutchinson Cancer Research Center"],"disclosure":""},{"name":"Cynthia X Ma, MD, PhD","credentials":["Associate Professor of Medicine\n","Washington University in St. Louis"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [breast cancer treatment (palbociclib)]; Puma Biotechnology [breast cancer treatment (neratinib)]; Eisai [breast cancer treatment (eribulin)]. Consultant/Advisory Boards: Pfizer [breast cancer treatment (palbociclib)]; Novartis [breast cancer treatment (ribociclib)]; AstraZeneca [breast cancer treatment (fulvestrant)]; Merck [breast cancer treatment (pembrolizumab)]."},{"name":"Carole Macaron, MD","credentials":["Assistant Professor\n","Case Western Reserve University and Louis Stokes VA Medical Center"],"disclosure":""},{"name":"Mitchell Machtay, MD","credentials":["Professor and Chair\n","Radiation Oncology Department\n","Ireland Cancer Center\n","University Hospitals Case Medical Center"],"disclosure":""},{"name":"Finlay A Macrae, MD","credentials":["Professor, Department of Medicine\n","University of Melbourne, Victoria, Australia"],"disclosure":""},{"name":"Cristina Magi-Galluzzi, MD, PhD","credentials":["Professor of Pathology\n","Director of Genitourinary Pathology\n","Department of Anatomic Pathology\n","Cleveland Clinic"],"disclosure":""},{"name":"Varocha Mahachai, MD","credentials":["Professor of Medicine\n","Chulalongkorn University Hospital\n","Bangkok, Thailand"],"disclosure":""},{"name":"Robert Maki, MD, PhD","credentials":["Section Editor — Bone and Soft Tissue Tumors\n","Professor of Medicine \n","Monter Cancer Center\n","Hofstra-Northwell School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Bayer [Medical oncology (Regorafenib)]; Gem Pharmaceuticals [Medical oncology (GPX-150)]; Immune Design [Medical oncology (LV305+G305)]; Janssen/Pharma Mar [Medical oncology (Trabectedin)]; Karyopharm [Medical oncology (Selinexor)]; Sarcoma Alliance for Research through Collaboration (SARC) [Medical oncology (Regorafenib, pembrolizumab)], Tracon (TRC105). Speaker’s Bureau:  ABIM [Medical oncology]; Sarcoma Alliance for Research through Collaboration (SARC) [Medical oncology (Regorafenib, pembrolizumab)].  Consultant/Advisory Boards: ABIM [Medical oncology]; AADi [Medical oncology (Nab-rapamycin)]; Arcus (medical oncology); Bayer [Medical oncology (Regorafenib); Gem Pharmaceuticals [Medical oncology (GPX-150)]; Immune Design [Medical oncology (LV305+G305)]; Janssen/Pharma Mar [Medical oncology (Trabectedin)]; Karyopharm [Medical oncology (Selinexor)]; Lilly/Imclone [Medical oncology (Olaratumab)]; Sarcoma Alliance for Research through Collaboration (SARC) [Medical oncology (Regorafenib, pembrolizumab)]."},{"name":"Fabien Maldonado, MD","credentials":["Associate Professor of Medicine\n","Vanderbilt University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Centurion Medical [Unexpandable lung, pleural pressure]."},{"name":"Andrew Malone, MB, BCh, MRCPI","credentials":["Assistant Professor of Medicine, Division of Nephrology\n","Department of Medicine, Washington University School of Medicine"],"disclosure":""},{"name":"Harvey Mamon, MD, PhD","credentials":["Associate Professor of Radiation Oncology\n","Harvard Medical School"],"disclosure":""},{"name":"William J Mann, Jr, MD","credentials":["Section Editor — Gynecologic Surgery\n","Clinical Professor\n","Department of Obstetrics and Gynecology\n","Virginia Commonwealth University School of Medicine"],"disclosure":""},{"name":"David M Mannino, MD","credentials":["Director, Pulmonary Epidemiology Research Laboratory\n","University of Kentucky School of Medicine"],"disclosure":""},{"name":"Paul F Mansfield, MD, FACS","credentials":["Vice President, Acute Care Services\n","Professor of Surgical Oncology\n","The University of Texas MD Anderson Cancer Center"],"disclosure":""},{"name":"Ellen F Manzullo, MD, FACP","credentials":["Professor of Medicine\n","University of Texas\n","MD Anderson Cancer Center"],"disclosure":""},{"name":"Karen J Marcus, MD","credentials":["Associate Professor of Radiation Oncology\n","Harvard Medical School\n","Boston Children's Hospital\n","Dana-Farber Cancer Institute"],"disclosure":""},{"name":"Maurie Markman, MD","credentials":["Clinical Professor of Medicine\n","Drexel University College of Medicine\n","President, Medicine & Science\n","Cancer Treatment Centers of America"],"disclosure":""},{"name":"Lawrence B Marks, MD","credentials":["Department of Radiation Oncology\n","UNC Hospitals and University of North Carolina at Chapel Hill"],"disclosure":"Grant/Research/Clinical Trial Support: Vision RT [Radiation therapy (Breath-holding system to reduce cardiac effects of radiation)]."},{"name":"John A Martin, MD","credentials":["Associate Professor, Senior Associate Consultant, and Associate Chair for Endoscopy\n","Mayo Clinic"],"disclosure":""},{"name":"Renato G Martins, MD, MPH","credentials":["Medical Director\n","Professor\n","University of Washington\n","Seattle Cancer Care Alliance"],"disclosure":""},{"name":"Shanthi Marur, MD, MBBS","credentials":["Medical Officer,\n","Oncology Center of Excellence, Food and Drug Administration (FDA)\n","Adjunct Assistant Professor,\n","Johns Hopkins Sidney Kimmel Comprehensive Cancer Center"],"disclosure":""},{"name":"Masao Matsuoka, MD, PhD","credentials":["Professor\n","Department of Hematology, Kumamoto University Medical School\n","Institute for Virus Research, Kyoto University"],"disclosure":""},{"name":"Ursula A Matulonis, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School \n","Director/Program Leader\n","Medical Gynecologic Oncology\n","Dana-Farber Cancer Institute"],"disclosure":""},{"name":"Hani Haytham Mawardi, BDS, DMSc, DABOM, FDS RCSEd","credentials":["King Abdulaziz University\n","Faculty of Dentistry\n","Jeddah, Saudi Arabia"],"disclosure":""},{"name":"Jessica N McAlpine, MD, FACOG, FRCPSC","credentials":["Associate Professor\n","Department of Gynecology and Obstetrics Division of Gynecologic Oncology\n","University of British Columbia"],"disclosure":""},{"name":"Kenneth L McClain, MD, PhD","credentials":["Professor of Pediatrics\n","Texas Children's Cancer Center/Hematology Service\n","Baylor College of Medicine"],"disclosure":""},{"name":"Elizabeth McCormick, MD","credentials":["Assistant Professor of Geriatrics and Palliative Medicine\n","Mount Sinai School of Medicine"],"disclosure":""},{"name":"W. Joseph McCune, MD, MACR","credentials":["Michael H and Marcia S Klein Professor of Rheumatic Diseases\n","Associate Chief, Division of Rheumatology\n","Director, Lupus Program\n","University of Michigan"],"disclosure":"Grant/Research/Clinical Trial Support: AstraZeneca [Lupus (Anifrolumab)]; Eli Lilly [Lupus (Baricitinab)]; GlaxoSmithKline [Lupus (Belimumab)]."},{"name":"Shaunagh McDermott, MD","credentials":["Assistant Professor\n","Harvard Medical School"],"disclosure":""},{"name":"Derek R McHaffie, MD","credentials":["Attending Physician\n","Levine Cancer Institute\n","Carolinas Medical Center"],"disclosure":""},{"name":"William J McKenna, MD","credentials":["Section Editor — Myopericardial Disease\n","Professor of Cardiology\n","University College, London"],"disclosure":""},{"name":"Mary-Ellen Meadows, PhD, ABPP","credentials":["Clinical Neuropsychologist\n","Brigham and Women's Hospital\n","Assistant Professor of Psychology\n","Harvard Medical School"],"disclosure":""},{"name":"Babak Mehrara, MD","credentials":["Associate Professor of Surgery\n","Cornell Weill Medical Center"],"disclosure":""},{"name":"Bhoomi Mehrotra, MD","credentials":["Director\n","Cancer Institute at St. Francis Hospital\n","Roslyn, NY"],"disclosure":""},{"name":"Atul C Mehta, MBBS, FCCP","credentials":["Professor of Medicine\n","Cleveland Clinic Foundation"],"disclosure":""},{"name":"Minesh Mehta, MD","credentials":["Chair, Radiation Oncology\n","Florida International University"],"disclosure":"Consultant/Advisory Boards: Varian [Radiotherapy (Linear Accelerators)]; Agenus [Biotech start-up]; Insys [Pharma]; Remedy [Biotech start-up]; IBA [Proton therapy device company]; Oncoceutics [Biotech start-up]; AstraZeneca [Pharma]; Celgene [Pharma]; Tocagen [Biotech start-up]; AbbVie [Pharma]. Other Financial Interest: Monteris [DSMB (Laser ablation)]; Oncoceutics [Biotech start-up (Board of directors)]."},{"name":"Zankhana Mehta, MD","credentials":["Department of Palliative and Supportive Medicine\n","Geisinger Medical Center"],"disclosure":""},{"name":"Diane E Meier, MD, FACP","credentials":["Director, Center to Advance Palliative Care \n","Director, Hertzberg Palliative Care Institute, Mount Sinai School of Medicine\n","Professor, Geriatrics and Internal Medicine, Mount Sinai School of Medicine"],"disclosure":""},{"name":"Shlomo Melmed, MD","credentials":["Senior Vice President and Dean\n","Cedars Sinai Medical Center\n","Professor of Medicine\n","University of California at Los Angeles School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Ipsen [Acromegaly (Lanreotide)]; Pfizer [Acromegaly (Pegvisomant)]. Consultant/Advisory Boards: Chiasma [Acromegaly (Oral octreotide)]; Ionis Pharmaceuticals [Acromegaly (Antisense drug)]; Novartis [Acromegaly (Octreotide)]; Stonebridge Pharma [Acromegaly]."},{"name":"Sanaz Memarzadeh, MD, PhD","credentials":["Associate Professor \n","Department of Obstetrics and Gynecology\n","Division of Gynecologic Oncology\n","David Geffen School of Medicine at UCLA\n","Director G.O. Discovery Laboratory"],"disclosure":""},{"name":"William M Mendenhall, MD","credentials":["Department of Radiation Oncology\n","University of Florida College of Medicine"],"disclosure":""},{"name":"Avedis Meneshian, MD","credentials":["Assistant Professor of Surgery\n","Division of Thoracic Surgery\n","Johns Hopkins Hospital\n","\n","Thoracic Surgeon\n","Anne Arundel Medical Center"],"disclosure":""},{"name":"Sofia D Merajver, MD, PhD","credentials":["Professor of Internal Medicine\n","University of Michigan Medical School"],"disclosure":""},{"name":"Jaime R Merchan, MD, MMSc","credentials":["Associate Professor of Medicine\n","University of Miami Miller School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Agensys [Cancer (ASG-22CE)]; Rexahn Pharmaceuticals [Cancer (RX-3117)]; Lilly [Cancer (LY3039478)]; Tracon [Cancer (TRC105)]; Acceleron [Cancer (Dalantarcept)]; Novartis [Cancer (Trametinib/ribociclib)]. Consultant/Advisory Boards: Exelixis [Cancer (cabozantinib)]."},{"name":"Christian Meyer, MD, PhD","credentials":["Instructor in Oncology\n","Sidney Kimmel Comprehensive Cancer Center\n","Johns Hopkins Hospital"],"disclosure":""},{"name":"Fremonta L Meyer, MD","credentials":["Assistant Professor of Psychiatry\n","Harvard Medical School"],"disclosure":""},{"name":"Janelle Meyer, MD","credentials":["Hematology Oncology of Salem"],"disclosure":""},{"name":"Jeffrey J Meyer, MD","credentials":["Assistant Professor\n","University of Texas-Southwestern Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Peregrine Pharmaceuticals, Inc. [Cancer (Bavituximab - an antibody drug)]; DFine, Inc. [Cancer (Medical device for radiofrequency ablation of spine tumors)]."},{"name":"Jeffrey A Meyerhardt, MD, MPH","credentials":["Associate Professor of Medicine\n","Dana-Farber Cancer Institute"],"disclosure":"Consultant/Advisory Boards: Genentech [Oncology (Oncology drugs, payment <$5000)]; Chugai Pharmaceutical [Therapeutics for gastrointestinal cancers (Bevacizumab and capecitabine, payment <$5000)]."},{"name":"M Dror Michaelson, MD, PhD","credentials":["Associate Professor in Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Dominique Michaud, Sc.D","credentials":["Professor\n","Department of Public Health & Community Medicine\n","Tufts University Medical School"],"disclosure":""},{"name":"David E Midthun, MD","credentials":["Section Editor — Lung Cancer\n","Professor of Medicine, Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Martin C Mihm, Jr, MD","credentials":["Clinical Professor of Pathology\n","Harvard Medical School\n","Brigham and Women's Hospital"],"disclosure":"Consultant/Advisory Boards: Novartis [Multiple tumor therapies]; Alnylam [Question of allergic reaction to injected microRNA conjugates]; MelaSciences [Clinical diagnosis in melanoma]; Caliber I.D. [Confocal microscope diagnosis of tumors (Pre- and postbiopsy drugs)]; Biocoz [Skin activation and wound recovery (Cutaneous lotion/moisturizer)]. Other Financial Interest: John Wiley & Sons [Published book]."},{"name":"Michael T Milano, MD, PhD","credentials":["Associate Professor\n","Department of Radiation Oncology\n","University of Rochester"],"disclosure":""},{"name":"Andrea Milbourne, MD","credentials":["Professor of Gynecologic Oncology\n","The University of Texas"],"disclosure":""},{"name":"Dianne M Miller, MD, FRCSC","credentials":["Division Head of Gynecologic Oncology\n","University of British Columbia and the BC Cancer Agency"],"disclosure":""},{"name":"York E Miller, MD","credentials":["Thomas L Petty Chair of Lung Research\n","Division of Pulmonary Sciences and Critical Care Medicine\n","Co-Leader, Lung, Head and Neck Cancer Program \n","University of Colorado Cancer Center\n","Staff Physician\n","Denver Veterans Affairs Medical Center\n","University of Colorado School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: SomaLogic [Proteomic detection of lung cancer (None)]; HealthTell [Autoantibody detection of lung cancer (None)]; VisionGate [Cancer chemoprevention (3D imaging of sputum cells for the detection of lung cancer)]. Patent Holder: University of Colorado [Cancer chemoprevention (prostacyclin analogs such as iloprost)]."},{"name":"Omar A Minai, MD","credentials":["Pulmonary and Critical Care Associates\n","Southside regional medical Center"],"disclosure":""},{"name":"Jennifer Minnix, PhD","credentials":["UT MD Anderson Cancer Center"],"disclosure":""},{"name":"Timur Mitin, MD, PhD","credentials":["Assistant Professor\n","Department of Radiation Medicine\n","Oregon Health and Science University"],"disclosure":""},{"name":"Anirban P Mitra, MD, PhD","credentials":["Resident, Institute of Urology\n","University of Southern California\n","Keck School of Medicine & Norris Comprehensive Cancer Center"],"disclosure":""},{"name":"Kathleen M Moore, MD","credentials":["Associate Professor\n","Division of Gyn Oncology\n","Mai Eager Anderson Chair of Cancer Clinical Trials \n","Stephenson Cancer Center\n","Universitiy of Oklahoma HSC"],"disclosure":"Grant/Research/Clinical Trial Support: Astra Zeneca [Ovarian cancer (Olaparib)]; Genentech/Roche [Ovarian cancer (Bevacizumab)]."},{"name":"Douglas Morgan, MD, MPH","credentials":["Division of Gastroenterology, Hepatology, & Nutrition \n","VIGH Director for Latin America sites \n","Vanderbilt Institute for Global Health (VIGH) \n","Vanderbilt Ingram Cancer Center (VICC) \n","Vanderbilt University"],"disclosure":"Grant/Research/Clinical Trial Support: Cancer Prevention Pharmaceuticals (CPP) [Gastric cancer prevention (Eflornithine - CPP provided donation of study drug for an NIH-funded study)]; Biomerica  [H pylori diagnostic assay (multicenter trial)."},{"name":"James P Morgan, MD, PhD","credentials":["Professor of Medicine\n","Tufts University School of Medicine"],"disclosure":""},{"name":"Jeffrey Morgan, MD","credentials":["Instructor in Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"R Sean Morrison, MD","credentials":["Section Editor — Selected End Stage Conditions\n","Hermann Merkin Professor of Palliative Care\n","Mount Sinai School of Medicine"],"disclosure":""},{"name":"Maria Moschovi, MD","credentials":["Assistant Professor of Pediatric Hematology-Oncology\n","University of Athens"],"disclosure":""},{"name":"Craig Moskowitz, MD","credentials":["Attending Physician, Lymphoma and Adult BMT Services\n","Member, Memorial Sloan Kettering Cancer Center \n","Professor of Medicine, Weill Medical College of Cornell University"],"disclosure":""},{"name":"Judd W Moul, MD, FACS","credentials":["James H. Semans, MD Professor of Surgery\n","Division of Urologic Surgery\n","Duke University Medical Center\n","Director, Duke Prostate Center\n","Duke Cancer Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Astelas [Prostate cancer (Enzalutamide)]; Medication [Prostate cancer (Enzalutamide)]. Speaker's Bureau: Dendreon [Prostate cancer (Sipuleucel-T)]; Janssen [Prostate cancer (Abiraterone)]; Ferring [Prostate cancer (Degarelix)]; Sanofi [Prostate cancer (N/A)]; Genomic Health [Prostate cancer (Oncotype GPS)]. Consultant/Advisory Boards: Theralogic [Nutrition (Various nutritional supplements)]; Blue Earth Diagnostics [Prostate cancer (Axumin PET scan)]."},{"name":"Beverly Moy, MD, MPH","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards (spouse/partner): Motus GI [gastroenterology (endoscopy technology)]."},{"name":"Timothy J Moynihan, MD","credentials":["Associate Professor of Medical Oncology\n","Mayo Clinic College of Medicine"],"disclosure":""},{"name":"John T Mullen, MD, FACS","credentials":["Associate Professor of Surgery\n","Harvard Medical School\n","Division of Surgical Oncology\n","Massachusetts General Hospital"],"disclosure":""},{"name":"Arno J Mundt, MD","credentials":["Section Editor — Radiation Therapy\n","Chairman of Radiation Oncology\n","University of California, San Diego"],"disclosure":""},{"name":"Nikhil C Munshi, MD","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Janssen [Castleman disease (siltuximab)]."},{"name":"Septimiu Murgu, MD","credentials":["Associate Professor\n","University of Chicago"],"disclosure":"Grant/Research/Clinical Trial Support: Pinnacle Biologics [PDT (Porfimer sodium). Consultant/Advisory Boards: Pinnacle Biologics [PDT (Porfimer sodium)."},{"name":"Barbara A Murphy, MD","credentials":["Professor of Medicine\n","Director, Pain and Symptom Management Program\n","Vanderbilt Ingram Cancer Center"],"disclosure":""},{"name":"Janet E Murphy, MD, MPH","credentials":["Instructor of Medicine, Harvard Medical School\n","Massachusetts General Hospital Cancer Center\n","Tucker Gosnell Center for GI Malignancies"],"disclosure":""},{"name":"Jodi A Muscal, MD","credentials":["Assistant Professor of Pediatric Hematology and Oncology\n","Baylor College of Medicine"],"disclosure":""},{"name":"Michael G Muto, MD","credentials":["Associate Professor of Obstetrics, Gynecology, and Reproductive Biology\n","Harvard Medical School"],"disclosure":""},{"name":"Lida Nabati, MD","credentials":["Instructor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Maurice Nahabedian, MD","credentials":["Professor of Plastic Surgery\n","Georgetown University"],"disclosure":"Speaker's Bureau: LifeCell [Breast and abdominal wall reconstruction (Acellular dermal matrices)]; Allergan [Breast and abdominal wall reconstruction (Breast implants)]. Consultant/Advisory Boards: LifeCell [Breast and abdominal wall reconstruction (Acellular dermal matrices)]; Allergan [Breast and abdominal wall reconstruction (Breast implants)]."},{"name":"Eiad Nasser, MD","credentials":["University at Buffalo\n","Gastroenterology Division"],"disclosure":""},{"name":"Jim Natale, PharmD, BCOP","credentials":["Clinical Pharmacy Specialist\n","UPMC Cancer Centers"],"disclosure":"Speaker's Bureau: Merck [Lung Cancer (Keytruda)]."},{"name":"Joel W Neal, MD, PhD","credentials":["Assistant Professor of Medicine (Oncology)\n","Stanford University/ Stanford Cancer Institute"],"disclosure":"Grant/Research Support: Genentech/Roche [lung cancer (erlotinib)]; Merck [lung cancer]; Novartis [lung cancer (ceritinib)]; Nektar [lung cancer (brigatinib)]. Consultant/Advisory Boards: Takeda [lung cancer (brigatinib)]; Lilly [lung cancer]; Astra Zeneca [lung cancer (osimertinib)]."},{"name":"Robert S Negrin, MD","credentials":["Section Editor — Bone Marrow Transplantation\n","Professor of Medicine\n","Stanford University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Amgen [Immuno-oncology]; Jazz Pharmaceuticals [Veno-occlusive disease (Defibrotide)]; Cell Source [Cellular therapy]; Magenta Pharmaceuticals [Transplantation]. Equity Ownership/Stock Options: Concentrx [Cellular immunotherapy]; Magenta Pharmaceuticals [Transplantation]; Cell Source [Cellular therapy]. Other Financial Interest: American Society of Hematology [Editor in Chief of \"Blood Advances\"]."},{"name":"Larissa Nekhlyudov, MD, MPH","credentials":["Section Editor — Cancer Survivorship\n","Associate Professor\n","Department of Medicine\n","Brigham & Women’s Hospital\n","Harvard Medical School"],"disclosure":""},{"name":"Peter S Nelson, MD","credentials":["Member, Divisions of Human Biology and Clinical Research\n","Fred Hutchinson Cancer Research Center\n","Professor, Division of Medical Oncology, University of Washington"],"disclosure":""},{"name":"Andrea K Ng, MD, MPH","credentials":["Professor, Radiation Oncology, Harvard Medical School\n","Brigham and Women's Hospital\n","Dana-Farber Cancer Institute"],"disclosure":""},{"name":"Lynnette K Nieman, MD","credentials":["Section Editor — Adrenal Disease\n","Senior Investigator\n","Bethesda, MD"],"disclosure":"Grant/Research/Clinical Trial Support: HRA Pharma [Cushing's syndrome (Metapyrone)]."},{"name":"Errol R Norwitz, MD, PhD, MBA","credentials":["Professor and Chair\n","Department of Obstetrics and Gynecology\n","Tufts Medical Center and Tufts University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Illumina [Preeclampsia (primary investigator on a prospective cohort study to collect samples from patients with preeclampsia to facilitate development of a biomarker test to predict/diagnose this disorder)]. Consultant/Advisory Boards: Hologic [Preterm birth (Fetal fibronectin test to predict preterm birth)]; Natera [Fetal aneuploidy testing (NIPT as a screening test for fetal aneuploidy)]; Seracare [Fetal aneuploidy testing (Developing controls for NIPT screening test for fetal aneuploidy)]; Bayer [Prediction test for preeclampsia (Use of urinary angiogenic factors to predict preeclampsia)]."},{"name":"Jed G Nuchtern, MD, FACS, FAAP","credentials":["Professor of Surgery, Pediatric Surgery Division\n","Baylor College of Medicine"],"disclosure":""},{"name":"Michael A O'Donnell, MD, FACS","credentials":["Professor of Urology\n","University of Iowa"],"disclosure":"Grant/Research/Clinical Trial Support: Abbot Molecular [Bladder cancer diagnostic (Urovision FISH test)]; Roche [Bladder cancer clinical trial investigator (Atezolizumab)]; Photocure [Bladder Cancer Clinical Trial with Diagnostic Investigator (Cysview and new flexible imaging system)]. Consultant/Advisory Boards: Medical Enterprises [Bladder cancer treatment- microwave hyperthermia (synergo device)]; Telesta [Bladder cancer treatment (MCNA)]; Viventia [Bladder cancer treatment (Vicinium)]; Spectrum (Bladder cancer treatment-apaziquone); Fidia Pharmaceuticals (Bladder cancer treatment). Equity Ownership/Stock: Therlasae [Bladder cancer-Laser (New therapeutic laser for photo dynamic therapy)]."},{"name":"Ronan O'Driscoll, BSc, MD, FRCP","credentials":["Consultant Respiratory Physician\n","Salford Royal University Hospital, United Kingdom"],"disclosure":""},{"name":"Robert D Odze, MD, FRCPC","credentials":["Professor of Pathology\n","Harvard Medical School"],"disclosure":""},{"name":"Kevin Oh, MD","credentials":["Assistant Professor of Radiation Oncology\n","Harvard Medical School\n","\n","Attending Radiation Oncologist\n","Massachusetts General Hospital"],"disclosure":"Grant/Research/Clinical Trial Support: Merck [Immunotherapy in brain metastases (pembrolizumab)]; Elekta [Funding for multi-institutional brain metastases consortium (Linear accelerator)]."},{"name":"William K Oh, MD","credentials":["Section Editor — Testicular Cancer\n","Professor of Medicine\n","Mount Sinai School of Medicine\n","Chief, Division of Hematology Oncology\n","Tisch Cancer Institute"],"disclosure":""},{"name":"Devin J Okay, DDS","credentials":["Division of Prosthodontics\n","Mount Sinai Beth Israel"],"disclosure":""},{"name":"M Fatih Okcu, MD, MPH","credentials":["Professor of Pediatrics\n","Baylor College of Medicine"],"disclosure":""},{"name":"Tomasz R Okon, MD","credentials":["Clinical Assistant Professor\n","Department of Internal Medicine\n","University of Wisconsin - Madison\n","Marshfield Clinic, Wisconsin"],"disclosure":""},{"name":"Scott Okuno, MD","credentials":["Professor of Oncology\n","Division of Medical Oncology\n","Mayo Clinic"],"disclosure":"Other Financial Interest: AXIS Medical Education Faculty [Certified educational activities]."},{"name":"Alexander B Olawaiye, MD","credentials":["Associate Professor of Obstetrics, Gynecology and Reproductive Sciences\n","University of Pittsburgh"],"disclosure":""},{"name":"Kenneth R Olivier, MD","credentials":["Associate Professor\n","Mayo Clinic, Rochester, MN"],"disclosure":""},{"name":"Elise A Olsen, MD","credentials":["Professor of Dermatology and Oncology\n","Duke University Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Bioniz [CTCL, consultant]; Galderma [CTCL, investigator clinical trial]; Elorac [CTCL, investigator clinical trial]."},{"name":"Lynn Bunch O'Neill, MD","credentials":["Associate Professor\n","Emory University School of Medicine"],"disclosure":""},{"name":"David Ost, MD, MPH","credentials":["Professor, Department of Pulmonary Medicine\n","The University of Texas MD Anderson Cancer Center"],"disclosure":""},{"name":"Jamie Ostroff, PhD","credentials":["Behavioral Sciences Service \n","Department of Psychiatry & Behavioral Sciences \n","Memorial Sloan-Kettering Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: CVS Health [Smoking cessation (Nicotine replacement products)]; Pfizer Inc. [Smoking cessation (Varenicline)]. Speaker's Bureau: Bristol-Myers Squibb [Lung cancer survivorship (Psychosocial adaptation methods)]."},{"name":"Shirley Otis-Green, MSW, MA, LCSW, ACSW, OSW-C","credentials":["Consultant\n","Collaborative Caring"],"disclosure":""},{"name":"Michael J Overman, MD","credentials":["Associate Professor\n","Department of Gastrointestinal Medical Oncology\n","MD Anderson Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen [small bowel adenocarcinoma (panitumumab)]; Roche [small bowel adenocarcinoma (bevacizumab)]; BMS [colon cancer (cetuximab)]. Consultant/Advisory Boards: Roche [colon cancer (atezolizumab)]; BMS [colon cancer (nivolumab)]."},{"name":"Cindy Owen, MD","credentials":["Assistant Professor of Medicine\n","University of Louisville"],"disclosure":""},{"name":"Eric Padron, MD","credentials":["Assistant Member, Malignant Hematology\n","H. Lee Moffitt Cancer Center and Research Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Incyte, CTI, KaloBios [CMML (ruxolitinib, pacritinib)]. Consultant/Advisory Boards: CTI, Incyte [myelofibrosis (pacritinib)]."},{"name":"Lance C Pagliaro, MD","credentials":["Professor of Oncology\n","Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Sumanta K Pal, MD","credentials":["Assistant Professor, Department of Medical Oncology & Experimental Therapeutics\n","City of Hope Comprehensive Cancer Center"],"disclosure":"Speaker's Bureau: Genentech [Papillary RCC (Atezolizumab)]. Consultant/Advisory Boards: Pfizer [Papillary RCC (Sunitinib, axitinib)]; Genentech [Papillary RCC (Bevacizumab, atezolizumab)]; Novartis [Papillary RCC (Everolimus)]; Exelixis [Papillary RCC (Cabozantinib)]; BMS [Papillary RCC (Nivolumab, ipilimumab)]."},{"name":"Joel M Palefsky, MD","credentials":["Professor\n","University of California San Francisco\n","Immediate Past President, International Papillomavirus Society\n","Past President, International Anal Neoplasia Society"],"disclosure":"Grant/Research/Clinical Trial Support: Merck and Co [HPV vaccine (Gardasil-9)]. Consultant/Advisory Boards: Antiva Therapeutics [HPV therapeutics]; Agenovir Corporation [HPV therapeutics]. Equity Ownership/Stock Options: Antiva Therapeutics [HPV therapeutics]; Agenovir Corporation [HPV therapeutics]; Ubiome [HPV diagnostics]."},{"name":"Manisha Palta, MD","credentials":["Assistant Professor of Radiation Oncology\n","Duke University"],"disclosure":"Grant/Research/Clinical Trial Support: Merck [Esophago-gastric cancer (Pembrolizumab; research support for investigator-initiated clinical trial)]. Speaker's Bureau: Oakstone CME [lower GI cancers (product unrelated to UpToDate contribution; received honorarium)]."},{"name":"Liron Pantanowitz, MD","credentials":["Professor of Pathology\n","University of Pittsburgh Medical Center"],"disclosure":""},{"name":"Allan J Pantuck, MD, MS, FACS","credentials":["Associate Professor\n","UCLA David Geffen School of Medicine"],"disclosure":"Consultant/Advisory Boards: Pfizer [Renal cell carcinoma (Sunitinib)]."},{"name":"John K Park, MD, PhD","credentials":["Santa Barbara Neuroscience Institute"],"disclosure":""},{"name":"Ann H Partridge, MD, MPH","credentials":["Director, Adult Survivorship Program\n","Dana-Farber Cancer Institute\n","Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Harvey I Pass, MD","credentials":["Stephen E. Banner Professor of Thoracic Oncology\n","NYU Langone Medical Center"],"disclosure":"Speaker’ s Bureau (Spouse): Genetech [Breast surgery (none)]."},{"name":"Devanshi Patel, MS, CGC","credentials":["Senior Genetic Counselor\n","Massachusetts General Hospital Center for Cancer Risk Assessment"],"disclosure":""},{"name":"Maitray D Patel, MD","credentials":["Associate Professor of Radiology\n","Department of Radiology\n","Mayo Clinic Arizona"],"disclosure":""},{"name":"Shreyaskumar R Patel, MD","credentials":["Center Medical Director, Sarcoma Center\n","Professor of Medicine and Deputy Chairman\n","Department of Sarcoma Medical Oncology\n","MD Anderson Cancer Center\n","The University of Texas"],"disclosure":"Grant/Research/Clinical Trial Support: Johnson & Johnson [Sarcomas (Trabectedin)]; Eisai [Sarcomas (Eribulin)]; Morphotek [Sarcomas (Farletuzumab)]. Consultant/Advisory Boards: Novartis [GIST (Imatinib mesylate)]; CytRx [Sarcomas (Aldoxorubicin)]; Johnson & Johnson [Sarcomas (Trabectedin)]; EMD Serono [Sarcomas (Evofosfamide)]; Eli Lilly [Sarcomas (Olaratumab)]; Bayer [GIST (Regorafenib)]; Immune Design [Liposarcomas (CMB305 vaccine)]; Epizyme [Epithelioid sarcomas/chordomas (Tazemetostat)]."},{"name":"Erik K Paulson, MD","credentials":["Professor and Chairman\n","Department of Radiology\n","Duke University School of Medicine"],"disclosure":""},{"name":"Aimee S Payne, MD, PhD","credentials":["Associate Professor\n","Department of Dermatology\n","University of Pennsylvania"],"disclosure":""},{"name":"York Pei, MD, FRCPC, FACP, FASN","credentials":["Professor of Medicine\n","University Health Network and University of Toronto"],"disclosure":""},{"name":"Tobias Peikert, MD","credentials":["Consultant, Division of Pulmonary and Critical Care Medicine\n","Mayo Clinic, Rochester, MN"],"disclosure":""},{"name":"Jeffrey F Peipert, MD, PhD","credentials":["Clarence E. Ehrlich Professor and Chair\n","Department of Obstetrics & Gynecology\n","Indiana University School of Medicine"],"disclosure":""},{"name":"David F Penson, MD, MPH","credentials":["Professor of Urologic Surgery\n","Director of Vanderbilt Center for Surgical Quality and Outcomes Research"],"disclosure":"Consultant/Advisory Boards: Astellas; Dendreon, Janssen [Prostate cancer (Enzalutamide, abiraterone, apalutamide, sipuleucel-T)]."},{"name":"Richard T Penson, MD, MRCP","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Array BioPharma, AstraZeneca, Cerulean Pharma, Eisai, Genentech, Regeneron, Sanofi-Aventis US LLC, Tesaro, Vascular Biogenics Ltd [Ovarian cancer. Consultant/Advisory Boards: Amgen, Genentech, AstraZeneca, Eisai, Vascular Biogenics Ltd, Baxalta Oncology, AbbVie, Clovis Oncology, Tesaro [Ovarian cancer]. Other Financial Interest: BMJ; Blackwell Publishing Medicine at a Glance [Royalties]; Advance Medical HCMS, SA [Consulting]."},{"name":"Mark A Perazella, MD, FACP","credentials":["Professor of Medicine\n","Yale University School of Medicine"],"disclosure":""},{"name":"Beth N Peshkin, MS, CGC","credentials":["Professor of Oncology, Senior Genetic Counselor\n","Georgetown University Medical School\n","Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research"],"disclosure":"Consultant/Advisory Boards: Clear Genetics [Genetic counseling and testing (Technology to expand access)]."},{"name":"Amy H Peterman, PhD","credentials":["Associate Professor\n","University of North Carolina at Charlotte"],"disclosure":""},{"name":"Curtis A Pettaway, MD","credentials":["Professor of Urology\n","University of Texas"],"disclosure":""},{"name":"Lori J Pierce, MD","credentials":["Section Editor — Radiation Therapy\n","Professor of Radiation Oncology\n","University of Michigan School of Medicine"],"disclosure":""},{"name":"Phillip M Pierorazio, MD","credentials":["Associate Professor of Urology and Oncology, \n","Brady Urological Institute and Department of Urology, \n","Johns Hopkins Medicine"],"disclosure":""},{"name":"Eugene J Pietzak, MD","credentials":["Assistant Attending Surgeon, Urology Service\n","Department of Surgery\n","Memorial Sloan Kettering Cancer\n","Assistant Professor of Urology\n","Weill Medical College of Cornell University"],"disclosure":""},{"name":"Roberto Pili, MD","credentials":["Robert Wallace Miller Professor of Medicine, Director of GU Oncology Division of Hematology/Oncology\n","Department of Medicine Professor of Pharmacology and Toxicology Indiana University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech, Syndax, Merck [Renal and urothelial cancer (drug development)]."},{"name":"Louis L Pisters, MD","credentials":["Professor\n","The University of Texas School of Medicine\n","MD Anderson Cancer Center"],"disclosure":""},{"name":"Marie Plante, MD","credentials":["Full Professor of Gynecologic Oncology\n","Department of Obstetrics and Gynecology\n","Division of Gynecologic Oncology\n","L'Hôtel-Dieu de Québec\n","Centre Hospitalier Universitaire de Québec\n","Laval University"],"disclosure":""},{"name":"Steven C Plaxe, MD","credentials":["Professor, Reproductive Medicine\n","Director, Gynecologic Oncology\n","University of California, San Diego School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Tesaro, Milennium, Pfizer, Astra-Zeneca, Pharma Mar, Bind, Janssen, Novartis, Incyte, Azaya [Oncology (various study drugs)]. Equity Ownership/Stock Options (Spouse): Abbvie."},{"name":"Sharon E Plon, MD, PhD","credentials":["Professor, Departments of \n","Pediatrics/Hematology-Oncology\n","Molecular and Human Genetics\n","Human Genome Sequencing Center\n","Baylor College of Medicine"],"disclosure":"Consultant/Advisory Boards: Baylor Genetics Laboratories [genetic testing (hereditary cancer genetic testing)]."},{"name":"Scott L Pomeroy, MD, PhD","credentials":["Bronson Crothers Professor of Neurology\n","Harvard Medical School"],"disclosure":""},{"name":"Colin S Poon, MD, PhD, FRCPC","credentials":["Clinical Assistant Professor of Radiology\n","Department of Diagnostic Radiology\n","Yale University School of Medicine"],"disclosure":""},{"name":"Thaddeus M Pope, JD, PhD","credentials":["Director, Health Law Institute\n","Professor, Mitchell Hamline School of Law (Saint Paul, MN)"],"disclosure":""},{"name":"Sandro V Porceddu, MD","credentials":["Radiation Oncologist, Princess Alexandra Hospital\n","Associate Professor, University of Queensland"],"disclosure":"Consultant/Advisory Boards: Merck Serono [Head and neck (Cetuximab)]; Merck Sharpe Dome [Head and Neck (Pembrolizumab)]."},{"name":"Russell K Portenoy, MD","credentials":["Chief Medical Officer\n","MJHS Hospice and Palliative Care\n","Professor of Neurology and Family and Social Medicine\n","Albert Einstein College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: AstraZeneca [Pain (Opioid antagonist)]; Tabula Rasa [Decision support]."},{"name":"Didier Portilla, MD","credentials":["Professor of Medicine\n","University of Virginia"],"disclosure":""},{"name":"Michael Postow, MD","credentials":["Assistant Attending Physician\n","Memorial Sloan-Kettering Cancer Center\n","Assistant Professor of Medicine\n","Weill Medical College of Cornell University"],"disclosure":"Grant/Research/Clinical Trial Support: Bristol Myers Squibb [Immunotherapy (ipilimumab, nivolumab)]. Consultant/Advisory Boards: Bristol Myers Squibb [Immunotherapy (ipilimumab, nivolumab)]; Merck [Immunotherapy (pembrolizumab)]."},{"name":"Matthew A Powell, MD","credentials":["Associate Professor, Division of Gynecologic Oncology\n","Director, Gynecologic Oncology Fellowship"],"disclosure":"Speaker's Bureau: Roche/Genetech [Ovary, Cervix (Bevacizumab)]; AstraZeneca; Clovis Oncology; Tesaro, Inc. [Ovary]. Consultant/Advisory Board: Roche/Genetech [Ovary, cervix (Bevacizumab)]; AstraZeneca [Ovary (Olaparib)]; Clovis Oncology [Ovary (Rucaparib)]; Tesaro, Inc. [Ovary (Niraparib)]."},{"name":"Olga Pozdnyakova, MD","credentials":["Assistant Professor of Pathology\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Promedior [myeloproliferative neoplasms]."},{"name":"Josef T Prchal, MD","credentials":["Professor of Medicine\n","University of Utah"],"disclosure":""},{"name":"Kathleen I Pritchard, MD, FRCPC","credentials":["Professor Emerita\n","Division of Medical Oncology\n","Department of Medicine\n","University of Toronto\n","\n","Medical Oncologist\n","Sunnybrook Odette Cancer Centre\n","Senior Scientist\n","Sunnybrook Research Institute\n","Toronto, Canada"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer, Roche, Amgen, Novartis, Eisai [Breast cancer (Exemestane, letrozole, trastuzumab, pertuzumab)]. Consultant/Advisory Boards: Pfizer, Roche, Amgen, Novartis, Eisai [Breast cancer (Exemestane, letrozole, trastuzumab, pertuzumab])."},{"name":"Christina M Puchalski, MD, MS, FACP, FAAHPM","credentials":["Director and Professor\n","George Washington Institute for Spirituality and Health, School of Medicine and Health Sciences\n","The George Washington University, Washington, DC"],"disclosure":""},{"name":"Ching-Hon Pui, MD","credentials":["Chair of the Department of Oncology\n","Fahad Al-Rashid Chair of Leukemia Research\n","St. Jude's Children's Hospital\n","American Cancer Society Professor \n","Professor of Pediatrics\n","University of Tennessee Health Science Center"],"disclosure":"Consultant/Advisory Boards: Adaptive Biotechnologies [Deep sequencing for minimal residual disease detection]."},{"name":"Jose S Pulido, MD, MS, MPH","credentials":["Professor of Ophthalmology and Molecular Medicine\n","Mayo Clinic"],"disclosure":"Equity Ownership/Stock Options: Lagen Laboratories [Chemotherapy (Nonhuman laboratory use of iPSC-RPE cells)]."},{"name":"Bradley J Quade, MD, PhD","credentials":["Associate Professor of Pathology\n","Harvard Medical School"],"disclosure":""},{"name":"David I Quinn, MBBS (Hons I), PhD, FRACP, FACP","credentials":["Associate Professor of Medicine\n","University of Southern California Norris Cancer Center\n","Keck School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Millenium [Renal cell cancer (Tak700)]; Genentech [Renal cell carcinoma (Avastin, atezoluzimab)]; Glaxo Smith Kline/Novartis [Urothelial cancer (Everolimus, zometa, pazopanib)]. Consultant/Advisory Boards: Pfizer [Renal cell carcinoma, prostate cancer (Sunitinib, axitinib, temsirolimus, avelumab, enzalutamide)]; Novartis/GSK [Renal cell carcinoma, prostate (Everolimus, zometa, pazopanib)]; Genentech [Bladder cancer, renal cell carcinoma (Atezoluzimab, bevacuzimab)]; Bayer [Renal cell carcinoma, prostate cancer , urothelial cancer (Radium 223, sorafenib, rogaratinib)]; Dendeon [Prostate cancer (Sipuleucel-T)]; Astellas [Prostate cancer (Enzalutamide)]; BMS [Renal cancer, bladder cancer (Nivolumab, ipilumumab)]; Merck Sharp Dohme [Bladder cancer, renal cancer (Pembroluzimab)]; Exelexis [Renal cell carcinoma (Caboxantinib); Jannsen [Prostate cancer (Abiraterone, apalutamide)]; Sanofi Genzyme [Prostate cancer (Cabazitaxel)]."},{"name":"Jeanne M Quivey, MD, FACR","credentials":["Professor\n","Clinical Radiation Oncology\n","University of California, San Francisco"],"disclosure":""},{"name":"Dmitry J Rabkin, MD, PhD","credentials":["Assistant Professor\n","Harvard Medical School\n","Division of Angiography and Interventional Radiology\n","Brigham and Women's Hospital"],"disclosure":""},{"name":"Derek Raghavan, MD, PhD, FACP, FASCO","credentials":["Section Editor — Bladder Cancer\n","President, Levine Cancer Institute\n","Carolinas HealthCare System\n","Charlotte, NC"],"disclosure":"Other Financial Interest: Caris Life Sciences [Molecular prognostication (Panomic sequencing - unpaid)]."},{"name":"Kanti R Rai, MD","credentials":["Professor of Medicine and Molecular Medicine\n","Zucker School of Medicine at Hofstra/Northwell"],"disclosure":"Advisory Boards: Pharmacyclics [CLL (ibrutinib)], Gilead [CLL (idelalisib)], Roche/Genentech [CLL (obinutuzumab, rituximab)], Cellectis [CLL (not named, generic: allogeneic CAR-T cells)]."},{"name":"Isaac Raijman, MD","credentials":["Clinical Associate Professor of Medicine\n","Baylor College of Medicine, Houston, TX\n","Digestive Associates of Houston, PA"],"disclosure":"Speaker's Bureau: Covidien [ERCP, Spyglass, RFA]; Boston Scientific [ERCP, Spyglass, RFA]. Consult/Advisory Boards: Boston Scientific [Spyglass, ERCP]. Patent Holder: ENDO RX [Biliary Balloon]. Equity Ownership/Stock Options: ENDO RX [Co-owned]."},{"name":"Nino Rainusso, MD","credentials":["Assistant Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine\n","Texas Children's Cancer & Hematology Centers"],"disclosure":""},{"name":"S Vincent Rajkumar, MD","credentials":["Edward W. and Betty Knight Scripps Professor of Medicine\n","Mayo Clinic"],"disclosure":""},{"name":"Naren Ramakrishna, MD, PhD","credentials":["Director of Neuro and Pediatric Radiation Oncology\n","University of Florida Health Cancer Center at Orlando Health\n","Professor of Radiation Oncology \n","University of Central Florida College of Medicine"],"disclosure":"Speaker's Bureau: Brainlab Ag [Radiation treatment of brain tumors (Treatment planning software, Image-guided patient positioning)]."},{"name":"Suresh S Ramalingam, MD","credentials":["Professor\n","Director of Medical Oncology\n","Department of Hematology and Medical Oncology\n","Emory University, Winship Cancer Institute"],"disclosure":"Consultant/Advisory Boards: AbbVie; AstraZeneca; Bristol-Myers Squibb; Boehringer Ingelheim; Celgene; Lilly; Merck; Novartis; Genentech [Lung cancer (Pemetrexed)]."},{"name":"Scott D Ramsey, MD","credentials":["Professor of Medicine\n","University of Washington\n","Fred Hutchinson Cancer Research Center"],"disclosure":"Consultant/Advisory Boards: Epigenomics [Colorectal cancer (blood test to screen for colorectal cancer in average-risk persons)]."},{"name":"Shyam SD Rao, MD, PhD","credentials":["Assistant Professor of Radiation Oncology\n","University of California Davis Comprehensive Cancer Center"],"disclosure":""},{"name":"Chandrajit P Raut, MD, MSc, FACS","credentials":["Associate Professor of Surgery, Harvard Medical School\n","Division of Surgical Oncology, Brigham and Women's Hospital \n","Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute"],"disclosure":"Other Financial Interest: Novartis China [GIST (Clinical trial data discussions on neoadjuvant and adjuvant imatinib)]."},{"name":"Vinod Ravi, MD","credentials":["Associate Professor\n","Sarcoma Medical Oncology\n","MD Anderson Cancer Center\n","The University of Texas"],"disclosure":""},{"name":"Lawrence D Recht, MD","credentials":["Professor of Neurology\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Susan D Reed, MD, MPH","credentials":["Professor\n","Departments of Obstetrics and Gynecology & Epidemiology\n","Harborview Medical Center\n","University of Washington"],"disclosure":"Grant/Research/Clinical Trial Support: Bayer Pharmaceuticals [Uterine fibroids, endometriosis, uterine perforation (Levonorgestrel IUS)]."},{"name":"Samuel Refetoff, MD","credentials":["Professor of Medicine, Pediatrics, and Committee on Genetics\n","University of Chicago"],"disclosure":""},{"name":"Mara H Rendi, MD, PhD","credentials":["Department of Anatomic Pathology\n","University of Washington"],"disclosure":""},{"name":"Jerome P Richie, MD, FACS","credentials":["Section Editor — Cancer of the Urethra, Penis, and Ureter; Urologic Surgery; Prostate Cancer\n","Elliott Carr Cutler Professor of Surgery\n","Harvard Medical School"],"disclosure":""},{"name":"Stephen Riggs, MD, FACS","credentials":["Urologic Oncologist\n","Levine Cancer Institute\n","Carolinas HealthCare System"],"disclosure":"Speaker’s Bureau: Prostate Conditions Education Council. Equity Ownership/Stock Options: Exelixis."},{"name":"Mack Roach, III, MD","credentials":["Professor of Radiation Oncology and Urology\n","University of California, San Francisco\n","Department of Radiation Oncology\n","Helen Diller Family Comprehensive Cancer Center"],"disclosure":"Speaker’ s Bureau: Janssen (Johnson & Johnson) [Prostate cancer & hormonal therapy (ARN-509)]. Consultant/Advisory Boards: Accuray [Radiation devices (CyberKnife/Tomotherapy)], Ferring Pharmaceuticals [Drug company (Degarelix)]; Myriad [Prostate cancer (Polaris diagnostic test)]. Employment: NCI (National Cancer Advisory Board); IAEA (International Atomic Energy Agency) [Special Government Employee/Consultant]."},{"name":"William R Robinson, MD","credentials":["Professor of Gynecologic Oncology\n","Tulane Medical School"],"disclosure":""},{"name":"Dario Roccatello, MD","credentials":["Professor of Nephrology and Clinical Pathology\n","University of Turin Medical School"],"disclosure":"Consultant/Advisory Boards: Genzyme [Eliglustat (Gaucher Disease)]."},{"name":"James W Rocco, MD, PhD, FACS","credentials":["Professor and John and Mary Alford Chair of Head and Neck Surgery\n","The Ohio State University Wexner Medical Center"],"disclosure":""},{"name":"Richard J Rodeheffer, MD","credentials":["Professor of Medicine\n","Mayo Medical School"],"disclosure":""},{"name":"Linda Rodgers, MGC, CGC","credentials":["Genetic Counselor\n","Massachusetts General Hospital Center for Cancer Risk Assessment"],"disclosure":""},{"name":"Miguel A Rodriguez-Bigas, MD","credentials":["Professor of Surgery\n","MD Anderson Cancer Center"],"disclosure":""},{"name":"G David Roodman, MD, PhD","credentials":["Indiana University"],"disclosure":"Consultant/Advisory Boards: Amgen [bone metastasis (denosumab)]."},{"name":"Alain H Rook, MD","credentials":["Professor of Dermatology\n","Perelman School of Medicine at the University of Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: Soligenix [CTCL research (hypericin clinical trial)]; Medimmune [CTCL trial]; Galderma [CTCL trial]."},{"name":"Jonathan E Rosenberg, MD","credentials":["Associate Attending Physician\n","Associate Professor\n","Section Head, Non-Prostate Genitourinary Malignancies\n","Memorial Sloan-Kettering Cancer Center\n","Weill-Cornell Medical College"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech/Roche [Bladder cancer (Atezolizumab)]; AstraZeneca [Bladder cancer (durvalumab, olaparib)]; Bayer [Bladder cancer (rogaratinib)]. Consultant/Advisory Boards: Merck [Bladder cancer (Pembrolizumab)]; Bristol-Myers Squibb [Bladder cancer (Nivolumab)]; AstraZeneca [bladder cancer (durvalumab, tremelimumab]); Genentech/Roche (Bladder cancer [atezolizumab]); EMD-Serono [Bladder cancer (Avelumab)]; Agensys [bladder cancer (ASG-22CE)]; Seattle Genetics [bladder cancer]; Bayer [Bladder cancer]; Gristone [Bladder Cancer]."},{"name":"Laurie Rosenblatt, MD","credentials":["Assistant Professor of Psychiatry (Medicine)\n","Harvard Medical School"],"disclosure":""},{"name":"Myrna R Rosenfeld, MD, PhD","credentials":["Professor of Neurology\n","Hospital Clinic/IDIBAPS, University of Barcelona, Spain\n","Adjunct Professor of Neurology\n","University of Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support (spouse): CELLEX Foundation [unrestricted research grant focus on memory alteration in autoimmune encephalitis]; Euroimmun [autoimmune encephalitis (antibody testing kits)]. Patent Holder/Royalties: Euroimmun Inc [NMDAR encephalitis (antibody tests)]; Athena [Ma2 encephalitis (antibody tests)]. Patent Holder/Royalties (spouse): Euroimmun Inc [NMDAR encephalitis, DPPX, GABA-B encephalitis, GABA-A, IgLON5 (antibody tests)]; Athena [Ma2 encephalitis (antibody tests)]."},{"name":"Kenneth Rosenzweig, MD","credentials":["Professor and Chairman\n","Department of Radiation Oncology\n","Icahn School of Medicine at Mount Sinai"],"disclosure":""},{"name":"Ashley Ross, MD, PhD","credentials":["Associate Professor of Urology and Oncology\n","Johns Hopkins Brady Urological Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Metamark Genetics [Prostate cancer biomarker (Unrestricted research grant)]. Consultant/Advisory Boards: GenomeDX [Prostate cancer biomarker (Genomic classifier test)]; Healthtronics [Cryotherapy]. Equity Ownership/Stock Options: GenomeDX [Prostate cancer biomarker (Genomic classifier test)]."},{"name":"Douglas S Ross, MD","credentials":["Section Editor — Thyroid Disease\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Board: Medullary Thyroid Cancer Registry Consortium [Thyroid cancer]; Shire [Hypoparathyroidism (Parathyroid hormone for injection)]; Spectrix Therapeutics, LLC [Hypothyroidism (Thyroid hormone)]. Other Financial Interests: Abbott India (honorarium) [Hyperthyroidism (carbimazole, levothyroxine)]; Quest Diagnostics (honorarium) [Hyperthyroidism]."},{"name":"Michael E Ross, MD","credentials":["Senior Deputy Editor — UpToDate\n","Deputy Editor — Oncology"],"disclosure":""},{"name":"Nan Rothrock, PhD","credentials":["Research Associate Professor\n","Medical Social Sciences\n","Feinberg School of Medicine\n","Northwestern University"],"disclosure":""},{"name":"Peter P Roy-Byrne, MD","credentials":["Editor-in-Chief — Psychiatry\n","Section Editor — Depressive Disorders\n","Professor of Psychiatry and Behavioral Sciences\n","University of Washington School of Medicine"],"disclosure":"Employment: Mass Medical Society (journal Watch); Wiley Lliss (Depression and Anxiety) [Editor in Chief]. Stock Options: Valant Medical Solutions [behavioral health (EMR)]."},{"name":"James L Rubenstein, MD, PhD","credentials":["Professor of Medicine, Division of Hematology/Oncology\n","University of California, San Francisco"],"disclosure":"Grant/Research Support: Celgene [Lymphoma (Lenalidomide)]; Genentech [Lymphoma (Rituximab)]."},{"name":"Kathryn J Ruddy, MD, MPH","credentials":["Director of Cancer Survivorship\n","Associate Professor of Oncology\n","Mayo Clinic"],"disclosure":""},{"name":"Michelle A Rudek, PharmD, PhD","credentials":["Associate Professor of Oncology\n","Director of the Analytical Pharmacology Core Lab\n","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins"],"disclosure":"Grant/Research/Clinical Trial Support: Celgene [Drug analysis (5-azacitidine, romidepsin)]; Taiho Pharmaceutical [Organ dysfunction (TAS-102)]; RenovoRx [Drug analysis]. Other Financial Interest: Otsuka [Honorarium]. Equity Ownership/Stock Options (spouse/partner): Novavax; Amplimmune. Employment (spouse/partner): Novavax [Vaccines to treat infectious diseases] - No relevant conflict on topic."},{"name":"Charles M Rudin, MD, PhD","credentials":["Chief, Thoracic Oncology Service\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":""},{"name":"Hope S Rugo, MD","credentials":["Professor of Medicine\n","UCSF Helen Diller Family Comprehensive Cancer Center"],"disclosure":""},{"name":"Carolyn D Runowicz, MD","credentials":["Executive Associate Dean for Academic Affairs\n","Professor of Obstetrics and Gynecology\n","Florida International University\n","Herbert Wertheim College of Medicine"],"disclosure":""},{"name":"Bruce A Runyon, MD","credentials":["Section Editor — Cirrhosis and Its Complications\n","Special Hepatology Consultant to the Indian Health Service \n","Northern Navajo Medical Center, Shiprock, New Mexico"],"disclosure":""},{"name":"Erich W Russi, MD","credentials":["Professor of Medicine\n","University Hospital, Switzerland"],"disclosure":""},{"name":"Andrea L Russo, MD","credentials":["Assistant Professor\n","Harvard Medical School\n","Department of Radiation Oncology\n","Massachusetts General Hospital"],"disclosure":""},{"name":"Jose Russo, MD","credentials":["Senior Member\n","Director Breast Cancer Research\n","Fox Chase Cancer Center"],"disclosure":""},{"name":"Charles J Ryan, MD","credentials":["Professor of Clinical Medicine and Urology\n","UCSF/Helen Diller Family Comprehensive Cancer"],"disclosure":"Grant/Research/Clinical Trial Support: Karyopharm [Prostate cancer (Selinexor)]; Clovis Oncology [Prostate cancer (Rucaparib)]. Speaker's Bureau: Janssen [Prostate cancer (Abiraterone)]; Astellas [Prostate cancer (Enzalutamide)]. Consultant/Advisory Boards: Astra Zeneca [Prostate cancer (Olaparib)]; Asana [Prostate cancer]; Bayer [Prostate cancer (Rad223)]; Sanofi [Prostate cancer]; Churchill Pharmaceuticals [Prostate cancer (Abiraterone Solumatrix)]."},{"name":"Christopher W Ryan, MD","credentials":["Professor\n","Oregon Health & Science University\n","Knight Cancer Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Eisai [Sarcoma (Eribulin)]; Janssen [Sarcoma (Trabectedin)]; Bayer [Sarcoma (Sorafenib)]; Threshold [Sarcoma (Investigational agent)]; Tracon [Renal carcinoma (Investigational agent)]; GSK/Novartis [Sarcoma (Pazopanib)]; Argos Therapeutics [Renal carcinoma (Investigational agent)]; Bristol Myers Squib [Renal carcinoma (Nivolumab, ipilumumab)]; CytRx [Sarcoma (Investigational agent)]; Exelexis [Renal carcinoma (Cabozantinib)]; MabVax [Sarcoma (Investigational agent)]; Morphotek [Sarcoma (Investigational agent)]; OSI [Renal carcinoma (Erlotinib)]; Ziopharm [Sarcoma (Investigational agent)]; Daiichi [Sarcoma (Investigational agent)]; Pfizer [Renal carcinoma (sunitinib)]. Consultant/Advisory Boards: Eisai [Sarcoma and renal carcinoma (Eribulin)]; Karyopharm [Sarcoma (No commercial drug)]; EMD-Serono [Sarcoma (No commercial drug)]; Pfizer [Renal carcinoma (N/A)]; Janssen [Sarcoma (Trabectedin)]; Onyx [Renal carcinoma (N/A)]; Exelixis [Renal carcinoma (N/A)]; Novartis[Renal carcinoma (pazopanib)]."},{"name":"David P Ryan, MD","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: MPM Capital [Drug development (Clinical trials)]."},{"name":"Nabil F Saba, MD, FACP","credentials":["Professor, Department of Hematology and Medical Oncology\n","Director of Head and Neck Oncology \n","Winship Cancer Institute of Emory University"],"disclosure":"Consultant/Advisory Boards: BMS; Pfizer [Development of head and neck cancer (Nivolumab)]; Merck [development of head and neck cancer (pembrolizumab)]; Lilly [development of head and neck cancer (cetuximab)]; Pfizer [development of head and neck cancer (avelumab)]."},{"name":"Paul Sabbatini, MD","credentials":["Attending Physician\n","Gynecologic Medical Oncology Service\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Bristol M Squibb [ovarian cancer (nivolumab)(immunologic trial )]."},{"name":"Michael S Sabel, MD","credentials":["Associate Professor of Surgery\n","University of Michigan Medical School"],"disclosure":""},{"name":"A Mazin Safar, MD","credentials":["Associate Professor of Medicine\n","University of Arkansas for Medical Sciences"],"disclosure":""},{"name":"Sunil K Sahai, MD, FAAP, FACP","credentials":["Associate Professor of Medicine\n","Department of General Internal Medicine\n","MD Anderson Cancer Center"],"disclosure":""},{"name":"Wasif M Saif, MD","credentials":["Professor of Medicine\n","Tufts University School of Medicine\n","Director, Gastrointestinal Oncology Program\n","Leader, Experimental Therapeutics Program\n","Tufts  Medical Center Cancer Center"],"disclosure":"Grant/Research/Trial Support: Taiho [Colorectal cancer (trifluridine and tipiracil hydrochloride)]; Genetech [Colorectal cancer (FOLFOXIRI-bevacizumab versus FOLFOX-BEV for the first-line treatment)]; Celgene [Pancreatic cancer (Metronomic fluorouracil in Combination With nab-paclitaxel, bevacizumab, leucovorin, and oxaliplatin)]; Pharmcyclic [Blood cancers and immune-mediated disorders (Ibrutinib)]; NanoCarrier [Various types of cancer (Cisplatin)]; Ipsen [Neuroendocrine tumors (Somatuline depot)]. Speaker's Bureau: Genentech [Colorectal cancer (Bevacizumab)]; Amgen [Colorectal cancer (Panitumumab)]; Novartis [Pancreatic cancer (Everolimus)]; Ipsen [Pancreatic cancer (Lanreotide)]; Celgene [Pancreas (Paclitaxel)]; Lexicon [Neuroendocrine tumors (Xermalo)]. Consultant/Advisory Boards: EMD Sereno [Pancreatic cancer]."},{"name":"Joseph K Salama, MD","credentials":["Associate Professor\n","Department of Radiation Oncology\n","Duke University Cancer Institute"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie [Non-small cell lung cancer (Veliparib)]. Grant/Research/Clinical Trial Support (Spouse): Bristol-Myers Squibb [Melanoma (Ipilimumab)]; Merck [Melanoma (PD-1 inhibition)]; Genentech [Melanoma]; Celldex [Melanoma]; Immunocore [Melanoma]; Reata Pharmaceuticals [Melanoma]. Consultant/Advisory Boards: Bristol-Myers Squibb."},{"name":"Benjamin E Saltman, MD","credentials":["Assistant Professor of Otolaryngology\n","Division of Head and Neck Surgery\n","Hofstra North Shore LIJ School of Medicine"],"disclosure":""},{"name":"John R Saltzman, MD, FACP, FACG, FASGE, AGAF","credentials":["Section Editor — Therapeutic and Diagnostic Endoscopy\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Wolfram E Samlowski, MD","credentials":["Comprehensive Cancer Centers of Nevada (Las Vegas)\n","Clinical Professor\n","University of Nevada (Reno)"],"disclosure":"Speaker’ s Bureau: BMS; Merck; Pfizer; Novartis [renal cell carcinoma (trametinib, pembrolizumab, ipilimumab, nivolumab, dabrafenib)]. Consultant/Advisory Board: Pfizer [renal cell carcinoma (sunitunib, axitinib)]; Castle Biosciences [molecular testing for melanoma]."},{"name":"Hanna K Sanoff, MD, MPH","credentials":["Associate Professor\n","University of North Carolina at Chapel Hill"],"disclosure":"Grant/Research/Clinical Trial Support: Bayer [Colorectal cancer (Regorafenib, Sorafenib)]; Merck [Colorectal cancer (Pembrolizumab)]; Precision Biologics [Colorectal cancer (No approved agents)]."},{"name":"A Oliver Sartor, MD","credentials":["Laborde Professor for Cancer Research\n","Medical Director, Tulane Cancer Center\n","Depts. of Medicine and Urology\n","Tulane Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Bayer [Prostate cancer (Radium-223)]; Endocyte [Prostate cancer (EC1169)]; Innocrin [Prostate cancer (VT464)]; Johnson & Johnson [Prostate cancer (Abiraterone)]; Sanofi-Aventis [Prostate cancer (Cabazitaxel)]; Merk [Prostate cancer]. Consultant/Advisory Boards: AstraZeneca [Prostate cancer]; Bayer [Prostate cancer (Radium-223)]; Bellicum [Prostate cancer (vaccine development)]; Bristol-Myers Squibb [Prostate cancer (Nivolumab)]; Celgene [Prostate cancer (Lenalidomide)]; Dendreon [Prostate cancer (Sipuleucel-T)]; EMD Serono [Prostate cancer]; Johnson & Johnson [Prostate cancer (ARN-509, abiraterone)]; OncogeneX [Prostate cancer (Custirsen)]; Pfizer [Prostate cancer]; Sanofi-Aventis [Prostate cancer (Cabazitaxel)]; Tokai [Prostate cancer (Galeterone)]; NRG Oncology [Genitourinary cancer (Co-chairman of Genitourinary cancer committee)]; Constellation [Prostate cancer]; Endocyte [Prostate cancer]; Advanced Accelerator Applications [Prostate cancer]; Bavarian-Nordic [Prostate cancer]."},{"name":"Diane MF Savarese, MD","credentials":["Senior Deputy Editor — UpToDate\n","Deputy Editor — Oncology and Palliative Care\n","Clinical Instructor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Philip Saylor, MD","credentials":["Assistant Professor of Medicine \n","Harvard Medical School\n","Assistant Physician\n","Massachusetts General Hospital"],"disclosure":""},{"name":"Mark T Scarborough, MD","credentials":["Department of Orthopaedics and Rehabilitation\n","University of Florida College of Medicine"],"disclosure":""},{"name":"Steven J Scheinman, MD","credentials":["President and Dean, Professor of Medicine\n","Geisinger Commonwealth School of Medicine"],"disclosure":""},{"name":"Bradley Schiff, MD","credentials":["Associate Professor\n","Albert Einstein College of Medicine"],"disclosure":""},{"name":"David Schiff, MD","credentials":["Professor of Neurology, Neurological Surgery, and Medicine\n","University of Virginia School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Cavion [GBM (Mibefradil)]; Tocagen [GBM, AA (Toca 511)]; Bayer [IDHmt gliomas (BAY 1436032)]; BeiGene [GBM (BGB-290)]. Consultant/Advisory Boards: Orbus [AA (Eflornithine)]; Monteris [GBM (LITT probe)]."},{"name":"Rachel Schiff, PhD","credentials":["Associate Professor\n","Breast Center\n","Baylor College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Astra Zeneca [Kinase inhibitors, PARP inhibitors, oral anti-estrogen SERD (AZD 5363, AZD 2014, AZD 6244, Olaparib)];  Gilead [Endocrine therapy BET inhibitor (GS-649629, GS-626510). Consultant/Advisory Boards: E. Lilly [CDK4/6 inhibitor (Abemaciclib (a one time))]."},{"name":"Charles A Schiffer, MD","credentials":["Professor of Medicine and Oncology\n","Barbara Ann Karmanos Cancer Institute\n","Wayne State University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis, BMS, Ariad [CML (imatinib, nilotinib, dasatinib, ponatinib)]. Consultant/Advisory Boards: Celgene [AML, thrombotic complications (5-azacytidine, lenalidomide)]; Pfizer [CML (bosutinib)]; Takeda; Ambit; Pharmacyclics; Juno; Astellas [DSMB thrombotic complications]."},{"name":"Steven E Schild, MD","credentials":["Section Editor — Radiation Therapy\n","Professor of Radiation Oncology\n","Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Kathleen M Schmeler, MD","credentials":["Associate Professor\n","Department of Gynecologic Oncology\n","MD Anderson Cancer Center"],"disclosure":""},{"name":"Arthur B Schneider, MD, PhD","credentials":["Professor Emeritus of Medicine\n","University of Illinois at Chicago College of Medicine"],"disclosure":""},{"name":"John O Schorge, MD","credentials":["Gynecologic Oncologist\n","Obstetrics and Gynecology\n","Gynecologic Oncology\n","Tufts Medical Center"],"disclosure":""},{"name":"Anne F Schott, MD","credentials":["Professor of Medicine\n","University of Michigan"],"disclosure":""},{"name":"Kasmintan A Schrader, MBBS, FRCPC, PhD","credentials":["Medical Genetics\n","University of British Columbia"],"disclosure":""},{"name":"Stanley L Schrier, MD","credentials":["Editor-in-Chief — Hematology\n","Section Editor — Myeloproliferative Disorders; Red Blood Cell Disorders\n","Professor of Medicine\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Iris Schrijver, MD","credentials":["Adjunct Professor of Pathology\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Jonathan M Schwartz, MD","credentials":["Professor of Clinical Medicine\n","Montefiore Medical Center/Albert Einstein College of Medicine"],"disclosure":""},{"name":"Peter E Schwartz, MD","credentials":["Professor of Obstetrics, Gynecology and the Reproductive Sciences\n","Yale University School of Medicine"],"disclosure":""},{"name":"Angeles Alvarez Secord, MD","credentials":["Duke University Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie [Ovarian cancer (veliparib)]; Amgen [Ovarian cancer (trebananib)]; Astellas Pharma [Ovarian cancer (linsitinib)]; Astex Pharmaceuticals [Ovarian cancer (guadecitabine)]; AstraZeneca [Ovarian cancer (oliparib)]; Boerhinger Ingelheim [ovarian cancer (nintedanib)]; Bristol Myers Squibb [Ovarian cancer (ipilimumab)]; Eisai [Ovaryian (lenvatinib)]; Endocyte [Ovarian cancer (farletuzumab)]; Exelixis [Ovarian cancer (cabozantinib)]; Incyte [Ovarian cancer (acadostat); Merck [Ovarian cancer (pembrolizumab)]; PharmaMar [Ovarian cancer (lurbinectedin)]; Prima Biomed [Ovarian cancer (CVac)]; Roche/Genentech [Endometrial cancer (bevacizumab)]; TESARO [Ovarian cancer (niraparib)]. Consultant/Advisory Boards: Alexion [Endometrial cancer]; Astex [Ovarian cancer (guadecitabine)]; AstraZeneca [Ovarian cancer (olaparib)]; Clovis [Ovarian cancer (rucaparib)]; Janssen/Johnson & Johnson [Uterine sarcoma/ovarian cancer (trabectadin)]; Roche/Genentech [Endometrial cancer (atezolizumab/bevacizumab)]; TESARO [Ovarian cancer (niraparib)]."},{"name":"Pearl H Seo, MD, MPH","credentials":["Assistant Professor\n","Sylvester Cancer Center\n","University of Miami School of Medicine"],"disclosure":""},{"name":"Lecia V Sequist, MD, MPH","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trail Support: AstraZeneca; Boehringer Ingelheim; Genentech; Merrimack; Novartis; Pfizer; Incyte Corporation [Lung cancer (Multiple anti-cancer therapies)]. Consultant/Advisory Boards: AstraZeneca; Boehringer Ingelheim; Genentech; Merrimack; Novartis; Pfizer [Lung cancer (Multiple anti-cancer therapies)]."},{"name":"F John Service, MD, PhD","credentials":["Emeritus Professor of Medicine\n","Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Sanjeev Sethi, MD, PhD","credentials":["Professor of Laboratory Medicine and Pathology\n","Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Joshua Shadd, MD, CCFP","credentials":["Assistant Professor, Division of Palliative Care, Department of Family Medicine\n","McMaster University Faculty of Health Sciences"],"disclosure":""},{"name":"Mark Edwin Shaffrey, MD","credentials":["Professor and Chairman \n","UVA Health System\n","Department of Neurological Surgery"],"disclosure":""},{"name":"Mehnaz A Shafi, MD","credentials":["Professor of Medicine\n","Department of Gastroenterology, Hepatology and Nutrition\n","MD Anderson Cancer Center"],"disclosure":""},{"name":"Elizabeth Shane, MD","credentials":["Professor of Medicine\n","Columbia University Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen [Osteoporosis (denosumab)]. Consultant/Advisory Boards: Amgen [Osteoporosis (denosumab)]."},{"name":"Melissa L Shannon, MD","credentials":["Staff Physician\n","Catholic Health Initiatives\n","St Vincent Health System"],"disclosure":""},{"name":"Charles L Shapiro, MD","credentials":["Professor of Medicine\n","Director of Translational Breast Cancer Research\n","Director of Cancer Survivorship, Tisch Cancer Institute"],"disclosure":""},{"name":"Shahrokh F Shariat, MD, PhD","credentials":["Professor and Chairman \n","Department of Urology\n","Medical University of Vienna\n","Adjunct Professor of Urology and Medical Oncology\n","Weill Medical College of Cornell University\n","Adjunct Professor of Urology\n","University of Texas Southwestern Medical Center"],"disclosure":"Consultant/Advisory Boards: Astellas [Prostate cancer (Enzalutamide)]; AstraZeneca [Bladder cancer (Durvalumab)]; Bristol-Myers Squibb [Bladder cancer (Nivolumab)]; Cepheid [Bladder cancer (Urine test)]; Ipsen [Bladder cancer (Optical imaging agent)]; Ipsen [Prostate cancer (Triptorelin)]; Janssen [Prostate cancer (Abiraterone)]; Janssen [Bladder cancer (FGFR antibody)]; Merck & Co., Inc. [Bladder cancer (Pembrolizumab)]; Olympus [Bladder cancer (Endoscopes)]; Pfizer [Kidney cancer (Sunitinib)]; Pierre Fabre [Bladder cancer (Vinflunine)]; Richard Wolf [Endoscopy (Endoscopes)]; Roche [Bladder cancer (Atezolizumab)]; Sanochemia [Bladder cancer (Hypericin)]; Sanofi [Prostate cancer (Cabazitaxel)]."},{"name":"Alice T Shaw, MD, PhD","credentials":["Massachusetts General Hospital Cancer Center"],"disclosure":"Consultant/Advisory Boards: Pfizer [ALK inhibitor (Crizotinib, Lorlatinib)]; Novartis [ALK inhibitor (Ceritinib)]; Ariad [ALK inhibitor (Brigatinib)]; Genentech [ALK inhibitor (Alectinib)]; Ignyta [ALK inhibitor (Entrectinib)]; Roche [ALK inhibitor (Alectinib)]; Chugai [ALK inhibitor (Alectinib)]."},{"name":"David J Sher, MD, MPH","credentials":["Associate Professor of Radiation Oncology\n","UT Southwestern Medical Center"],"disclosure":""},{"name":"Amandeep Shergill, MD, MS","credentials":["Associate Clinical Professor of Medicine\n","University of CA, San Francisco/ San Francisco VA Medical"],"disclosure":"Grant/Research/Clinical Trial Support: Pentax [Ergonomics (Endoscopic ergonomics)]."},{"name":"Eric J Sherman, MD","credentials":["Assistant Attending\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":"Clinical Trial Support: Eisai [Thyroid cancer (Lenvatinib)]; Roche [HNSCC ((obimetinib/atezolizumab)]. Consultant/Advisory Boards: Eisai [Thyroid cancer (Lenvatinib)]; Bristol-Myers Squibb [Head and neck cancer (Nivolumab)]; Novartis [Thyroid cancer (dabrafenib/trametinib)]."},{"name":"Steven I Sherman, MD","credentials":["Associate Vice Provost, Clinical Research\n","Chair and Naguib Samaan Distinguished Professor in Endocrinology\n","University of Texas MD Anderson Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Genzyme [Thyroid cancer (Thyrotropin alfa)]. Consultant/Advisory Boards: Eisai [Thyroid cancer (Lenvatinib)]; Exelixis [Thyroid cancer (Cabozantinib)]; Novo Nordisk [Diabetes (Liraglutide)]; Veracyte [Thyroid cancer (Thyroid FNA analysis)]; Bristol-Myers Squibb [Thyroid cancer (Nivolumab)]; Loxo Oncology [Thyroid cancer (LOXO105)]; Genzyme [Thyroid cancer (Thyrotropin alfa; vandetanib)]."},{"name":"David Shibata, MD","credentials":["Professor and Chair\n","Department of Surgery\n","University of Tennessee Health Science Center"],"disclosure":""},{"name":"Helen A Shih, MD","credentials":["Associate Professor of Radiation Oncology\n","Harvard Medical School\n","Attending Radiation Oncologist\n","Massachusetts General Hospital"],"disclosure":"Consultant/Advisory Boards: Genentech [Lung cancer]. Other Financial Interest: International Journal of Radiation Oncology Biology Physics [CNS (senior editor, CNS section)]."},{"name":"Karin K Shih, MD","credentials":["Hofstra University School of Medicine"],"disclosure":""},{"name":"Dong Moon Shin, MD, FACP","credentials":["Emory University School of Medicine\n","Frances Kelly Blomeyer Distinguished Chair in Cancer Research\n","Professor and Executive Vice Chair, Department of Hematology and Medical Oncology\n","Associate Director, Academic Development\n","Adjunct Professor of Biomedical Engineering, The Wallace H. Coulter Departm"],"disclosure":"Grant/Research/Clinical Trial Support: Tarceva [Chemoprevention of the head and neck (Astellas)]; Bristol-Myers Squibb [Recurrent metastatic head and neck cancer (Nivolumab, ipilimumab)]."},{"name":"Jason M Shohet, MD, PhD","credentials":["Division Chair, Pediatric Hematology/Oncology\n","University of Massachusetts Medical School"],"disclosure":""},{"name":"Alexander N Shoushtari, MD","credentials":["Assistant Attending Physician\n","Memorial Sloan Kettering Cancer Center\n","Instructor\n","Weill Medical College of Cornell University"],"disclosure":"Grant/Research/Clinical Trial Support: Bristol-Myers Squibb [Immunotherapy (Ipilimumab, nivolumab)]. Consultant/Advisory Boards: Vaccinex [Immunotherapy (N/A)]; Castle Biosciences [Immunotherapy (N/A)]; Immunocore [Immunotherapy (IMCgp100)]; Bristol-Myers Squibb [Immunotherapy (Ipilimumab, nivolumab)]."},{"name":"Brian Shuch, MD","credentials":["Assistant Professor\n","Department of Urology\n","Yale School of Medicine"],"disclosure":""},{"name":"William M Sikov, MD, FACP","credentials":["Associate Professor of Medicine\n","Obstetrics and Gynecology\n","Warren Alpert Medical School of Brown University"],"disclosure":"Speakers Bureau: Eisai [Metastatic Breast cancer (eribulin). Consultant Advisory Board: Celgene [neaodjuvant therapy (nab-paclitaxel)]; Abbvie [neaodjuvant therapy (veliparib)]."},{"name":"Shonni J Silverberg, MD","credentials":["Professor of Medicine\n","Columbia University College of Physicians and Surgeons"],"disclosure":""},{"name":"Amit G Singal, MD","credentials":["Associate Professor of Medicine\n","UT Southwestern Medical Center, Dallas TX"],"disclosure":"Grant/Research/Clinical Trial Support: Abbvie [Hepatitis C]; Speaker's Bureau: Gilead [Hepatitis C (Velpatasvir, sofosbuvir, ledipasvir)]; Bayer [HCC (Sorafenib)]; BMS [HCC (Nivolumab)]. Consultant/Advisory Boards: Bayer [HCC (Sorafenib)]; Eisai [HCC (Lenvatinib)]; Roche [HCC biomarkers]; Wako Diagnostics [HCC biomarkers]."},{"name":"Ted A Skolarus, MD, MPH, FACS","credentials":["Associate Professor of Urology\n","University of Michigan\n","Research Investigator\n","VA HSR&D Center for Clinical Management Research\n","VA Ann Arbor Healthcare System"],"disclosure":""},{"name":"Priscilla J Slanetz, MD, MPH, FACR","credentials":["Associate Professor of Radiology\n","Harvard Medical School"],"disclosure":""},{"name":"Alexander Smith, MD","credentials":["Associate Professor of Medicine\n","University of California, San Francisco"],"disclosure":""},{"name":"Joseph A Smith, MD","credentials":["Professor and Chairman of Urologic Surgery\n","Vanderbilt University School of Medicine"],"disclosure":""},{"name":"Matthew R Smith, MD, PhD","credentials":["Professor of Medicine\n","Harvard Medical School\n","Massachusetts General Hospital Cancer Center"],"disclosure":""},{"name":"Richard Smith, MD","credentials":["Professor and Vice-Chair, Otorhinolaryngology-Head and Neck Surgery\n","Albert Einstein College of Medicine, Montefiore Medical Center"],"disclosure":"Speaker's Bureau: Medical Education Speakers Network (thyroid nodules). Other Financial Interest: [Education Coordinator, American Academy of Otolaryngology-Head and Neck Surgery]."},{"name":"Claire Snyder, PhD","credentials":["Professor of Medicine\n","Division of General Internal Medicine\n","Johns Hopkins School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech [Survivorship care planning (JourneyForward survivorship care plan tools)]. Consultant/Advisory Boards: Caret MD [Cancer disease management (Electronic disease management technology)]; Tower Health [Care delivery system]. Equity/Ownership/Stock Options: Immunomedics [Cancer (Cancer treatments)]."},{"name":"Peter J Snyder, MD","credentials":["Editor-in-Chief — Endocrinology\n","Section Editor — Pituitary Disease; Male Reproductive Endocrinology\n","Professor of Medicine\n","University of Pennsylvania School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie [Hypogonadism (Testosterone gel)]; Novo Nordisk [Growth hormone (Somatropin)]; Novartis [Cushing's (LCI699)]; Cortendo [Cushing's]. Consultant/Advisory Boards: AbbVie [Hypogonadism (Testosterone gel)]; Novartis [Cushing's (LCI699)]; Pfizer [Acromegaly (Pegvisomant)]; Watson [Testosterone (Testosterone gel)]."},{"name":"Carl Snyderman, MD, MBA","credentials":["Professor, Departments of Otolaryngology and Neurological Surgery\n","University of Pittsburgh School of Medicine"],"disclosure":"Consultant/Advisory Boards: SPIWay, LLC [Endoscopic endonasal surgery of the skull Base (SPIWay Endonasal Access Guide)]. Equity Ownership/Stock Options: SPIWay, LLC [Endoscopic Endoscopic endonasal surgery of the skull Base (SPIWay Endonasal Access Guide)]."},{"name":"Jonas M Sokolof, DO","credentials":["Assistant Professor\n","Department of Rehabilitation Medicine\n","Weill College of Medicine of Cornell University\n","Assistant Attending Physician \n","Department of Neurology/Rehabilitation Services\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":""},{"name":"Benjamin Solomon, MBBS, PhD","credentials":["Medical Oncologist\n","Peter MacCallum Cancer Centre"],"disclosure":"Consultant/Advisory Boards: Pfizer [Lung cancer, ALK inhibitors (Crizotinib, lorlatinib)]; Novartis [Lung cancer, ALK inhibitors (Ceritinib)]; Roche [Lung cancer, ALK inhibitors (Alectinib)]."},{"name":"Shiyu Song, MD, PhD","credentials":["Associate Professor of Radiation Oncology\n","Virginia Commonwealth University Health System"],"disclosure":"Grant/Research/Clinical Trial Support: Seattle Genetics [Cancer (Brentuxiam and total skin electron beam radiation)]."},{"name":"Guru Sonpavde, MD","credentials":["Associate Professor of Medicine\n","Director, Urologic Medical Oncology\n","UAB Comprehensive Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Onyx-Amgen [prostate cancer (carfilzomib)]; Bayer [bladder cancer (regorafenib)]; Boehringer- Ingelheim [penile cancer (afatinib)]; Celgene [bladder cancer (abraxane)]; Merck [penile cancer (pembrolizumab)]; Pfizer [renal cancer (avelumab, sunitinib)]. Speaker's Bureau: Clinical Care Options [prostate cancer (enzalutamide)]. Consultant/Advisory Boards: Merck; Bayer; Genentech; Sanofi; GSK; Agensys; Novartis; Argos; Pfizer; AstraZeneca; Exelixis; Eisai; BMS; Amgen [Bladder cancer, prostate cancer, kidney cancer (Pembrolizumab, atezolizumab, sunitinib, pazopanib, cabazitaxel, radium-223, everolimus, cabozantinib, lenvatinib, durvalumab, nivolumab, ABP215)]."},{"name":"Halfdan Sorbye, MD","credentials":["Professor of Medicine\n","Haukeland University Hospital, Bergen, Norway"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [neuroendocrine carcinoma (everolimus)]. Consultant/Advisory Boards: Novartis [neuroendocrine carcinoma (everolimus)]."},{"name":"Jeffrey A Sosman, MD","credentials":["Professor of Medicine\n","Robert H. Lurie Comprehensive Cancer Center of Northwestern"],"disclosure":"Grant/Research/Clinical Trial Support: Miomedical Valley [Cancer (BVD-523)]. Consultant/Advisory Boards: Gentech; Meck; Array; Novartis [Cancer (no specific drugs, BRAFi, Vem, MEKi, Ribociclib, Binimetinib, Pembrolizumab)]."},{"name":"Stuart J Spechler, MD","credentials":["Chief, Division of Gastroenterology \n","Co-Director, Center for Esophageal Diseases\n","Baylor University Medical Center at Dallas\n","Investigator/Professor\n","Co-Director, Center for Esophageal Research\n","Baylor Scott and White Research Institute"],"disclosure":"Consultant/Advisory Board: Ironwood Pharmaceuticals [GERD (Linaclotide)]; Takeda Pharmaceuticals [GERD (Lansoprazole, dexlansoprazole)]."},{"name":"Ulrich Specks, MD","credentials":["Professor of Medicine, Mayo Clinic College of Medicine\n","Division of Pulmonary and Critical Care Medicine, Mayo Clinic Rochester"],"disclosure":""},{"name":"Steven M Sperry, MD","credentials":["Assistant Professor\n","Head & Neck Oncology and Reconstructive Surgery\n","Dept of Otolaryngology—Head & Neck Surgery\n","University of Iowa Hospitals and Clinics"],"disclosure":""},{"name":"Philippe E Spiess, MD, MS, FRCSC","credentials":["Professor\n","Assistant chief of surgery\n","Moffitt Cancer Center\n","The University of South Florida"],"disclosure":""},{"name":"Peter P Stanich, MD","credentials":["Assistant Professor\n","Division of Gastroenterology, Hepatology and Nutrition\n","Director, Section of Intestinal Neoplasia and Hereditary Polyposis\n","The Ohio State University Wexner Medical Center"],"disclosure":""},{"name":"Paul Stark, MD","credentials":["Professor of Radiology\n","University of California San Diego"],"disclosure":""},{"name":"Graeme S Steele, MBBCh, FCS","credentials":["Assistant Professor of Surgery\n","Harvard Medical School"],"disclosure":""},{"name":"David P Steensma, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Celgene [MDS (Lenalidomide, azacitidine)]; Janssen [AML (Experimental agent)]; Takada/Millennium [MDS (None)]; Tesaro [MDS (None)]; Otsuka [MDS (Decitabine)]; Acceleron [MDS (Experimental agent)]; H3 Biosciences [MDS (Experimental agent)]."},{"name":"Jennifer A Stein, MD, PhD","credentials":["Associate Professor of Dermatology\n","NYU School of Medicine"],"disclosure":""},{"name":"Margaret M Steinhoff, MD","credentials":["Professor of Pathology and Laboratory Medicine\n","The Warren Alpert Medical School of Brown University"],"disclosure":""},{"name":"Kerstin M Stenson, MD, FACS","credentials":["Professor of Otolaryngology\n","Chief, Head and Neck Cancer Program, Rush University Medical Center\n","Department of Otolaryngology/Head and Neck Surgery"],"disclosure":""},{"name":"Andrew J Stephenson, MD","credentials":["Associate Professor\n","Cleveland Clinic Lerner College of Medicine\n","Chief, Section of Urologic Oncology\n","Glickman Urological and Kidney Institute"],"disclosure":""},{"name":"Daniel H Sterman, MD","credentials":["Director, Division of Pulmonary, Critical Care, and Sleep Medicine \n","NYU School of Medicine \n","NYU Langone Medical Center"],"disclosure":""},{"name":"Cora N Sternberg, MD, FACP","credentials":["Chief\n","Department of Medical Oncology\n","San Camillo and Forlanini Hospitals\n","Rome, Italy"],"disclosure":"Grant/Research/Clinical Trial Support: Lilly [Bladder cancer (Cyramza)]; Janssen [Bladder cancer (JNJ42756493/Erdafitinib)]. Consultant/Advisory Boards: Bristol-Myers Squibb [Bladder cancer (Nivolumab)]; Merck [Bladder cancer (Avelumab)]; Pfizer [Bladder cancer (Avelumab)]; Clovis [Bladder cancer (Rucaparib)]."},{"name":"C Philip Steuber, MD","credentials":["Professor of Pediatric Hematology and Oncology\n","Baylor College of Medicine"],"disclosure":""},{"name":"Elizabeth A Stewart, MD","credentials":["Consultant and Professor of Obstetrics and Gynecology\n","Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology\n","Mayo Clinic and Mayo Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: NIH Grants [Uterine fibroids (R01HD060503, P50 HS023418, R01HD074711, K12HD065987)]. Consultant/Advisory Boards: AbbVie [Uterine fibroids (Leuprolide acetate)]; Allergan [Uterine fibroids (None)]; Astellas Pharma [Uterine fibroids (None)]; Bayer Health Care [Uterine fibroids (Levonorgestrel IUS)]; Glaxo Smith Kline [Adenomyosis (None)]; Gynesonics [Uterine fibroids (VizAblate (investigational in US))]; Welltwigs [Infertility (None)]. Patent Holder: Methods and compounds for treatment of abnormal uterine bleeding [Nowak RA, Stewart EA, US 6440445 (No commercial activity)]."},{"name":"Stephan Stilgenbauer, MD","credentials":["Professor of Medicine\n","Ulm University"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie (CLL, NHL [venetoclax]); Amgen (CLL, NHL [blinatumumab]); Boehringer-Ingelheim (CLL, NHL); Celgene (CLL, NHL [lenalidomide]); Genentech (CLL, NHL [venetoclax, rituximab, obinutuzumab]); Genzyme (CLL, NHL [alemtuzumab]); Gilead (CLL, NHL [idelalisib]); GSK (CLL, NHL); Janssen (CLL, NHL [ibrutinib]); Mundipharma (CLL, NHL [bendamustine]); Novartis (CLL, NHL); Pharmacyclics (CLL, NHL[ibrutinib]); Roche (CLL, NHL [venetoclax, rituximab, obinutuzumab]). Consultant/Advisory Boards: AbbVie (CLL, NHL [venetoclax]); Amgen (CLL, NHL [blinatumumab]); Boehringer-Ingelheim (CLL, NHL); Celgene (CLL, NHL [lenalidomide]); Genentech (CLL, NHL [venetoclax, rituximab, obinutuzumab]); Genzyme (CLL, NHL [alemtuzumab]); Gilead (CLL, NHL [idelalisib]); GSK (CLL, NHL); Janssen (CLL, NHL [ibrutinib]); Mundipharma (CLL, NHL [bendamustine]); Novartis (CLL, NHL); Pharmacyclics (CLL, NHL[ibrutinib]); Roche (CLL, NHL [venetoclax, rituximab, obinutuzumab])."},{"name":"Thomas E Stinchcombe, MD","credentials":["Associate Professor\n","University of North Carolina, Chapel Hill"],"disclosure":""},{"name":"Wendy Stock, MD","credentials":["Professor of Medicine\n","Pritzker School of Medicine of the University of Chicago"],"disclosure":"Consultant/Advisory Boards: Pfizer [ALL (Inotuzumab)]; Jazz [ALL (Erwinia asparaginase)]; Astellas [AML (Gilteritinib)]."},{"name":"Elena Stoffel, MD, MPH","credentials":["Assistant Professor Internal Medicine, Division of Gastroenterology\n","Director, Cancer Genetic Clinic\n","University of Michigan"],"disclosure":""},{"name":"Michael Stone, MD","credentials":["Chairman of Surgery\n","Stamford Hospital"],"disclosure":"Grant/Research/Clinical Trial Support: Roche [Vasculitis (Tocilizumab)]; Genentech [IgG4-related disease (Rituximab)]; Xencor [IgG4-related disease (Xmab5871)]. Consultant/Advisory Boards: Roche [Vasculitis (Tocilizumab)]; Genentech [IgG4-related disease (Rituximab)]; Xencor [IgG4-related disease (Xmab5871)]."},{"name":"Richard M Stone, MD","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis. Consultant/Advisory Boards: Abbvie, Agios, Amgen, Celator, Celgene, Novartis, Pfizer, Jazz, FujiFilm, Ono, Orsenix."},{"name":"Alison T Stopeck, MD","credentials":["Professor of Medicine\n","Associate Director For Clinical and Translational Research\n","Stony Brook Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen [Breast cancer (Denosumab)]. Consultant/Advisory Boards: Amgen [Breast Cancer (Denosumab and biosimilar therapeutics)], Novartis [Breast cancer (ribociclib)] , Sandoz [Breast cancer (biosimilars)], Pfizer [Breast cancer (palbociclib and biosimilar trastuzumab)]."},{"name":"E Alessandra Strada, PhD, MSCP, FT","credentials":["Director of Integrative Medicine and Bereavement Services\n","MJHS Institute for Innovation in Palliative Care, MJHS Hospice and Palliative Care, New York City\n","Adjunct Associate Professor of East-West Psychology\n","California Institute of Integral Studies, San Francisco\n","Adjunct Faculty, Postdoctoral Ps"],"disclosure":""},{"name":"J Michael Straughn, Jr, MD","credentials":["Professor\n","Division of Gynecologic Oncology\n","University of Alabama at Birmingham"],"disclosure":""},{"name":"Carrie Tompkins Stricker, PhD, RN","credentials":["Nurse Practitioner Division of Hematology/Oncology\n","University of Pennsylvania Health System\n","Chief Clinical Officer, Carevive Systems, Inc."],"disclosure":"Equity/Ownership/Stock Options: Carevive Systems, Inc [Clinical decision support and care planning (Electronically generated survivorship care plans)]. Employment: Carevive Systems, Inc [Clinical decision support and care planning (Electronically generated survivorship care plans)]."},{"name":"Jonathan R Strosberg, MD","credentials":["Associate Professor\n","Department of Gastrointestinal Oncology\n","H. Lee Moffitt Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [NETs (Octreotide, 177Lu-Dotatate)]. Speaker's Bureau: Ipsen [NETs (Lanreotide)]; LEXICON [NETs (Telotristat)]. Consultant/Advisory Boards: Novartis [NETs (Octreotide, 177Lu-Dotatate)]."},{"name":"Keith E Stuart, MD","credentials":["Chairman, Department of Hematology and Oncology\n","Lahey Hospital and Medical Center\n","Professor of Medicine,\n","Tufts University School of Medicine"],"disclosure":""},{"name":"Michael D Stubblefield, MD","credentials":["National Medical Director for Cancer Rehabilitation\n","Select Medical Corporation\n","Medical Director for Cancer Rehabilitation\n","Kessler Institute for Rehabilitation"],"disclosure":""},{"name":"Jack M Su, MD, MS","credentials":["Associate Professor\n","Texas Children's Cancer Center\n","Baylor College of Medicine"],"disclosure":""},{"name":"Ryan J Sullivan, MD","credentials":["Massachusetts General Hospital \n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Lilly [Melanoma (LY3214996)]; Genentech [Melanoma (atezolizumab)]; Merck [Melanoma (pembrolizumab)]; Viralytics [Melanoma (CVA-021)]; Novartis [Melanoma (dabrafenib, trametinib)]; BMS [Melanoma (nivolumab)]; BioMed Valley Discoveries [Melanoma (ulixertinib)]; Aelgea [Melanoma (AEB1102)]; Adaptimmune [Melanoma (MAGE-A10 TCR product)]; Moderna [Melanoma (MRNA-2416)]; Immunocore [Melanoma (IMC-gp100-202)]; Sanofi [Melanoma (SAR439459, REGN2810)]. Consultant/Advisory Boards: Amgen [Melanoma immunotherapy (TVEC and IO pipeline)]; Novartis [Melanoma immunotherapy (Dabrafenib, trametinib)]; Roche-Genentech [Melanoma (Targeted therapy and immunotherapy)]; Takeda [Melanoma (Immunotherapy toxicity)]; Merck [Melanoma immunotherapy]."},{"name":"Christina Sun-Edelstein, MD, FRACP","credentials":["Department of Clinical Neurosciences\n","St. Vincent's Hospital"],"disclosure":""},{"name":"Arief Suriawinata, MD","credentials":["Professor of Pathology and Laboratory Medicine\n","Geisel School of Medicine at Dartmouth"],"disclosure":""},{"name":"Ritsuro Suzuki, MD, PhD","credentials":["Associate Professor, Department of Oncology and Hematology\n","Shimane University Hospital Cancer Center"],"disclosure":"Speaker's Bureau: Kyowa-Kirin [lymphoma (L-asparaginase)]."},{"name":"Richard Swanson, MD","credentials":["Chief of Surgery\n","Cambridge Health Alliance"],"disclosure":""},{"name":"Scott Swanson, MD","credentials":["Professor of Surgery\n","Harvard Medical School\n","Director of Minimally Invasive Thoracic Surgery\n","Brigham and Women's Hospital\n","Chief Surgical Officer, Dana Farber Cancer Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Ethicon [lung cancer (PATHWAY trial)]; Covidien [Minimally invasive surgery (support seminars and training)]."},{"name":"Susan Swetter, MD","credentials":["Professor of Dermatology\n","Director, Pigmented Lesion & Melanoma Program\n","Physician Leader, Cancer Care Program in Cutaneous Oncology\n","Stanford University Medical Center and Cancer Institute/\n","VA Palo Alto Health Care System"],"disclosure":""},{"name":"Karen L Syrjala, PhD","credentials":["Fred Hutchinson Cancer Research Center"],"disclosure":""},{"name":"Alphonse Taghian, MD, PhD","credentials":["Professor of Radiation Oncology\n","Harvard Medical School"],"disclosure":""},{"name":"Patricia Tai, MB, BS, DABR, FRCR, FRCPC","credentials":["Clinical Oncologist\n","Clinical Professor\n","University of Saskatchewan\n","Canada Department of Radiation Oncology\n","Allan Blair Cancer Center"],"disclosure":""},{"name":"Martin S Tallman, MD","credentials":["Chief, Leukemia Service, Memorial Sloan-Kettering Cancer Center\n","Professor of Medicine\n","Weill Cornell Medical College"],"disclosure":""},{"name":"Kenneth K Tanabe, MD","credentials":["Section Editor — Gastrointestinal Malignancies\n","Professor of Surgery\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Nimbus Therapeutics [Hepatocellular carcinoma (ND654, Acetyl Co-A Carboxylase allosteric inhibitor)]. Consultant/Advisory Boards: Best Doctors [GI cancers; melanoma (Medical care)]; CRICO [Medical malpractice (Case review)]. Patent Holder: EGF SNP to determine risk for HCC [Cirrhosis, hepatocellular carcinoma]; Use of EGFR inhibitors to prevent HCC [Cirrhosis, hepatocellular carcinoma]. Equity Ownership/Stock Options: Helix12 [Breast cancer (Company owns IP on selective estrogen receptor modulators for breast cancer)]."},{"name":"Mary-Ellen Taplin, MD","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Janssen; Medivation/Pzier; Bayer; Clovis [Systemic therapy for rising PSA (Zytiga, Xtandi, Xofigo, PARP inhibitors)]. Consultant/Advisory Boards: Janssen; Clovis [Systemic therapy for rising PSA (Zytiga, Apalutamide, Niraparib)]."},{"name":"Katherine Tarlock, MD","credentials":["Research Associate\n","Fred Hutchinson Cancer Research Center"],"disclosure":""},{"name":"Jerome B Taxy, MD","credentials":["Clinical Professor of Pathology\n","University of Chicago Pritzker School of Medicine"],"disclosure":""},{"name":"Nicholas P Taylor, MD","credentials":["Section Chief of Gynecologic Oncology\n","St. Lukes Hospital\n","Temple University"],"disclosure":""},{"name":"Henry D Tazelaar, MD","credentials":["Consultant\n","Mayo Clinic Arizona\n","Professor of Pathology\n","Mayo Clinic College of Medicine\n","Chair of the Department of Laboratory Medicine and Pathology\n","Mayo Clinic Arizona"],"disclosure":""},{"name":"Ayalew Tefferi, MD","credentials":["Professor of Medicine and Hematology\n","Mayo Medical School"],"disclosure":""},{"name":"Theodoros N Teknos, MD","credentials":["Professor and Chair\n","The Ohio State University Wexner Medical Center"],"disclosure":""},{"name":"Clare M C Tempany, MD","credentials":["Professor of Radiology\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead [Liver imaging]. Consultant/Advisory Boards: Profound Medical[Prostate gland cancer ablation Device development]. Consultant/Advisory Board Member (Spouse): Echosens; Ligand; Shionogi  Gilead; Merck; [Liver disease]. Employment (Spouse): Chief Medical Officer, Spring Bank Pharmaceuticals; Director, TRIO Healthcare. Equity Ownership/Stock Options: Springbank; TRIO."},{"name":"Marita S Teng, MD, FACS","credentials":["Associate Professor and Residency Program Director\n","Department of Otolaryngology\n","Head & Neck Surgery Icahn School of Medicine at Mount Sinai New York, NY"],"disclosure":""},{"name":"Amanda M Termuhlen, MD","credentials":["Professor of Clinical Pediatrics\n","Keck School of Medicine, University of Southern California"],"disclosure":""},{"name":"William P Tew, MD","credentials":["Associate Member\n","Memorial Sloan Kettering Cancer Center\n","Associate Professor of Medicine\n","Weill Medical College of Cornell University\n","New York Presbyterian Hospital"],"disclosure":""},{"name":"Michael J Thirman, MD","credentials":["Associate Professor of Medicine\n","Pritzker School of Medicine of the University of Chicago"],"disclosure":""},{"name":"David M Thomas, FRACP, PhD","credentials":["Medical Oncologist\n","Director, Kinghorn Cancer Centre\n","Garvan Institute of Medical Research\n","National Health and Medical Research Council Principal Research Fellow"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen [IL23 antibody]."},{"name":"Karl W Thomas, MD","credentials":["Professor of Medicine - Pulmonary, Critical Care, Allergy and Immunology\n","Wake Forest School of Medicine"],"disclosure":""},{"name":"Charles F Thomas, Jr, MD","credentials":["Associate Professor of Medicine\n","Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Robert D Timmerman, MD","credentials":["Professor of Radiation Oncology and Neurosurgery\n","University of Texas Southwestern"],"disclosure":"Grant/Research/Clinical Trial Support: Varian Medical Systems [Clinical trials (TruBeam linear accelerator); Elekta Oncology [Clinical trials (Agility, Versa linear accelerators)]; Accuray Incorporated [Clinical trials(Cyberknife)]."},{"name":"Joseph A Toljanic, DDS","credentials":["Professor\n","Midwestern University School of Dental Medicine"],"disclosure":""},{"name":"Vicente E Torres, MD","credentials":["Professor of Medicine\n","Mayo Clinic College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support [Otsuka (ADPKD)]."},{"name":"William D Travis, MD","credentials":["Adjunct Professor of Pathology\n","Weill Medical College - Cornell University"],"disclosure":""},{"name":"Nathaniel S Treister, DMD, DMSc","credentials":["Assistant Professor of Oral Medicine\n","Department of Oral Medicine, Infection and Immunity\n","Harvard School of Dental Medicine\n","Division of Oral Medicine & Dentistry\n","Brigham and Women's Hospital"],"disclosure":""},{"name":"Anne S Tsao, MD","credentials":["Associate Professor\n","The University of Texas MD Anderson Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: MedImmune [Mesothelioma, non-small cell lung cancer]; Merck [Thymoma, non-small cell lung cancer]; Bristol-Myers Squibb [Mesothelioma]; ARIAD [Non-small cell lung cancer]; Seattle Genetics [Mesothelioma], Genentech [Non-small cell lung cancer, mesothelioma]; Polaris Partners [Mesothelioma]; Boehringer Ingelheim [Mesothelioma]. Consultant/Advisory Boards: Astellas Pharma [Mesothelioma, non-small cell lung cancer]; Boehringer Ingelheim [Mesothelioma, non-small cell lung cancer]; Eli Lilly and Company [Mesothelioma, non-small cell lung cancer]; Genentech [Mesothelioma, non-small cell lung cancer]; MedImmune [Mesothelioma, non-small cell lung cancer]; Roche [Mesothelioma, non-small cell lung cancer], AstraZeneca [Non-small cell lung cancer]."},{"name":"Hensin Tsao, MD, PhD","credentials":["Section Editor — Melanocytic Lesions and Disorders of Pigmentation\n","Professor of Dermatology\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Epiphany Dermatology [Med advisory board]."},{"name":"George Tsoulfas, MD","credentials":["Assistant Professor of Surgery\n","Strong Memorial Hospital\n","University of Rochester Medical Center"],"disclosure":""},{"name":"R Michael Tuttle, MD","credentials":["Professor of Medicine\n","Memorial Sloan Kettering Cancer Center"],"disclosure":"Grant/Research Support: AstraZeneca [Thyroid cancer (Selumetinib)]. Consultant/Advisory Boards: Bayer/Onyx [Thyroid cancer (Sorafenib)]; Eisai [Thyroid cancer (Lenvatinib)]; Genzyme/Sanofi [Thyroid cancer (Recombinant human TSH)]; Novo Nordisk [Thyroid cancer (Liraglutide)]; Roche [Thyroid cancer (Thyroglobulin assay)]; Veracyte [Thyroid cancer (Gene testing)]."},{"name":"Douglas Tyler, MD","credentials":["Chair\n","Department of Surgery\n","University of Texas Medical Branch at Galveston"],"disclosure":"Consultant/Advisory Boards: Castle Biosciences [Melanoma (Gene signature risk predictor)]."},{"name":"Frederick Rand Ueland, MD","credentials":["Professor of Gynecologic Oncology\n","Vice Chair, Department of Obstetrics and Gynecology\n","Markey Cancer Center\n","University of Kentucky"],"disclosure":""},{"name":"Renata R Urban, MD","credentials":["Assistant Professor\n","Gynecologic Oncology\n","University of Washington School of Medicine"],"disclosure":""},{"name":"Eric Vallières, MD, FRCSC","credentials":["Section Editor — Lung Cancer\n","Surgical Director of the Lung Cancer Program\n","Swedish Cancer Institute"],"disclosure":""},{"name":"Martin van den Bent, MD, PhD","credentials":["Daniel den Hoed Oncology Center\n","Neuro-Oncology Unit"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie [Glioma (ABT414)]. Consultant/Advisory Boards: AbbVie [Glioma (ABT414)]; Roche [Glioma (Bevacizumab)]; Novartis [Glioma (IDH305)]; BMS [Glioma (Nivolumab)]; Celldex (rindopepimut)."},{"name":"Richard A Van Etten, MD, PhD","credentials":["Professor of Medicine\n","University of California, Irvine"],"disclosure":""},{"name":"Catherine Van Poznak, MD","credentials":["Associate Professor Department of Internal Medicine\n","University of Michigan"],"disclosure":"Grant/Research/Clinical Trial Support: Bayer [Bone metastases (Ra223)]."},{"name":"Nicholas Vander Els, MD","credentials":["Assistant Professor of Medicine\n","Cornell University Medical College"],"disclosure":""},{"name":"Donald Vander Griend, PhD","credentials":["Assistant Professor of Surgery\n","University of Chicago"],"disclosure":""},{"name":"Thomas J Vander Salm, MD","credentials":["Clinical Professor\n","Harvard Medical School"],"disclosure":""},{"name":"David J Vaughn, MD","credentials":["Professor of Medicine\n","Abramson Cancer Center of the University of Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: Merck [Bladder cancer (Pembrolizumab)]; Genentech [Bladder cancer (Atezoliumab)]."},{"name":"Adrian Vella, MD","credentials":["Professor of Medicine\n","Mayo Clinic"],"disclosure":"Grant/Research Support: vTv Therapeutics [Diabetes]; XOMA [Hypoglycemia]; Novo Nordisk [Diabetes (Liraglutide)]. Consultant/Advisory board: vTv Therapeutics [Diabetes]."},{"name":"Shambhavi Venkataraman, MD","credentials":["Instructor\n","Harvard Medical School\n","Staff Radiologist\n","Beth Israel Deaconess Medical Center"],"disclosure":""},{"name":"Alan P Venook, MD","credentials":["Professor of Clinical Medicine\n","University of California at San Francisco"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech [colon cancer (Bbvacizumab)]; BMS [colon cancer (cetuximab). Consultant/Advisory Boards: Genentech/Roche [colon cancer (bevacizumab)]; BMS [colon cancer (cetuzimab)]."},{"name":"David M Vernick, MD","credentials":["Assistant Professor of Otolaryngology\n","Harvard Medical School"],"disclosure":""},{"name":"Nicholas Vogelzang, MD","credentials":["Section Editor — Prostate Cancer\n","Professor of Medicine\n","University of Nevada School of Medicine\n","US Oncology Research"],"disclosure":"Speaker's Bureau: Pfizer [Kidney cancer (Sunitinib, axitinib)]; Bayer [Prostate cancer (Radium 223)]; Novartis [Kidney cancer, PNET (Pazopanib, everolimus); Sanofi [Prostate cancer (Cabazitaxel)], BMS [Kidney cancer (BMS-nivolumab)]; Genentech/Roche [Bladder cancer (Atezolizumab); Astra Zeneca {Bladder cancer (durvalumab)]. Consultant/Advisory Boards: Amgen [Prostate cancer (Denosumab)]; Bayer [Prostate cancer (Radium 223)]; Pfizer [Kidney cancer (Sunitinib, axitinib)]; Novartis [Kidney cancer, PNET (Pazopanib, everolimus)]; Sanofi [Prostate cancer (cabazitaxel)]; BMS [Kidney cancer (BMS-nivolumab)]; Genentech/Roche (Bladder cancer (Atezolizumab)]; Astra Zeneca {Bladder cancer (durvalumab)]   Exelexis [Kidney cancer (Cabozantinib)];  Clinical Care Options, Cerulean [Kidney cancer (Liposomal irinotecan)]; Dava Oncology/PER; Dendreon; Medivation/Astellas [Prostate (Enzalutamide)], Janssen [Prostate cancer (Abiraterone,apalutamide)]; Heron [Nausea control (Liposomal granisetron)]; Eisai [Kidney cancer (Levantinib)]; Agensys [Kidney cancer (New targeted agent)]; Boehringer Ingelheim [Mesothelioma (Nerantinib)]. Employment: US Oncology [GU research (none)].  Equity Ownership/Stock Options: Caris [Genetic testing for cancer (none)]."},{"name":"Everett E Vokes, MD","credentials":["John E. Ultmann Professor\n","Chairman, Department of Medicine\n","Physician-in-Chief, University of Chicago Medicine and Biologic Sciences"],"disclosure":"Consultant/Advisory Boards: Amgen [Head and neck and Lung (Epo)]; Ariad [Lung cancer]; AstraZeneca [Head and neck and Lung (Immune Modulation)]; Bayer [Lung cancer]; Boehringer-Ingelheim [Head and neck and Lung (Nintedanib, Afatinib)]; Celgene [Head and neck and Lung (Abraxane)]; Eli Lilly [Head and neck and Lung (EGFR inhibition)]; Genentech [Head and neck and Lung (Immune modulation)]; Merck [Head and neck and Lung (Immune modulation)]; VentiRx [Head and neck and Lung (Immune modulation)] ; Abbvie [Lung]; Bristol Meyers Squibb [Lung, Head and Neck]; Leidos [Lung]; Novartis [Lung]; Regeneron [Lung]; Serono [all tumor types]; Takeda [Lung]."},{"name":"Sadhna R Vora, MD","credentials":["Deputy Editor — Oncology\n","Instructor in Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Heather Wakelee, MD","credentials":["Associate Professor of Medicine\n","Stanford Cancer Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Clovis, Exelixis, AstraZeneca, MedImmune, Genentech/Roche, Bristol-Myers Squibb, Gilead, Novartis, Xcovery, Pfizer, Celgene, Pharmacyclics, Lilly Oncology, ACEA Oncology [Thoracic Oncology]. Consultant/Advisory Boards: Novartis, Genentech, AstraZeneca (uncompensated) [Thoracic Oncology]."},{"name":"Janet R Walczak, MSN, RN, CRNP","disclosure":""},{"name":"Lisa L Wang, MD","credentials":["Associate Professor\n","Pediatric Hematology and Oncology\n","Baylor College of Medicine"],"disclosure":""},{"name":"John F Ward, MD, FACS","credentials":["Associate Professor of Surgery\n","University of Texas MD Anderson Cancer Center"],"disclosure":"Consultant/Advisory Boards: Healthtronics [Prostate cancer, kidney cancer (Cryoablation)]."},{"name":"Donald L Weaver, MD","credentials":["Professor of Pathology\n","University of Vermont College of Medicine"],"disclosure":""},{"name":"Randal S Weber, MD","credentials":["Professor and Chairman\n","Department of Head and Neck Surgery \n","The University of Texas MD Anderson Cancer Center"],"disclosure":""},{"name":"Harrison G Weed, MS, MD, FACP","credentials":["Professor of Internal Medicine\n","The Ohio State University College of Medicine"],"disclosure":""},{"name":"Steven E Weinberger, MD","credentials":["Adjunct Professor of Medicine\n","University of Pennsylvania School of Medicine\n","Executive Vice President and CEO Emeritus\n","American College of Physicians"],"disclosure":""},{"name":"Gerald L Weinhouse, MD","credentials":["Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Elisabeth Weiss, MD","credentials":["Associate Professor\n","Department of Radiation Oncology\n","Virginia Commonwealth University"],"disclosure":""},{"name":"Roy E Weiss, MD, PhD","credentials":["Professor and Chairman\n","The University of Miami Miller School of Medicine"],"disclosure":""},{"name":"William C Welch, MD, FACS, FICS","credentials":["Professor of Neurosurgery\n","University of Pennsylvania School of Medicine\n","Chief of Neurological Surgery\n","The Pennsylvania Hospital"],"disclosure":"Equity Ownership/Stock Options: Transcendental Spine, LLC (Spine products)."},{"name":"Corrine K Welt, MD","credentials":["Professor of Medicine\n","University of Utah School of Medicine"],"disclosure":"Consultant/Advisory Board: Novartis [Polycystic ovary syndrome (Letrozole)]."},{"name":"Patrick Y Wen, MD","credentials":["Section Editor — Neurooncology\n","Professor of Neurology\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Acerta [Brain tumor (ACP196); Agios [Brain tumor (AG120, AG881); Angiochem [Brain tumor (ANG1005); AstraZeneca [Brain tumor (Vandetanib)]; Kadmon [Brain tumor 9tesevatinib); Karyopharm [Brain tumor (Selinexor)]; Merck [Brain tumor (Pembrolizumab)]; Novartis [Brain tumor (Trametanib, dabrafenib, BGJ398, INC208)]; Oncoceutics [Brain tumor (ONC201)]; Vascular Biogenics [Brain tumor (VB111)]; Roche [Brain tumor (Bevacizumab)]; Sanofi-Aventis [Brain tumor (Plerixafor)]. Speaker's Bureau: Merck [Brain tumor]. Consultant/Advisory Boards: Agios [Brain tumor (AG120)]; Astra Zeneca [Brain tumor]; Cavion [Brain tumor (Mibefradil)]; Cortice Biosciences [Brain tumor (TP12887)]; Foundation Medicine [Brain tumor (none)]; Genentech/Roche [Brain tumor (Bevacizumab)]; Monteris [Brain tumor (Neuroblate)]; Novartis [Brain tumor (LDK298)]; Novogen [Brain tumor (GDC0084); Regeneron [Brain tumor (PD1 antibodies)]; Vascular Biogenics [Brain tumor (VB111)]; VBI Vaccines [Brain tumors]."},{"name":"Barry L Wenig, MD, MPH","credentials":["Francis L. Lederer Professor of Otolaryngology\n","Director of Head and Neck and Robotic Surgery\n","University of Illinois College of Medicine at Chicago"],"disclosure":""},{"name":"Howard J West, MD","credentials":["Section Editor — Lung Cancer\n","Medical Director\n","Thoracic Oncology Program\n","Swedish Cancer Institute (Seattle)"],"disclosure":"Speaker’s Bureau: BristolMyersSquibb [Non-small cell lung cancer (Nivolumab)]; Genentech/Roche [Non-small cell lung cancer (Atezolizumab)]. Consultant/Advisory Boards: AstraZeneca [Non-small cell lung cancer (Gefitinib)]; Boehringer-Ingelheim [Non-small cell lung cancer (Afatinib)]; BristolMyersSquibb [Non-small cell lung cancer (Nivolumab)]; Celgene [Non-small cell lung cancer (nab-paclitaxel)]; Genentech/Roche [Non-small cell lung cancer (Alectinib, Atezolizumab, Erlotinib)]; Merck [Non-small cell lung cancer (Pembrolizumab)]; Novartis [Non-small cell lung cancer (Ceritinib)]; Pfizer [Non-small cell lung cancer (Crizotinib)]; Takeda [Non-small cell lung cancer (nab-Paclitaxel, dabrafenib, trametinib, durvlumab)]."},{"name":"Julia White, MD","credentials":["Professor and Vice Chair\n","Department of Radiation Oncology\n","Klotz Sister Chair of Cancer Research\n","The James CCC, Ohio State University"],"disclosure":""},{"name":"Louise Wilkins-Haug, MD, PhD","credentials":["Section Editor — Prenatal Diagnosis and Genetics\n","Professor of Obstetrics, Gynecology, and Reproductive Biology\n","Harvard Medical School"],"disclosure":""},{"name":"Rein Willemze, MD","credentials":["Professor and Chairman, Department of Dermatology\n","Leiden University Medical Center"],"disclosure":""},{"name":"Christopher G Willett, MD","credentials":["Section Editor — Radiation Therapy\n","Professor\n","Duke University Medical School"],"disclosure":"Consultant/Advisory Boards: Entrinsic Health [Esophageal, stomach,  pancreatic, and colorectal cancer and GIST (Amino acid medical foods, a liquid solution that may improve mucosal reactions to chemotherapy and radiation therapy)]."},{"name":"Aung Ko Win, MBBS, MPH, PhD","credentials":["Senior Research Fellow\n","The University of Melbourne"],"disclosure":""},{"name":"John R Wingard, MD","credentials":["Professor of Medicine\n","University of Florida College of Medicine"],"disclosure":"Consultant/Advisory Boards: Astellas [CMV, antifungal drugs]; Ansun, Gilead [respiratory virus antivirals]; Merck [CMV, antifungal drugs, vaccine]; Shire [CMV antiviral drug]; Fate Therapeutics [Cell product]; Celgene [CAR T-cell product]."},{"name":"Scott M Wirth, PharmD, BCOP","credentials":["Clinical Pharmacy Specialist\n","UPMC Cancer Centers"],"disclosure":"Speaker's Bureau: Celgene Corporation [NSCLC, pancreatic cancer, breast cancer (Nab-paclitaxel)]; Tesaro, Inc. [Gynecologic malignancies (Niraparib)]."},{"name":"Jedd Wolchok, MD, PhD","credentials":["Chief \n","Melanoma and Therapeutics Service\n","Memorial Sloan Kettering Cancer Center\n","\n","Professor of Medicine\n","Weill Medical College of Cornell University"],"disclosure":"Grant/Research/Clinical Trial Support: Bristol-Myers Squibb; Merck; Medimmune; Genentech [Cancer immunotherapy (Ipilimumab, nivolumab, pembrolizumab)]. Consultant/Advisory Boards: Bristol-Myers Squibb; Merck; Medimmune; Genetech [Cancer immunotherapy (Ipilimumab, nivolumab, pembrolizumab)]."},{"name":"Benjamin Wong, DSc, MD, PhD","credentials":["Honorary Clinical Professor\n","Department of Medicine\n","University of Hong Kong"],"disclosure":""},{"name":"Eric T Wong, MD","credentials":["Associate Professor of Neurology\n","Harvard Medical School"],"disclosure":""},{"name":"Julia S Wong, MD","credentials":["Assistant Professor of Radiation Oncology\n","Harvard Medical School"],"disclosure":""},{"name":"Francis P Worden, MD","credentials":["Professor\n","Department of Internal Medicine\n","Division of Hematology and Oncology\n","University of Michigan"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Oncology (Axitinib)]; BMS [Oncology, metastatic head and neck cancer (Nivolumab)]; Merck [Oncology, head and neck cancer (Pembrolizumab and cisplatin and radiation)]. Consultant/Advisory Boards: Merck [Oncology, head and neck cancers (Pembrolizumab)]."},{"name":"Cameron D Wright, MD","credentials":["Division of Thoracic Surgery\n","Massachusetts General Hospital"],"disclosure":""},{"name":"Jason D Wright, MD","credentials":["Sol Goldman Associate Professor of Obstetrics and Gynecology \n","Chief, Division of Gynecologic Oncology \n","Columbia University College of Physicians and Surgeons"],"disclosure":"Consultant/Advisory Boards: Tesaro [Gynecologic cancer (Drug development)]; Clovis Oncology [Gynecologic cancer (Drug development)]."},{"name":"Jonathan L Wright, MD, MS","credentials":["AssociateProfessor\n","Department of Urology\n","University of Washington School of Medicine\n","Affiliate Investigator\n","Fred Hutchinson Cancer Research Center"],"disclosure":""},{"name":"Matthew Wszolek, MD","credentials":["Instructor of Urology\n","Harvard Medical School\n","Assistant in Urology\n","Massachusetts General Hospital"],"disclosure":""},{"name":"Julian K Wu, MD","credentials":["Professor of Neurosurgery\n","Tufts University School of Medicine"],"disclosure":""},{"name":"Peggy A Wu, MD","credentials":["Assistant Professor of Dermatology\n","Harvard Medical School"],"disclosure":""},{"name":"Joachim Yahalom, MD","credentials":["Member and Professor of Radiation Oncology\n","Memorial Sloan-Kettering Cancer Center \n","Cornell University Weill College of Medicine"],"disclosure":""},{"name":"Motoko Yamaguchi, MD, PhD","credentials":["Assistant Professor, Department of Hematology and Oncology\n","Mie University Graduate School of Medicine"],"disclosure":""},{"name":"Hideko Yamauchi, MD","credentials":["Adjunct Instructor\n","Department of Breast and Endocrine Surgery,\n","Juntendo University School of Medicine\n","Director of Breast Surgical Oncology\n","Breast Center\n","St. Luke's International Hospital\n","Tokyo, Japan"],"disclosure":"Speaker's Bureau: Elsevier Japan, Shionogi, Novartis, Pfizer, Galderma; Eisai; Taiho; AstraZeneca; Chugai Pharmaceutical Co; Allergan Japan [Breast cancer]."},{"name":"Ximing J Yang, MD, PhD","credentials":["Professor\n","Northwestern University Feinberg School of Medicine\n","Chief of Urologic Pathology"],"disclosure":""},{"name":"Zhaohai Yang, MD, PhD","credentials":["Associate Professor of Pathology\n","Penn State Health Milton S. Hershey Medical Center\n","Penn State College of Medicine"],"disclosure":""},{"name":"Catheryn Yashar, MD","credentials":["Associate Professor of Radiation Medicine and Applied Sciences\n","University of California San Diego"],"disclosure":""},{"name":"Sriram Yennurajalingam, MD","credentials":["Associate Professor, Department of Palliative Care and Rehabilitation Medicine\n","University of Texas, MD Anderson Cancer Center at Houston"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech [patient experience]; Bayer [fatigue (fish oil and exercise)]; Helsinn [fatigue (Anamorelin)]."},{"name":"Jean Chiyon Yi, PhD","credentials":["Fred Hutchinson Cancer Research Center"],"disclosure":""},{"name":"Linwah Yip, MD","credentials":["Associate Professor of Surgery\n","University of Pittsburgh School of Medicine"],"disclosure":""},{"name":"Kaleb Yohay, MD","credentials":["Co-Director, Comprehensive Neurofibromatosis Center\n","Department of Neurology\n","Division of Child Neurology\n","NYU School of Medicine"],"disclosure":""},{"name":"Sue S Yom, MD, PhD, MAS","credentials":["Associate Professor \n","Departments of Radiation\n","Oncology and Otolaryngology\n","Head and Neck Surgery\n","University of California, San Francisco School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech [Skin cancer (Vismodegib)]; Bristol-Myers Squibb [Head and neck cancer (Nivolumab)]; Merck [Lung cancer (Pembrolizumab)]."},{"name":"David S Yoo, MD, PhD","credentials":["Medical Instructor\n","Department of Radiation Oncology\n","Duke University Medical Center"],"disclosure":""},{"name":"Harry H Yoon, MD, MHS","credentials":["Associate Professor of Oncology,\n","Co-Chair, Esophageal/Gastric Cancer Disease Group, \n","Mayo Clinic"],"disclosure":"Grant/Research/Clinical Trial Support: Eli Lilly [Esophagogastric cancer (Ramucirumab)]; Merrimack [Esophagogastric cancer (MM-111)]; Genetech/Roche [Esophagogastric cancer (Trastuzumab)]; Boston Biomedical [Esophagogastric cancer (BBI608)]; Merck [Esophagogastric cancer (Pembrolizumab)]. Consultant/Advisory Boards: FivePrime Therapeutics [Esophagogastric cancer (FPA144)]. Other Financial Interest: Eli Lilly [Esophagogastric cancer (CME activity)]."},{"name":"William F Young, Jr, MD, MSc","credentials":["Professor of Medicine\n","Mayo Clinic College of Medicine"],"disclosure":"Consultant/Advisory Boards: Nihon Medi-Physics Co, Ltd [Primary aldosteronism (Novel PET-based adrenal imaging)]."},{"name":"H Michael Yu, MD, ScM","credentials":["Associate Member, Department of Radiation Oncology\n","H. Lee Moffitt Cancer Center and Research Institute"],"disclosure":"Consultant/Advisory Boards: Novocure [Glioblastoma (tumor treatment field)]; Abbvie [Glioblastoma (ABT-414 - not yet commercialized or on the market)]."},{"name":"James L Zehnder, MD","credentials":["Professor of Pathology and Medicine (Hematology)\n","Stanford University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Novo Nordisk [Hemostasis testing methods]; Novartis [Thrombopoietin agonists (Eltrombopag)]; Instrumentation Laboratory [laboratory instrumentation (hemostasis testing methods)]."},{"name":"Joseph Zenga, MD","credentials":["Fellow, Head and Neck Oncology and Microvascular Reconstruction\n","Massachusetts Eye and Ear Infirmary\n","Harvard Medical School"],"disclosure":""},{"name":"Michael R Zenn, MD, FACS","credentials":["Adjunct Professor – Clinical Professor of Plastic Surgery\n","Duke University Medical Center"],"disclosure":"Consultant/Advisory Boards: Stryker [ICG angiography (Imaging system)]."},{"name":"Yanming Zhang, MD","credentials":["Attending\n","Director of Cytogenetics Laboratory\n","Memorial Sloan Kettering Cancer Center"],"disclosure":""},{"name":"Ming Zhou, MD, PhD","credentials":["Dr. Charles T. Ashworth\n","Professor of Pathology\n","University of Texas Southwestern"],"disclosure":""},{"name":"Oliver Zivanovic, MD","credentials":["Attending Surgeon\n","Memorial Sloan Kettering Cancer Center\n","Assistant Professor\n","Cornell Weill Medical College"],"disclosure":""},{"name":"Jeffrey Zonder, MD","credentials":["Professor of Medicine and Oncology\n","Barbara Ann Karmanos Cancer Institute\n","Wayne State University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Celgene [amyloidosis (lenalidomide, thalidomide, pomalidomide [IMiDs])]. Consultant/Advisory Boards: Celgene [myeloma, amyloidosis (IMiDs)]; Janssen [myeloma, amyloidosis (daratumumab)]; BMS [myeloma, amyloidosis (elotuzumab)]; Seattle Genetics [myeloma, amyloidosis (investigational mAb)]; Takeda [myeloma, amyloidosis (bortezomib, Ixazomib)]; Prothena [myeloma, amyloidosis (NEOD001)]; Amgen [myeloma, amyloidosis (carfilzomib)]. Other Financial Interest (contributor and spouse): \tMMRF travel grant supported by Takeda and CURE magazine [Moving Mountains for Multiple Myeloma Fundraising team for the MMRF]."}]},{"name":"Peer Reviewers","contributors":[{"name":"Sanjiv S Agarwala, MD","credentials":["Professor of Medicine\n","Temple University School of Medicine\n","Chief of Oncology & Hematology\n","St Luke’s Cancer Center"],"disclosure":""},{"name":"Jose Banchs, MD, FACC, FASE","credentials":["Director of Echocardiography\n","Associate Professor of Medicine\n","Cardiology Department\n","University of Texas \n","MD Anderson Cancer Center"],"disclosure":""},{"name":"Sally Y Barbour, PharmD, BCOP, CPP","credentials":["Clinical Oncology Pharmacist\n","Duke Comprehensive Cancer Center"],"disclosure":"Consultant/Advisory Boards: Genentech, Taiho, Teva, Astra Zeneca [EGFR drugs in lung cancer (trifuridine/tipiracil)]."},{"name":"Aditya Bardia, MD, MPH","credentials":["Attending Physician\n","Massachusetts General Hospital Cancer Center\n","Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Novartis [Breast cancer (Letrozole)]; Pfizer [Breast cancer (Exemestane)]."},{"name":"Emily Bergsland, MD","credentials":["Professor of Medicine \n","University of California San Francisco"],"disclosure":"Grant/Research/Clinical Trial Support: Lexicon [Carcinoid (telotristat)]; Merck [Carcinoid/panNET (Pembrolizumab)]; Novartis [Carcinoid/pNET]. Consultant/Advisory Board: Lexicon [Carcinoid (telotristat)]; Ipsen [ Neuroendocrine tumors (lanreotide)]; Exelixis [Carcinoid/panNET (cabozantinib)]."},{"name":"Lawrence Blaszkowsky, MD","credentials":["MGH Cancer Center"],"disclosure":""},{"name":"Linda D Bosserman, MD, FACP","credentials":["President and Medical Oncologist\n","Wilshire Oncology Medical Group, Inc"],"disclosure":"Speaker's Bureau: Genentech [oncology value panel]; Association of Managed Care Pharmacy [value in specialty pharmacy]; PER [case studies and value talks]; Association of Nurse Navigators [Value-based cancer care (talk)]; Pfizer [Value-based cancer and breast care (None)]. Consultant/Advisory Boards:  Pfizer [Biosimilars for Her2 and breast cancer]; Anthem Blue Cross Wellpoint [Breast cancer standards (None)]; American Society of Breast Surgeons [Breast cancer value-based care (None)]; GSK [Cancer care (None)]; Genentech/Roche [Breast cancer (None)]; ACCC [Value-based cancer care (None)]; Novartis [ Breast cancer value-based care (None)]; Sandox-Novartis [Value-based breast cancer care (None)]. Employment: City of Hope Medical Foundation [value based care initiatives]; Front Line Medical Communications Inc [editor]."},{"name":"John Buatti, MD","credentials":["Professor of Radiation Oncology\n","University of Iowa"],"disclosure":""},{"name":"Mark Buyyounouski, MD, MS","credentials":["Associate Professor\n","Stanford University\n","Department of Radiation Oncology\n","Director, Genitourinary Cancers"],"disclosure":""},{"name":"George P Canellos, MD","credentials":["Editor-in-Chief — Oncology\n","Section Editor — Miscellaneous Tumors\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Shamus Carr, MD, FACS","credentials":["Assistant Professor of Surgery\n","University of Maryland School of Medicine"],"disclosure":""},{"name":"Robert L Coleman, MD","credentials":["Professor & Vice Chair\n","Clinical Research\n","Ann Rife Cox Chair in Gynecology\n","Department of Gynecologic Oncology\n","University of Texas MD Anderson Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Merck, Oncomed, Janssen, Clovis, Astrazeneca, Genentech/Roche, Abbvie [ovarian, uterine, cervix (pembrolizumab, demcizumab, trabectedin, rucaparib, olaparib, veliparib, bevacizumab, emactuzumab, durvalumab, tremelumumab, nivolumab, selumetinib, everolimus, ribociclib, AZD-1775)]. Consultant/Advisory Boards: Merck, Oncomed, Janssen, Clovis, Astrazeneca, Genentech/Roche, Abbvie, Bayer, immunogen [ovarian, uterine (pembrolizumab, demcizumab, trabectedin, rucaparib, olaparib, veliparib, bevacizumab, emactuzumab, AZD-1775, IMGN-853)]."},{"name":"A Dimitrios Colevas, MD","credentials":["Associate Professor of Medicine\n","Stanford University Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: BMS [head and neck (nivolumab)]; Astra Zeneca [head and neck (durvalumab, tremelimumab); Regeneron [squamous cell cancer skin (REGN2810)]; Fourty Seven [generic ph 1 (Hu5F9-G4)]; Novartis [ameloblastoma (dabrafenib, trametinib)]; IRX [head and neck (IRX-2 Regimen)]; Merck [basal cell cancer (pembrolizumab)]; Celldex [head and neck (varlilumab)]."},{"name":"Siamak Daneshmand, MD","credentials":["Associate Professor of Urology\n","Director, Center for Urologic Oncology\n","University of Southern California"],"disclosure":""},{"name":"Laura A Dawson, MD","credentials":["Professor\n","Department Radiation Oncology, University of Toronto\n","Radiation Medicine Program, Princess Margaret Cancer Centre"],"disclosure":"Consultant/Advisory Boards: Merck [Hepatocellular carcinoma]. Patent Holder/Lisensure: Raysearch [Image registration (Radiation planning systems may include image registration tools)]."},{"name":"Jennifer F De Los Santos, MD","credentials":["Associate Professor\n","Department of Radiation Oncology\n","University of Alabama at Birmingham"],"disclosure":"Speaker's Bureau: Varian Medical Systems [Breast cancer (Course in breast cancer treatment)]."},{"name":"Shrina Duggal, PharmD, BCOP","credentials":["Clinical Pharmacy Specialist\n","UPMC Cancer Centers"],"disclosure":"Speaker’s Bureau: Incyte [Gastrointestinal cancer (Ruxolitinib)]; Boehringer Ingelheim [Gastrointestinal cancer (Afatinib)]; Pfizer/Astellas [Gastrointestinal cancer (Enzalutamide)]."},{"name":"Anthony Elliott, PharmD","credentials":["Duke University Hospital"],"disclosure":""},{"name":"Katherine Evans, PharmD","credentials":["Director, Pharmacy Technology\n","Cape Fear Community College"],"disclosure":""},{"name":"Shelly A Fallo, BS, RPh","credentials":["Clinical Pharmacy Specialist of Oncology\n","Department of Pharmacy Services\n","Tufts Medical Center"],"disclosure":""},{"name":"Karen M Fancher, PharmD, BCOP","credentials":["Clinical Pharmacist\n","Blood & Marrow Transplantation\n","H Lee Moffitt Cancer Center and Research Institute"],"disclosure":""},{"name":"Heidi D Finnes, PharmD, BCOP","credentials":["Assistant Professor of Pharmacy\n","Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Harold Frucht, MD","credentials":["Associate Professor of Clinical Medicine\n","College of Physicians and Surgeons, Columbia University"],"disclosure":""},{"name":"Thomas Galloway, MD","credentials":["Assistant Professor\n","Department of Radiation Oncology\n","Fox Chase Cancer Center"],"disclosure":"Consultant/Advisory Boards: Varian Medical Systems [Head and neck cancer (Training course)]."},{"name":"Jennifer Suzanne Gass, MD, FACS","credentials":["Chief of Surgery\n","Breast Fellowship Director\n","Program in Women’s Oncology\n","Women and Infants’ Hospital\n","Associate Professor of Surgery \n","Associate Professor of Obstetrics and Gynecology"],"disclosure":""},{"name":"Geoffrey T Gibney, MD","credentials":["Lombardi Comprehensive Cancer Center\n","Medstar Georgetown University Hospital"],"disclosure":"Consultant/Advisory Boards: Novartis [oncology (dabrafenib/trametinib)]; Genentech [oncology (vemurafenib/cobimetinib)]; Newlink Genetics [oncology (indoximod)]; Incyte [oncology (epacadostat)]; Boston Biomedical [oncology]. Speaker's Bureau: Merek [melanoma (pembrolizumab)]; Genentech [oncology (vemurafenib/cobimetinib)]."},{"name":"Timothy D Gilligan, MD","credentials":["Associate Professor of Medicine\n","Cleveland Clinic Lerner College of Medicine\n","Vice-Chair for Education\n","Cleveland Clinic Taussig Cancer Institute\n","Director of Coaching, Center for Excellence in Healthcare Communication\n","Cleveland Clinic"],"disclosure":""},{"name":"Stephen L Graziano, MD","credentials":["Professor of Medicine\n","SUNY Upstate Medical University"],"disclosure":""},{"name":"Robert I Haddad, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: BMS; Merck; Astra Zeneca; Celgene [Head and neck cancer clinical trials support to institution (None)]. Consultant/Advisory Boards: BMS; Astra Zeneca; Merck; Pfizer; Eisai [Head and neck cancer clinical trials (None)]."},{"name":"R Donald Harvey, PharmD, FCCP, BCPS, BCOP","credentials":["Assistant Professor of Hematology/Medical Oncology\n","Director of Phase I Program\n","Emory University/Winship Cancer Institute"],"disclosure":""},{"name":"Thomas J Herzog, MD","credentials":["Deputy Director\n","University of Cincinnati Cancer Institute"],"disclosure":"Consultant/Advisory Boards: AstraZeneca; J & J; Roche; Clovis; Tesaro [Ovarian cancer (Olaparib, PLD, bevacizumab, rucaparib, niraparib)]; Genmab [Cervical cancer (Tisotumab)]."},{"name":"Warner K Huh, MD","credentials":["Margaret Cameron Spain Chair in Obstetrics/Gynecology\n","Professor, Division of Gynecologic Oncology\n","Senior Scientist, UAB Comprehensive Cancer Center"],"disclosure":"Consultant/Advisory Boards: Merck [Cervical cytology (HPV vaccines)]; Intuitive Surgical (Robotic Surgery); LICOR (fluorescence imaging); InCellDx (cervical cancer screening)."},{"name":"Gregory P Kalemkerian, MD","credentials":["Professor of Medicine\n","Co-Director, Thoracic Oncology\n","University of Michigan Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Takeda Pharmaceuticals [Lung cancer (pevonedistat)]; Novartis [Lung cancer (Dabrafenib/trametinib)]; Merck [Lung cancer (Pembrolizumab)]; OncoMed Pharmaceuticals [Lung cancer (OMP-59R5)]; Abbvie [Lung Cancer (SC002)]. Consultant/Advisory Boards (spouse): Takeda Pharmaceuticals, BioMed Valley Discoveries, Esperion [drug development and safety analysis]."},{"name":"Sara S Kim, BS, PharmD, BCOP","credentials":["Clinical Oncology Pharmacy Specialist\n","The Mount Sinai Medical Center"],"disclosure":""},{"name":"Jeffrey Kirshner, MD","credentials":["Principal Investigator, HOACNY CCOP\n","Director of Research and Partner \n","Hematology Oncology Associates of Central NY\n","Clinical Associate Professor\n","Department of Medicine\n","Upstate Medical University, Syracuse, NY"],"disclosure":""},{"name":"Laura A Lambert, MD","credentials":["Assistant Professor of Surgery\n","Director of Peritoneal Surface Malignancy Program\n","UMass Memorial Medical Center"],"disclosure":""},{"name":"Robert D Legare, MD","credentials":["Director, Breast Health Center\n","Director, Cancer Risk Assessment and Prevention Program\n","Associate Professor Obstetrics, Gynecology and Medicine\n","Warren Alpert Medical School\n","Brown University"],"disclosure":""},{"name":"Ellis Levine, MD","credentials":["Associate Professor of Medicine\n","State University of New York at Buffalo/Roswell Park Cancer Institute"],"disclosure":""},{"name":"Emily Mackler, PharmD, BCOP","credentials":["Clinical Pharmacist in Hematology/Oncology\n","University of Michigan Hospitals and Health Centers"],"disclosure":"Consultant/Advisory Board: NCCN (neutropenic fever, chemotherapy templates)."},{"name":"Martin A Martino, MD","credentials":["Associate Professor\n","Department of Ob/Gyn\n","Division of Gynecologic Oncology\n","University of South Florida"],"disclosure":"Consultant/Advisory Boards: Medtronic [Gynecologic cancers]; Verb Surgical, Intuitive Surgical, Inc., Tesaro, Inc. [Gynecologic cancers (Educational and patient safety consultant)]."},{"name":"Jacqueline P Masker, PharmD","credentials":["Duke University Hospital"],"disclosure":""},{"name":"Mary S McCabe, RN, MA","credentials":["Clinical Director, Survivorship Center\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":""},{"name":"Carolyn McCourt, MD","credentials":["Assistant Professor\n","Division of Gynecologic Oncology\n","Department of Obstetrics & Gynecology\n","Washington University School of Medicine"],"disclosure":"Speaker's Bureau: Genentech [Ovarian cancer (Bevacizumab)]."},{"name":"Matthew L Meyerson, MD, PhD","credentials":["Professor of Pathology \n","Dana-Farber Cancer Institute and Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Origimed [Cancer diagnosis]. Equity Ownership/Stock Options: Origimed [Cancer diagnosis]."},{"name":"David Mutch, MD","credentials":["Professor and Division Chief, Obstetrics & Gynecology, Gynecologic Oncology\n","Washington University School of Medicine"],"disclosure":"Speaker's Bureau: Clovis Oncology [Ovarian cancer (Rucaparib)]; AstraZeneca [Ovarian cancer (Olaparib)]."},{"name":"Jim Natale, PharmD, BCOP","credentials":["Clinical Pharmacy Specialist\n","UPMC Cancer Centers"],"disclosure":"Speaker's Bureau: Merck [Lung Cancer (Keytruda)]."},{"name":"Larissa Nekhlyudov, MD, MPH","credentials":["Section Editor — Cancer Survivorship\n","Associate Professor\n","Department of Medicine\n","Brigham & Women’s Hospital\n","Harvard Medical School"],"disclosure":""},{"name":"Scott Okuno, MD","credentials":["Professor of Oncology\n","Division of Medical Oncology\n","Mayo Clinic"],"disclosure":"Other Financial Interest: AXIS Medical Education Faculty [Certified educational activities]."},{"name":"Bert H O'Neil, MD","credentials":["The Jackie and Joseph Cusick Professor of Oncology\n","Indiana University Simon Cancer Center"],"disclosure":"Consultant/Advisory Boards: Bayer [GI (regorafenib)]; Genentech [GI (bevacizumab, cobimetinib)]; Amgen [GI tumors (talimogene laherpravec); CRC (panitumumab)]; Merrimack [pancreatic cancer (Nal-IRI)]."},{"name":"David F Penson, MD, MPH","credentials":["Professor of Urologic Surgery\n","Director of Vanderbilt Center for Surgical Quality and Outcomes Research"],"disclosure":"Consultant/Advisory Boards: Astellas; Dendreon, Janssen [Prostate cancer (Enzalutamide, abiraterone, apalutamide, sipuleucel-T)]."},{"name":"Sandro V Porceddu, MD","credentials":["Radiation Oncologist, Princess Alexandra Hospital\n","Associate Professor, University of Queensland"],"disclosure":"Consultant/Advisory Boards: Merck Serono [Head and neck (Cetuximab)]; Merck Sharpe Dome [Head and Neck (Pembrolizumab)]."},{"name":"Daniel Przybysz, MD","credentials":["Radiation Oncology\n","Siteman Cancer Center\n","Washington University in St. Louis"],"disclosure":""},{"name":"David I Quinn, MBBS (Hons I), PhD, FRACP, FACP","credentials":["Associate Professor of Medicine\n","University of Southern California Norris Cancer Center\n","Keck School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Millenium [Renal cell cancer (Tak700)]; Genentech [Renal cell carcinoma (Avastin, atezoluzimab)]; Glaxo Smith Kline/Novartis [Urothelial cancer (Everolimus, zometa, pazopanib)]. Consultant/Advisory Boards: Pfizer [Renal cell carcinoma, prostate cancer (Sunitinib, axitinib, temsirolimus, avelumab, enzalutamide)]; Novartis/GSK [Renal cell carcinoma, prostate (Everolimus, zometa, pazopanib)]; Genentech [Bladder cancer, renal cell carcinoma (Atezoluzimab, bevacuzimab)]; Bayer [Renal cell carcinoma, prostate cancer , urothelial cancer (Radium 223, sorafenib, rogaratinib)]; Dendeon [Prostate cancer (Sipuleucel-T)]; Astellas [Prostate cancer (Enzalutamide)]; BMS [Renal cancer, bladder cancer (Nivolumab, ipilumumab)]; Merck Sharp Dohme [Bladder cancer, renal cancer (Pembroluzimab)]; Exelexis [Renal cell carcinoma (Caboxantinib); Jannsen [Prostate cancer (Abiraterone, apalutamide)]; Sanofi Genzyme [Prostate cancer (Cabazitaxel)]."},{"name":"Valerie Relias, PharmD, BCOP","credentials":["Clinical Pharmacy Specialist\n","Assistant Professor of Medicine\n","Division of Hematology/Oncology\n","Tufts Medical Center"],"disclosure":"Speaker's Bureau:  Genentech [CLL/indolent lymphoma (Obinutuzumab)."},{"name":"Jerome P Richie, MD, FACS","credentials":["Section Editor — Cancer of the Urethra, Penis, and Ureter; Urologic Surgery; Prostate Cancer\n","Elliott Carr Cutler Professor of Surgery\n","Harvard Medical School"],"disclosure":""},{"name":"Tina Rizack, MD, MPH","credentials":["Alpert Medical School of Brown University"],"disclosure":""},{"name":"David I Rosenthal, MD","credentials":["Director\n","Head and Neck Translational Research\n","Professor\n","The University of Texas MD Anderson Cancer Center"],"disclosure":"Grant/Research/Clinical Trail Support: Merck Serono KGA [Head and neck cancer (Cetuximab)]. Consultant/Advisory Boards: Merck Serono KGA [Head and neck cancer (Cetuximab)]."},{"name":"Howard Safran, MD","credentials":["Associate Professor of Medicine\n","Brown University Oncology Group"],"disclosure":""},{"name":"Walter M Stadler, MD, FACP","credentials":["Professor\n","University of Chicago"],"disclosure":"Grant/Research/Clinical Trial Support: Astra-Zeneca [Renal cancer (savolitinib)]; BMS [Renal cancer (Nivolumab)]; Boehringer-Ingelheim [Bladder (Afatanib)]; Dendreon [Prostate cancer (Sipuleucel-T, investigational bladder cancer drug)]; Exilixis [Renal cancer (Cabozantinib)]; Novartis [Renal cancer (Pazopanib; everolimus)]; Genentech [Bladder cancer (Atezolizumab)]; Jansen [Prostate cancer (Abiraterone)]; Johnson & Johnson [Bladder cancer (Investigational FGFR inhib)]; Merck [Bladder cancer (Pembrolizumab)]; Millenium [Prostate cancer (Enzalutamide)]; Pfizer [Renal cancer (Sunitinib; axitinib)]. Speaker's Bureau: CME innovations; CME Network; Dava Oncology, Research-to-Practice; Medical Communications Media [Bladder, kidney, prostate cancer CME (Standard of care drugs)]. Consultant/Advisory Boards: Astra-Zeneca [Bladder cancer (DSMB)]; Caremark/CVS [formulary advice]; Bristol-Myers-Squibb [Renal Cancer (Immunotherapy development)]; Bayer [Prostate Cancer (DSMB)]; Genentech [Bladder cancer (atezolizumab development)]; Sotio [Prostate cancer (DSMB chair for novel immunotherapy)]; Pfizer [Renal cancer (Utilization of sunitinib and axitinib)]."},{"name":"Ashley Stuckey, MD","credentials":["Program in Women’s Oncology\n","Gynecologic Oncology and Breast Surgery\n","Women & Infants’ Hospital of Rhode Island\n","Assistant Professor of Obstetrics & Gynecology \n","The Warren Alpert Medical School of Brown University"],"disclosure":""},{"name":"Stephanie D Sutphin, PharmD, BCOP","credentials":["Hematology/Oncology Pharmacy Specialist\n","University of Kentucky HealthCare\n","Adjunct Assistant Professor\n","College of Pharmacy"],"disclosure":"Consultant/Advisory Board: Seattle Genetics [Hodgkins (Brentuximab)], Amgen [Biosimilars (Neupogen, Neulasta)]."},{"name":"William D Tap, MD","credentials":["Section Chief, Sarcoma Oncology\n","Memorial Sloan Kettering Cancer Center"],"disclosure":"Consultant/Advisory Boards: Blueprint Medicines [Sarcoma (BLU-285)]; Daiichi Sankyo [Sarcoma (Pexidartinib)]; Eisai [Sarcoma (Eribulin)]; Eli Lilly [Sarcoma (Olaratumab, Abemaciclib, Ly1309478)]; EMD Serono [Sarcoma (Exofosfamide)]; Plexxikon [Sarcoma (PLX9486)]; Novartis [Sarcoma (Votrient)]; Janssen [Sarcoma (Trabectadin)], Immune Design (CMB305)]."},{"name":"Premal H Thaker, MD","credentials":["Assistant Professor in Gynecologic Oncology\n","Washington University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Merck [Uterine Cancer (Pembrolizumab)]. Speaker’s Bureau: Zoll[Sudden cardiac death (Life vest);Aralez Pharmaceuticals (yosprala)]. Consultant/Advisory Boards: Celsion [Ovarian Cancer (GEN-1 immunotherapy)]."},{"name":"Evan Tong, PharmD","credentials":["Duke University Hospital"],"disclosure":""},{"name":"Tiffany Traina, MD","credentials":["Assistant Attending Physician\n","Breast Cancer Medicine Service\n","Assistant Professor in Medicine \n","Weill Cornell Medical College of Cornell University"],"disclosure":"Grant/Research/Clinical Trial Support: Medivation [Breast cancer (Enzalutamide)]; Eisai [Breast cancer (Eribulin)]; Pfizer [Breast cancer (Palbociclib, enzalutamide)]; Myriad Genetics [Breast cancer (HRD assays)]; Innocrin Pharma [Breast cancer (Seviteronel)]; AstraZeneca [Breast cancer (Bicalutamide, olaparib)]; Astellas Pharma [Breast cancer (Enzalutamide)]; Lilly [Breast cancer (Notch inhibitor)]. Speaker's Bureau: Genentech/Roche [Breast cancer (Pertuzumab, TDM1)]; Eisai [Breast cancer (Eribulin)]; Medivation [Breast cancer (Enzalutamide)]; Pfizer [Breast cancer (Palbociclib, enzalutamide)]; AstraZeneca [Breast cancer (Olaparib, bicalutamide)]; Bayer [Breast cancer (IMMU132)]; Immunomedics [Breast cancer (IMMU132)]; Merck [Breast cancer (Pembrolizumab)]; Astellas Pharma [Breast cancer (Enzalutamide)]; Puma Biotechnology [Breast cancer (Neratinib)]; Advaxis [Breast cancer]; Celgene [Breast cancer (nab-paclitaxel)]; Innocrin Pharma [Breast cancer (Seviteronel)]; Genomic Health [Breast cancer (OncotypeDx)]."},{"name":"Nicholas Vogelzang, MD","credentials":["Section Editor — Prostate Cancer\n","Professor of Medicine\n","University of Nevada School of Medicine\n","US Oncology Research"],"disclosure":"Speaker's Bureau: Pfizer [Kidney cancer (Sunitinib, axitinib)]; Bayer [Prostate cancer (Radium 223)]; Novartis [Kidney cancer, PNET (Pazopanib, everolimus); Sanofi [Prostate cancer (Cabazitaxel)], BMS [Kidney cancer (BMS-nivolumab)]; Genentech/Roche [Bladder cancer (Atezolizumab); Astra Zeneca {Bladder cancer (durvalumab)]. Consultant/Advisory Boards: Amgen [Prostate cancer (Denosumab)]; Bayer [Prostate cancer (Radium 223)]; Pfizer [Kidney cancer (Sunitinib, axitinib)]; Novartis [Kidney cancer, PNET (Pazopanib, everolimus)]; Sanofi [Prostate cancer (cabazitaxel)]; BMS [Kidney cancer (BMS-nivolumab)]; Genentech/Roche (Bladder cancer (Atezolizumab)]; Astra Zeneca {Bladder cancer (durvalumab)]   Exelexis [Kidney cancer (Cabozantinib)];  Clinical Care Options, Cerulean [Kidney cancer (Liposomal irinotecan)]; Dava Oncology/PER; Dendreon; Medivation/Astellas [Prostate (Enzalutamide)], Janssen [Prostate cancer (Abiraterone,apalutamide)]; Heron [Nausea control (Liposomal granisetron)]; Eisai [Kidney cancer (Levantinib)]; Agensys [Kidney cancer (New targeted agent)]; Boehringer Ingelheim [Mesothelioma (Nerantinib)]. Employment: US Oncology [GU research (none)].  Equity Ownership/Stock Options: Caris [Genetic testing for cancer (none)]."},{"name":"Ageliki G Vouyouka, MD, FACS","credentials":["Associate Professor in Surgery \n","Associate Professor in Radiology\n","Mt Sinai Medical Center/ Icahn School of Medicine"],"disclosure":""},{"name":"Antonio C Wolff, MD, FACP","credentials":["Professor of Oncology\n","The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins"],"disclosure":"Grant/Research/Clinical Trial Support: Myriad [Breast cancer (HRD assay)]. Patent Holder: cMethDNA [Breast cancer (Breast cancer methylation)]."},{"name":"Jason D Wright, MD","credentials":["Sol Goldman Associate Professor of Obstetrics and Gynecology \n","Chief, Division of Gynecologic Oncology \n","Columbia University College of Physicians and Surgeons"],"disclosure":"Consultant/Advisory Boards: Tesaro [Gynecologic cancer (Drug development)]; Clovis Oncology [Gynecologic cancer (Drug development)]."}]}]}